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I Abstract 
Biotin-dependent carboxylases are ubiquitous enzymes that play pivotal roles in 
key biosynthetic pathways. They employ a mobile biotin carboxyl carrier protein 
(BCCP) to catalyze ATP-dependent two-step carboxylation reactions utilizing two 
distinct enzyme activities, biotin carboxylase (BC) and carboxyl transferase (CT). 
Their substrate specificity is either towards small organic molecules, such as 
urea and pyruvate, or towards acyl-Coenzyme A (acyl-CoA) esters. 
One of the most prominent members of acyl-CoA carboxylases, acetyl-CoA 
carboxylase (ACC), catalyzes the conversion of acetyl-CoA to malonyl-CoA, the 
highly regulated committed step of fatty acid biosynthesis. Eukaryotic ACC is a 
giant multienzyme, encompassing all catalytic domains, the BCCP and a large 
non-catalytic central domain (CD) on one type of polypeptide chain. The overall 
structure of eukaryotic ACCs as well as the structure of the CD, which is unique 
to eukaryotic ACCs, and its role in ACC regulation, remain unknown. 
This thesis provides a comprehensive characterization of the dynamic structure 
of fungal ACC by combining crystal structure determination, small-angle X-ray 
scattering (SAXS) and electron microscopy (EM). The crystal structure of yeast 
CD, accompanied by low-resolution data on larger fragments up to intact fungal 
ACCs, reveals that the CD acts as a multi-hinged link between the BC and CT 
domains. Phosphorylation has an impact on the dynamic architecture resulting in 
a unique “mechanical” control mechanism. 
A novel class of prokaryotic multi-domain acyl-CoA carboxylases (YCCs) was 
discovered recently. They share the same domain organization with eukaryotic 
ACCs, but lack the CD. A hybrid model of the Deinococcus radiodurans YCC  
(Dra YCC), together with quantitative analysis of BC domain mobility, provides 
novel insights into active site structure, domain interactions and dynamic 
assembly of these prokaryotic multienzymes. The implications of our structural 
studies of yeast ACC and Dra YCC for multienzyme engineering are discussed.  
In addition, the crystal structure and NMR analyses of the membrane-bound, 
dimeric bacterial extracellular foldase PrsA reveal a bowl-like crevice as the key 
structural element for binding and folding of unfolded proteins.   
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1.1! Proteins, enzymes and metabolic pathways 
Proteins account for one of the three cornerstones of the central dogma of 
molecular biology, which states that the genetic code is first transcribed into RNA 
and subsequently translated into proteins. Proteins are large macromolecules 
consisting of single or multiple long linear chains of amino acid residues. In all 
organisms, proteins are the main workers and responsible for diverse cellular 
functions such as catalyzing metabolic reactions, DNA replication and 
transcription, cellular trafficking, signal transduction and the maintenance of 
structural integrity. To achieve these tasks, they can, amongst other things, bind 
with varying affinity to other proteins, to ribonucleic acids and to small molecules, 
they can sense electric current and potential, and they can form cavities and 
pores1.  
Enzymes are proteins that act as molecular biocatalysts. They are required to 
accelerate chemical reactions in cells to rates fast enough to sustain life. This is 
achieved by reducing the activation energy of the reaction so it can take place at 
ambient temperatures. The ability to lower the activation energy is based on their 
three-dimensional fold that is encoded in the gene sequence itself. Enzymes are 
involved in almost all metabolic processes and in their entirety catalyze more 
than 5000 reaction types in all organisms2. They are specialized molecular 
machines that are highly specific to their cellular task and they can be regulated 
by diverse factors, leading to inhibition or activation1. 
The biosynthesis and degradation of complex metabolites cannot be achieved by 
catalysis of one single reaction but requires several sequential chemical reactions 
in a row, where the product of one reaction is the substrate for the next. This 
series of reactions is called a metabolic pathway and all the sequential reactions 
are catalyzed by enzymes, transforming the initial metabolite into the product. In 
compartmented eukaryotic cells metabolic pathways are located in all 
compartments and some pathways are distributed between compartments.  
Metabolic pathways may be categorized into two classes3: First, those that 
produce intermediates that can also be used in other pathways, as for example 
glycolysis, the sequential breakdown of sugars into pyruvate. The intermediate 
1 Introduction  
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glucose-6-phosphate can also branch off and enter the pentose phosphate 
pathway or it can be converted to glycogen for storage. Second, pathways in 
which only the end products are of relevant biological function. A simple example 
for a pathway where the intermediates cannot be used is protein translation, 
since the only function of the intermediate is to become a protein. Many 
metabolic pathways are connected via their substrates and products (and as 
explained sometimes also their intermediates) and this flexible network can be 
tightly regulated and adapted to the environmental needs of a cell or organism. 
Through this tight regulation they ensure homeostasis within an organism. 
Metabolic pathways are normally mono-directional, one famous exception being 
again the glycolysis, where the direction of the pathway can be reversed and 
then be used to produce glucose from non-carbohydrate substrates such as 
pyruvate, glycerol or lactate.  
In prokaryotes, the series of enzymes responsible for catalyzing all the steps in a 
pathway are often encoded in the same operon. The use of operons allows 
translation of polycistronic mRNAs which ensures a fixed stoichiometry of the 
respective enzymes4. Before and after every reaction in the active sites of the 
involved enzymes, the intermediate substrates need to diffuse from one protein 
to the next (Figure 1.1). However, free diffusion of reaction intermediates allows 
no control over efficiency and selectivity and the intermediates are in equilibrium 
with the bulk solvent. In addition, reaction intermediates can be highly reactive, 
unstable or insoluble, and may require specific support or shielding from the 
environment. In several metabolic pathways, small helper proteins are employed, 
which bind to the reaction intermediates, increase the efficiency and selectivity 
and provide protection4. 
 
 
Figure 1.1!Proteins involved in metabolic pathways are organized in operons.  
Schematic representation of the genome organization and the catalytic action of isolated 
enzymes involved in a multi-step reaction. 
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1.2! Carrier proteins shuttle and protect reaction 
intermediates 
These small, so-called carrier proteins consist of only approximately 60 to 80 
amino acids. Bound to carrier proteins, the selectivity and affinity of an 
intermediate towards the next active site in the pathway can be increased5 and, 
according to the ‘hot potato’ hypothesis6, unstable intermediates are sheltered 
on their reaction path and protected from aggregation. Binding to the carrier 
protein occurs via a prosthetic group that is attached to a conserved residue in 
the carrier protein (Figure 1.2A). 
One prime example of a small carrier protein is the acyl carrier proteins (ACP, 
Figure 1.2B) involved in fatty acid biosynthesis, which consist of a four-helix 
bundle with a hydrophobic core. ACP is functionalized post-translationally with a 
4-phosphopantheteine, derived from coenzyme A (CoA), at a conserved serine 
residue by the action of a dedicated phosphopantetheine transferase, the holo-
acyl carrier protein synthase. During fatty acid biosynthesis, the growing fatty 
acid is covalently bound to the phosphopantetheine arm of ACP and, in E. coli, it 
was shown that the fatty acid chain is accommodated in the hydrophobic core as 
fatty acids are usually insoluble in an aqueous environment7. ACP shuttles the 
reaction intermediate between the active sites of the different enzymes working 
on it to produce a fully reduced fatty acid. 
Peptidyl carrier proteins (PCPs, Figure 1.2B) are structurally similar to ACPs and 
are functionalized in the same way, by attachment of a phosphopantetheine 
moiety to a conserved serine. Analogous to ACP, PCPs are shuttling growing 
peptides in non-ribosomal peptide synthesis. 
The lipoyl domain (Figure 1.2B), another carrier protein, consists of two small 
four-stranded !-sheets. It was originally discovered as a product of limited 
proteolysis of the E2-component of the pyruvate dehydrogenase complex8,9 
(PDC, see below). In the lipoyl domain, the N- and C-termini are located close 
together on one side and a highly conserved lysine resides in a loop on the other 
side of the protein. The lysine is post-translationally modified with its prosthetic 
group, lipoic acid, by a lipoate protein ligase. During pyruvate decarboxylation, it 
is responsible for the shuttling of an acyl group between different active sites. 
Biotin carboxyl carrier protein (BCCP, Figure 1.2B) is structurally related to the 
lipoyl domain, consisting of a !-sandwich with quasi two-fold symmetry. As in 
the lipoyl domain, the N- and C-termini are on the opposing sites of the 
1 Introduction  
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conserved lysine that is covalently modified with biotin by a biotin ligase. BCCP 
is capable of shuttling a CO2 group bound to its N1’ nitrogen atom of the 
attached biotin and is utilized by carboxylases, decarboxylases and during 
transcarboxylation reactions10, where it transfers the CO2 moiety between two 
active sites. 
Increasing selectivity of chemical reactions and sheltering of intermediates may 




Figure 1.2!Overview of different cofactors and carrier proteins.  
A. Chemical structure of the cofactors lipoic acid, phosphopantetheine and biotin.  
B. (from left to right) Crystal structure of FAS ACP from Escherichia coli (pdb: 2FAE). 
NMR solution structure of PCP (pdb: 2GDW) of the NRPS tyrocidine A synthetase from 
Brevibacillus parabrevis. NMR solution structure of Homo sapiens lipoyl domain from 2-
oxoacid dehydrogenase. Crystal structure of Pyrococcus horikoshii BCCP (pdb: 2EVB) 
from a putative methylmalonyl-CoA decarboxylase. The functionalized residues are 
shown as sticks and marked with a circle and the hydrophobic core of ACP is labeled. 
Structural similarities between ACP and PCP and the lipoyl domain and BCCP, 
respectively, can be observed. 
1.3! Integration of enzymatic functions into larger 
assemblies 
The cell is a crowded environment1, and as outlined before, some reaction 
intermediates need to be protected or shuttled and carrier proteins are one 
possibility to achieve this task. Additionally, relying only on diffusion may not 
always be efficient enough. Multi-subunit enzymes and multienzymes are 
1 Introduction 
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nature’s way to increase the efficiency of catalyzed multi-step reactions where 
labile substrates are protected and either shuttled or channeled from one active 
site to the next. 
1.3.1! Multi-subunit enzymes 
Multi-subunit enzymes are ubiquitous and can be defined as ‘non-covalent 
aggregates of protein subunits that catalyze successive steps of a multistep 
chemical reaction’8. Multiple enzymes are assembled into larger protein 
complexes held together by non-covalent interactions. Through the proximity of 
the individual proteins, only limited diffusion is required for the reaction 
intermediates in order to travel from one enzyme to the next, leading to increased 
speed and selectivity11. Metabolites can be ‘channeled’ between juxtaposed 
enzymes. Channeling was originally defined as the situation, when several 
sequential enzymatic reactions are performed on a substrate where the 
intermediates are out of the diffusion equilibrium compared to the same 
molecules in the solvent3. Direct interactions between sequential proteins also 
generate additional potential for allosteric regulation.  
Depending on the lifetime of the protein-protein interaction, multi-subunit 
enzymes can be classified as transient or permanent12 (Figure 1.3A). A transient 
complex associates and dissociates in vivo and is in a dynamic oligomeric 
equilibrium in solution with interactions forming and breaking continuously. The 
components of such transient complexes are initially not colocalized and thus 
require to be stable on their own, but the selectivity for the right partner has to be 
high. The equilibrium of dissociated and associated proteins can also be shifted 
by molecular triggers, such as a substrate binding. Transient interactions often 
occur in signal transduction pathways. For example, a heterotrimeric G-protein 
dissociates upon binding of guanosin triphosphate (GTP) into G" and G!#, but is 
a stable heterotrimer when guanosin diphosphate (GDP) is bound. A further 
example for a transient multi-subunit enzyme, E. coli acetyl-CoA carboxylase 
(ACC), is discussed below. Ultimately, the interactions between subunits are 
driven by the localization and concentration of the individual subunits and the 
free energy of the complex, relative to the individual proteins. The interaction 
properties can thus be regulated by increasing or decreasing the local 
concentration of a subunit, by altering the localization or also by perturbing the 
1 Introduction  
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binding affinity. The affinity of a protein to another can be altered by binding of 
effectors like adenosine triphosphate or a change in physiological conditions. 
In a permanent complex the protomers forming the complex cannot be observed 
as stable isolated structures in vivo. (Figure 1.3A) The protomers are often 
expressed simultaneously, for example under the control of the same promoter, 
facilitating colocalization. The protein interfaces are, in contrast to interaction 
areas in transient complexes, highly conserved. Examples for permanent 
complexes include the pyruvate dehydrogenase complex and various 
carboxylases and will be described in more detail in a later section. 
 
 
Figure 1.3 Difference between multi-subunit enzymes and multienzymes.  
A. Schematic representation of the same reaction as in Figure 1, but catalyzed by a multi-
subunit enzyme. In a permanent complex the individual enzymes are not stable in 
solution, in a transient complex one or all enzymes may dissociate from the complex.  
B. Schematic representation of the same reaction catalyzed by a multienzyme protein. In 
all cases, individual protein or subcomplexes can also oligomerize. 
1.3.2! Multienzymes 
In multienzymes, or multi-domain enzymes, several enzymatic components 
(domains) are encoded on a single polypeptide, as opposed to multi-subunit 
enzymes, where several catalytically active polypeptide chains assemble into one 
complex (Figure 1.3B). Multienzymes have often evolved by gene-fusion of 
separate multi-subunit ancestor proteins and occur more frequently in 
eukaryotes13. The single domains of such multienzymes show characteristics and 
properties of isolated enzymes and can sometimes be excised from the complex 
without loss of function. In other cases, domains are not active on their own 
without the interaction to their respective partner domains. 
1 Introduction 
 17 
Multienzymes have the same advantages as multi-subunit enzymes, namely the 
potential to channel and protect metabolites, and the increased possibility for 
allosteric regulation. In addition, having several domains on one polypeptide 
helps to ensure a fixed stoichiometric ratio in eukaryotes and coordinated 
regulation of expression. It also raises the possibility to accompany the catalytic 
domains by additional non-catalytic domains or extended linker regions. These 
additional domains may be used for structural purposes like providing a scaffold 
for the correct positioning of domains or to provide reaction cavities that are 
shielded from the cytoplasm. Additional non-catalytic domains can also have 
regulatory purposes, by providing docking platforms for effector molecules and 
proteins or by harboring sites for post-translational modification. 
Higher eukaryotic multienzymes often have simpler, independent analogues in 
prokaryotes, which can be exemplified by the enzyme CAD (a combination of the 
domain names: CPSase, ATCase and Dihydrooratase) that is involved in the de 
novo biosynthesis of pyrimidines. The first three enzymatic activities in this 
metabolic pathway are a glutamine-dependent carbamoyl phosphate synthase 
(CPSase), aspartate transcarbamoylase (ATCase) and dihydrooratase (D). In 
higher eukaryotes, these three enzyme entities are fused into one polypeptide 
chain with a molecular weight of 243 kDa while the three enzymes are 
independent in prokaryotes. In fungi, on the other hand, CPSase and ATCase 
enzymes are fused, but the dihydrooratase is encoded on a separate 
polypeptide14. 
Between the two mentioned extremes, multi-subunit enzymes and multienzymes, 
there are also intermediate assemblies, where some enzymatic domains are 
fused on a single polypeptide, that then interacts (in a stable or transient fashion) 
with additional proteins, for example the fungal fatty acid synthase multienzyme 
complex (discussed below).  
In the following, multi-subunit enzyme and multienzyme refer to their strict 
definitions, as outlined above, while the terms ‘enzyme complex’ may be used for 
both cases. ‘Multi-domain enzyme’ will be used synonymously with 
‘multienzyme’. The use of ‘multienzyme complex’ refers to an assembly of 
several distinct polypeptide chains where at least one of them carries more than 
one catalytic domain. 
1 Introduction  
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1.4! Carrier proteins in multienzymes 
In order to ensure highly efficient shuttling of reactive or unstable intermediates, 
some multienzyme families also employ carrier proteins. These are essential for 
the proper function of a multienzyme by shuttling of the intermediate substrates 
without the risk of loss and protected from the influence of competing enzymes.  
Before entering a more detailed description of different carrier protein-dependent 
multi-domain enzymes and multienzymes, some general consideration about 
flexibly tethered carrier proteins are outlined. 
1.4.1! Tethering of carrier proteins provides mobility and restrictions 
The prosthetic group of a carrier protein, together with the amino acid residue it 
is bound to, can be regarded as a swinging arm, and using simple geometry it 
can be calculated how far the ‘business end’ of the arm can travel when the 
domain itself is held in fix position. This consideration becomes important when 
the carrier protein is fused into a larger polypeptide and is tethered to this 
complex on at least one side. If the carrier protein is stably incorporated into the 
quaternary complex, the active sites that require to be served by the carrier 
protein have to be separated not farther than the distance the swinging arm can 
travel. Lipoic acid and biotin, bound to lysine, account for a swinging arm of 
about 16 $, while the phosphopantetheine arm spans approximately 20 $. 
If, however, rotation of the domain around its anchor point(s) is accounted for, 
this maximal distance would increase approximately by the diameter of the 
domain. During the catalysis of multi-step reactions, this would lead to 
architectures where the carrier protein resides approximately in the middle of the 
complex, while the active sites are located around it15. In the examples provided 
below it becomes evident, that distances between active sites in multienzymes 
are often exceeding the maximum distance that could be spanned by the 
swinging arm of a carrier domain. This leads to the conclusion that the entire 
domain has to move in order to accomplish its task, which has been termed 
‘swinging domain model’4. 
The length of the polypeptide linkers connecting the carrier domains to the 
multienzymes is defining the maximum range of movement and by this restrains 
their diffusion so they only reach the active sites that they are targeting. The 
linkers, however, should not be considered as simple molecular strings 8, as they 
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can be rich in alanines, prolines and glycines. 13C-NMR spectra of such linkers 
demonstrate that all of the Ala-Pro bonds (>95%) are in the all-trans 
conformation, indicating a stiffening of these regions as compared to random-
coil structures, for which about 80-85% all-trans would be expected16,17. 95% all-
trans correspond to an extended structure that allows substantial movement but 
also prevents entangling of the linker chains18,19. The length of these linkers is 
typically around 10-20 amino acid residues, which could span a maximal 
distance of approximately 30 to 60 $ in their most extended form, adding to the 
distance that the swinging arm can travel.  
1.4.2! Lipoic acid-dependent enzymes 
The lipoyl domain carrier protein is used in multienzymes responsible for the 
oxidative decarboxylation of 2-oxo acids, exemplified by the pyruvate 
dehydrogenase complex (PDC)20,21. PDC consists of 3 subunits (E1, E2 and E3) 
and catalyzes the conversion of pyruvate into acetyl-CoA, which then enters the 
citric acid cycle in mitochondria, and one to three lipoyl domains are tethered to 
E2. The first enzyme in this complex (E1) is a thiamine diphosphate-dependent 
decarboxylase that catalyzes the decarboxylation of pyruvate and acylates the 
lipoyl group. E2 also harbors a dihydrolipoyl acetyltransferase that catalyzes the 
transfer of the acyl group from the lipoyl domain to CoA, yielding acetyl-CoA. The 
reduced lipoyl group is then regenerated at the active site of E3, a dihydrolipoyl 
dehydrogenase. During this process the lipoyl domain shuttles between the 
active sites (Figure 1.4A).  
E2 is the core protein and assembles either in octahedral (24-mer, Gram-negative 
bacteria) or in icosahedral (60-mer, Gram-positive bacteria and eukaryotes) 
symmetry. In addition, it contains a small binding domain responsible for binding 
to E3, and in some organisms also to E122. Up to twelve E3 subunits and up to 24 
copies of E1 can bind tightly but non-covalent, via linker domains, to the 
octahedral core22. To the icosahedral core up to 60 E1 or E3 subunits can bind. 
The bound E1 and E3 subunits can adopt a variety of conformations and span a 
maximum range of motion of approximately 150 $20. In eukaryotes, an additional 
protein, E3BP, binds to the core, and further proteins, such as specific kinases 
and phosphatases involved in regulation, may also bind. The whole complex can 
reach a molecular weight of up to 10 MDa, including a large number of carrier 
proteins shuttling between the core and the peripheral enzymes.  
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1.4.3! Phosphopantetheine-dependent enzymes 
Phosphopantetheine-dependent enzymes include fatty acid synthase (FAS), 
polyketide synthase (PKS) and non-ribosomal peptide synthase (NRPS). 4’-
phosphopantheteine is bound covalently to a conserved serine residue in the acyl 
carrier protein23 (ACP, in the case of FAS and PKS) or the homologous peptide 
carrier protein24 (PCP, in NRPS). FAS is responsible for the biosynthesis of long-
chain fatty acids1. In E. coli, this is orchestrated by a series of individual enzymes, 
but in many other organisms the enzymes have been incorporated into 
multienzymes. FAS works iteratively19, meaning that the domains are reused in a 
circular fashion, increasing the size of the fully reduced growing fatty acid by two 
carbons in each round. It uses acetyl-CoA as starting molecule and malonyl-CoA 
for the subsequent elongation steps. The growing fatty acid is bound to ACP, 
which shuttles it throughout this whole process from one domain to the next, 
until it is released at the very end of the synthetic process.  
Fungal FAS is a barrel-shaped 2.6 MDa "6!6 hetero-dodecamer with two large 
reaction chambers, where the different enzymatic components are divided onto 
two polypeptide chains. ACP is tethered flexibly on two sides in the center of the 
formed cavity. Due to the hetero-dodecameric assembly, there are three ACPs in 
the upper reaction chamber and three in the lower. The linkers, N-terminally 
stiffened through a high content in alanine and proline to reduce entanglement, 
limit the free diffusion of ACP to the closest set of active sites, that are all facing 
the inside of the barrel. The distance covered between the linker attachment 
point and the sulfhydryl group of the phosphopantetheine arm is approximately 
55 $, while the distance between active sites range from 60 to 80 $25. These 
distances could be covered by little translation and a rotation of ACP using the 
linker attachment sites as a pivot point. However, it is currently unclear how 
exactly substrate shuttling is achieved. 
Mammalian FAS is an X-shaped homodimeric protein with all the seven proteins 
fused into a single polypeptide chain including the carrier protein ACP (Figure 
1.4B). ACP can be considered to be tethered on one side only, since the linker to 
the following highly mobile C-terminal thioesterase domain is extensive (25 amino 
acids). In the X-shaped homodimer, all active sites are lining the reaction clefts 
with inter-domain distances of up to 85 $, too large to be explained by a 
swinging-arm model of the phosphopantetheine. Therefore, large domain 
movements are required for proper function of the multienzyme25,26. In addition to 
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the movement of ACP, FAS is highly flexible, with the upper and the lower part 
only connected by two short polypeptide linkers. The reaction clefts can open 
and close and the upper part of the molecule can rotate and shift relative to the 
lower part26,27. In contrast to ACPs from prokaryotes, animal ACP does not bury 
the growing acyl chain in its core28. 
 
 
Figure 1.4 PDC and FAS, enzyme complexes involved in metabolic pathways.  
A. Simplified schematic depiction of the reaction catalyzed by PDC. The transfer of an 
acyl group by the lipoyl domain is shown. The enzymes are labeled as described in the 
main text. ThDP: thiamine pyrophosphate, Lip: lipoyl domain, CoA: Coenzyme A.  
B. Crystal structure of the mammalian FAS (pdb: 2VZ8) as a paradigm of multienzyme 
organization. Different domains of this dimeric protein are colored in different colors. 
 
PKS and FAS are related enzymes, consisting of the same core domains and 
using similar building blocks. While FAS exclusively synthesize fully reduced fatty 
acids, PKS have a wide variety of products, producing secondary metabolites, 
such as anti-cancer agents, immunosuppressants and antibiotics29-31. Like FAS in 
E. coli, all enzymes can be encoded by single genes and work as isolated 
proteins, or they can be joined in multi-functional polypeptides8. Iterative PKS 
work similar to FAS, but they may be arranged in a different order or specific 
domains may be doubled or left out. Modular PKS, on the other hand, utilize 
every domain only once, and in order to catalyze a complex multi-step reaction, 
many enzymes are required. These enzymes are organized in so-called modules, 
where every module consists of several domains and is responsible for a certain 
modification step in the biosynthesis pathway. Every module has an independent 
ACP, which is determined to shuttle the growing polyketide within its own 
module and to hand it over to the next module. The individual modules are 
organized in a beads-on-a-string fashion, resembling an assembly line, and there 
is clear colinearity between the genetic context of the domains and the synthesis 
of the product, e.g. the first domains that are translated are also the first to 
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engage a substrate. The product structure is thus directly encoded in the 
modular arrangement of the coding gene. 
NRPS are responsible for a the biosynthesis of a diverse set of peptide 
secondary metabolites, such as toxins, siderophores, pigments, antibiotics or 
immunosuppressants32. This large variety of non-ribosomal peptides (NRP) is 
achieved by the consecutive condensation of amino acids in an mRNA-
independent manner in a process that is not limited to the 20 proteinogenic 
amino acids. NRPS are large modular multienzymes, and every single 
condensation step is catalyzed by a distinct set of domains, again organized in 
modules. Following the reactions scheme established for FAS and PKS, the 
growing substrate is bound to the phosphopantetheine arm of PCP and shuttled 
from one module to the next, where it is handed over to the next carrier protein. 
As for PKS, depending on the domain composition of the module and the 
elongation substrate, different modifications take place. NRPS mostly occur in 
bacteria and fungi, and they can be multi-subunit complexes translated from 
operons or multienzyme complexes33. 
1.4.4! Biotin-dependent enzymes 
Biotin is used as cofactor in three different types of enzymatic reactions: First, in 
the ATP-dependent carboxylation of small organic substrates by biotin-
dependent carboxylases34. Second, in the decarboxylation of !-keto acids and 
their thioesters by biotin-dependent decarboxylases and, third, in the 
interconversion of oxaloacetate and propionyl-CoA into pyruvate and 
methylmalonyl-CoA, respectively, by transcarboxylase10. Biotin-dependent 
carboxylases are described in detail in later sections of this thesis. 
1.5! Multienzymes as tools for synthetic biology and 
combinatorial biosynthesis 
Polyketides offer a large biological and industrial potential, especially in the 
advent of the antibiotic crisis, with more and more bacteria developing resistance 
to available antibiotics. Blockbuster drugs like the antibiotics Zithromax and 
Biaxin and the immunosuppressants Rapamycin and Prograf sale for billions of 
dollars. These compounds are all complex polyketides, produced by modular 
PKS. Most naturally produced polyketides, however, are not working as drugs, 
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since they did not evolve to be active in human bodies. Additionally, the 
discovery of new compounds is a difficult and laborious task, which involves 
cultivation of soil-living bacteria and the chances of discovering a new antibiotic 
class are very small35. There is a need to not only discover new compounds, but 
also to modify them in order to, for example, increase their bioavailabilty36. Nature 
manages, however, to produce and modify compounds in large numbers, 
starting from simple precursors, utilizing the modular nature of PKS and NRPS.  
In an approach called ‘combinatorial biosynthesis’, modular multienzymes, such 
as PKS and NRPS, are ideal templates for synthetic assembly lines, as they can 
catalyze the complicated multi-step synthesis of important biological compounds 
that are difficult to produce chemically in a lab37. Since the structure of the 
product is encoded in the genetic context, swapping of single domains on the 
gene level allows researchers to alter the outcome of the reaction and thus the 
nature of the produced compound38,39. Applying this technique on 6-
deoxyerythronolide B synthase (DEBS), a PKS responsible for the synthesis of 
the antibiotic erythromycin, researchers were able to produce over 50 new 
unnatural compounds40. Engineering of PKS by point mutations and random 
mutagenesis has also been reported41.  
In order to construct new synthetic pathways, a large basis of structural and 
biochemical knowledge of natural multienzymes is desirable. Often single 
domains and parts of multienzymes are well characterized. However, the overall 
architecture of full-length enzymes including the position of flexible linkers, 
arrangement of docking and linking domains, domain interactions, substrate 
shuttling and regulation mechanisms lack proper characterization. Without these 
information and without the possibility to rely on structural data, the task of 
designing new synthetic enzymes becomes very difficult.  
Biotin-dependent carboxylases are another example for carrier protein-
dependent enzyme complexes, where individual parts are well studied but 
information on overall dynamic assembly modes, at least for the most prominent 
members, is sparse. 
1.6! Biotin-dependent carboxylases 
Biotin-dependent carboxylases were discovered more than 50 years ago and 
their biochemical properties and biological roles have been studied extensively. 
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They are widely distributed in all domains of life and they play pivotal roles in the 
metabolism of fatty acids, amino acids and carbohydrates42-45. In some 
microorganisms they are implicated with CO2 fixation46,47, methanol assimilation48, 
acetyl-CoA assimilation49-51, 3-hydroxypropionate assimilation52, polyketide 
biosynthesis53, utilization of urea as nitrogen source54,55, metabolism of 
terpenoids56 and mycolic acid and methyl-branched fatty acid biosynthesis55. 
 
 
Figure 1.5 Mechanism and substrates of biotin-dependent carboxylases.  
A. Schematic reaction scheme employed by biotin-dependent carboxylases. Biotin is 
covalently bound to BCCP (gray), which, after carboxylation in the active site of BC 
(ruby), shuttles carboxybiotin to the active site of CT (blue) for carboxyl transfer onto the 
substrate (R). Biotin and BCCP translocations are indicated by arrows and important 
distances are marked. B. Different substrates of biotin-dependent carboxylases. The site 
of carboxylation is marked by a red arrow. C. Chemical structure of CoA. 
 
The reaction catalyzed by biotin-dependent carboxylases occurs in two half-
reactions at two different enzymatic domains (Figure 1.5A): The biotin 
carboxylase (BC) component utilizes bicarbonate as CO2-donor for ATP-
dependent carboxylation of the N1’ atom of a biotin cofactor that is covalently 
bound to a conserved lysine in the biotin carboxyl carrier protein (BCCP). 
Subsequently, the carboxybiotin is shuttled to the carboxyl transferase (CT) 
component where the CO2 is transferred to an acceptor molecule. The acceptor 
(or substrate) is often a CoA-ester of organic acids and the site of carboxylation 
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is either the "-carbon or the #-carbon. In addition, small compounds, such as 
pyruvate or urea, can serve directly as substrates34. During the reaction, biotin 
must visit the active sites of both BC and CT. Recent structures of full-length 
carboxylases demonstrate that the distance between active sites is in the range 
between 55 and 85 $57-61. Based on a ‘swinging arm’ hypothesis4 with limited 
rotation of BCCP, biotin could translate only by approximately 30 $, showcasing 
that also carboxylases are dependent on a ‘swinging domain’ model. 
Depending on enzyme and organism, the BC, BCCP and CT can be on separate 
polypeptide chains or partially or fully fused into one (Figure 1.6). While sequence 
conservation in the different carboxylases is high for the BC and BCCP, the CT 
component is less conserved and the sequence and active site architecture differ 
depending on the nature of the substrate.  
Based on their substrate specificity, biotin-dependent carboxylases are classified 
in three groups: First, pyruvate carboxylase (PC) and second, urea carboxylases 
(UC) both act on small organic compounds while the third family of acyl-CoA 




Figure 1.6 Domain organization of biotin-dependent carboxylases.  
Overview of all families of biotin-dependent carboxylases, separated by class and 
kingdom of life. All individual domains are labeled and color-coded, the scale bar denotes 
the number of amino acids. All abbreviations are according to the main text. 
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1.7! Urea carboxylase and pyruvate carboxylase 
In order to utilize urea as energy source, many bacteria, fungi and algae possess 
the ability to convert urea to ammonium62,63. In these organisms, UC catalyzes 
the first step in this pathway, namely the carboxylation of urea to produce 
allophanate, which is then hydrolyzed to generate ammonia and CO2 by 
allophanate hydrolase (AH)54,64. In a subgroup of organisms, the AH can be fused 
to the UC, forming a multienzyme called urea amidolyase (UA, Figure 1.6). In the 
yeast S. cerevisiae, UA is part of the pyrimidine degradation pathway while in 
other fungi, such as C. albicans, it can be involved in the virulence. Here the 
released CO2 is a signal for hyphal switching and the ammonia product is 
secreted to alkalinize the extracellular environment65. On a sequence level, UC 
can be a multi-subunit enzyme or a multienzyme (Figure 1.6). 
A crystal structure of a 137 kDa UC component of an UA from the fungus K. 
lactis has been reported (Figure 1.7). It shows an elongated monomeric structure 
with the BCCP tightly bound to the CT domain. The active sites face each other 
and are separated by about 60 $, consistent with a swinging domain model. The 
CT domain does not share sequence homology with other carboxylases, and 
consistently, its structure and oligomerization state is distinct. The quaternary 
structure of CT domains of other carboxylases is at least that of a dimer, which 
leads to very distinct protein architectures in the following examples of different 
families.  
PC was discovered in 1960 in chicken and beef liver66 and by now has been 
found in most organisms. It catalyzes the carboxylation of pyruvate yielding 
oxaloacetate67,68 and in mammals it is involved in gluconeogenesis in liver and 
kidney, and glyceroneogenesis and lipogenesis in adipocytes (Figure 1.8). PC 
deficiencies are linked to lactic acidemia, hypoglycemia, psychomotor retardation 
and death69,70. In eukaryotes and most bacteria, PC is a multi-domain enzyme 
with a monomeric weight of approximately 130 kDa (Figure 1.6), with the BCCP 
tethered C-terminally to CT by a 14 amino residue long linker, functioning only as 
a tetramer. In archae and some bacteria, it can occur on two polypeptide chains, 
but the overall assembly mode is the same as in the multienzyme form. While the 
BC domain shows considerable conservation to other carboxylases, the CT 





Figure 1.7 Architectures of UC and PC.  
Crystal structures of monomeric UC from Kluyveromyces lactis (A, pdb: 3VAF) and the 
tetrameric PC from Staphylococcus aureus (B, pdb: 3BG5). The structure of the AH 
domain of UC was not determined. Color-coding according to the sequence scheme. 
Same domains are labeled where applicable and the molecules are to scale. 
 
Crystal structures are available and show the PC tetramer in a square shape, with 
two protomers stacked in the ‘bottom’ layer and two in the ‘upper’ layer, roughly 
obeying 222 point group symmetry61 (Figure 1.7). An additional domain was 
identified, that is important for the tetramerization of the complex, and thus was 
called PT (PC tetramerization). PT, BC and CT are all forming homodimers with 
domains in the other layer. BCCPs are located near the middle of the assembly, 
bound to the active site of a CT domain, inserting the biotinylated !-hairpin deep 
into a binding pocket. An interesting architectural feature is the fact that the 
BCCP-bound biotin is carboxylated by the BC domain of the own protomer and 
is then shuttled to the CT domain of the other protomer in the same layer, 
meaning that the carrier protein is not only serving its own protomer during 
catalysis. The respective active sites are separated by 75 $, again indicating that 
a swinging domain mechanism of the BCCP has to be employed. 
Strikingly different architectures have been presented for these two classes of 
biotin-dependent carboxylases, and this structural diversity will increase during 
the detailed description of acyl-CoA carboxylases in the next section. 
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1.8! The family of acyl-CoA carboxylases 
The family of acyl-CoA carboxylases includes acetyl-CoA carboxylase (ACC), 
propionyl-CoA carboxylase (PCC), 3-methylcrotonyl-CoA carboxylase (MCC) and 
geranyl-CoA carboxylase (GCC), and the individual family members will be 
discussed below. Generally, all of these carboxylases are present in prokaryotes 
and eukaryotes, except GCC, which is only found in Pseudomonas and 
Acetinobacter strains71,72 (Figure 1.6). 
1.8.1! Overview of biological role of acyl-CoA carboxylases 
PCC, located in mitochondria in mammals, converts propionyl-CoA to D-
methylmalonyl-CoA and, in most organisms, it is important for the catabolism of 
!-branched amino acids (Thr, Val, Ile) and fatty acids with an odd number of 
carbon atoms by feeding them ultimately into the tricarboxylic acid cycle (TCA 
cycle, Figure 1.8). In several archaeal organisms and bacteria, it is also implicated 
in CO2 fixation46,47, methanol assimilation48, acetyl-CoA assimilation49-51, 3-
hydroxypropionate assimilation52 and mycolic acid and methyl-branched fatty 
acid biosynthesis55. Deficiencies in PCC activity lead to propionic acidimia, which 
may lead to death in severe cases73. In addition, PCC deficiency leads to epilepsy 
and seizure, implicating that PCC expressed in the brain may be involved in 
neurodevelopment74,75. 
MCC shares considerable sequence conservation with PCC, even though it is 
acting on #-carbons while PCC acts on "-carbons. In eukaryotes, MCC is located 
in mitochondria and catalyzes the conversion of 3-methylcrotonyl-CoA to 3-
methylglutaconyl-CoA and is essential for the catabolism of leucine and 
isovalerate in most organisms76 (Figure 1.8). 3-Methylglutaconyl-CoA is ultimately 
turned over to acetyl-CoA and enters the TCA cycle. Deficiencies in MCC activity 
are linked to 3-methylcrotonylglycinuria, which manifests in a range from 
asymptotic individuals to severe cases of psychomotor retardation, seizure, 
coma and death77,78. 
GCC can be classified into the same class as MCC, since the amino acid 
sequences between the two are highly conserved and since they both work on a 
#-carbon of a "-! unsaturated acid. In Pseudomonas and Acetinobacter strains, 
GCC accepts geranyl-CoA and converts it to #-carboxygeranyl-CoA and is 
involved in the metabolism of the geranyl group and other acyclic terpenes56. 
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Owing to this activity, some bacteria can use geranyl as only carbon source in a 
process similar to !-oxidation, where they break down #-carboxygeranyl-CoA to 
3-methylcrotonyl-CoA (also releasing two acetyl-CoAs and acetate), which is 
then a substrate for MCC and is further degraded. 
ACC catalyzes the carboxylation of acetyl-CoA, yielding malonyl-CoA, the 
dedicated substrate for fatty acid biosynthesis and a potent inhibitor of !-
oxidation. The detailed biological role of ACC is discussed below. 
 
 
Figure 1.8 Functions of biotin-dependent carboxylases in mammalian cells.  
Important pathways that involve biotin-dependent carboxylases in mammalian cells are 
marked with the name of the corresponding enzyme. Multiple arrows indicate pathways 
where more than one enzyme is involved. Selected intermediates of the tricarboxylic acid 
cycle (TCA cycle) are shown. Malonyl-CoA, produced by ACC1, is the committed 
substrate for fatty acid biosynthesis while malonyl-CoA produced by ACC2 acts as 
inhibitor of CPT-I. All abbreviations according to the main text. 
1.8.2! Architectural features of acyl-CoA carboxylases 
All acyl-CoA carboxylases share the principle composition of BC, BCCP and CT, 
with well conserved BC and BCCP components and a more variable CT. In some 
cases, additional non-catalytic components are added to this core set (Figure 
1.6). A BC-CT interaction domain (BT) can be found in all eukaryotic members of 
the family as well as in prokaryotic PCC, MCC and GCC58,59. Eukaryotic ACC 
contains a large additional central domain (CD) that is biochemically and 
structurally poorly characterized, even though phosphorylation of certain 
residues in the CD has been implicated in regulation of ACC79-81.  
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Even though the domain composition is shared amongst all acyl-CoA 
carboxylases, the relative domain organization and stoichiometry differs vastly 
between the members of the family. Prokaryotic acyl-CoA carboxylases are 
multi-subunit enzymes, which consist of two to four subunits. Eukaryotic acyl-
CoA carboxylases can either be multi-subunit proteins, as for example the PCC, 
or multienzymes, such as the ACC, combining all domains on a single 
polypeptide chain of about 2300 amino acids34 (Figure 1.6). 
Structures of the intact assemblies of these enzymes are only available for the 
bacterial MCC58 and PCC59 (Figure 1.9A,B). Both proteins share the same domain 
arrangement on a sequence level and show the same stoichiometry, forming "6!6 
hetero-dodecamers with a size of approximately 750 kDa. The !-subunits (CT) 
form a hexameric core by trimerization of CT-dimers, similar to the 12S subunit of 
transcarboxylase82, with three "-subunits (combined BC, BT and BCCP) attached 
at the top and bottom of the CT ring. While both enzymes obey 32-point group 
symmetry, a striking rearrangement of the " subunits relative to the ! subunits 
can be observed. Overall, PCC forms a compact, cube-shaped assembly, while 
the MCC is more elongated. Additionally, the hexameric organization of the 
subdomains in the ! subunits and the structure and placement of the BT 
domains differ. BC domains in PCC are monomeric with contacts only to the BT 
and the CT, while in the case of MCC they associate into a trimer and show no 
contact to the CT ring. The active sites of BC and CT are separated by 55 $ in 
PCC and 80 $ in MCC, repeatedly underlining the fact that the carrier protein has 
to undergo large-scale conformational change to position the biotin cofactor in 
both active sites. 
Even though the large architectural difference between PCC and MCC was 
initially unanticipated, it fits well with the observation of large organizational 
freedom even within the family members of acyl-CoA carboxylases. This is 
exemplified in the case of ACC. Bacterial ACC consists of a transient assembly of 
four subunits following a (BC)2(BCCP)4(CT"CT!)2 stoichiometry42, while 
biochemical studies suggest that archaeal ACC works in a (BC)4(BCCP)4(CT)4 
stoichiometry83. Eukaryotic ACC, on the other hand, is a large multienzyme with 
BC, BT, BCCP, CD and CT combined on one polypeptide chain with a monomer 






Figure 1.9 Architectures of MCC and PCC.  
Crystal structures of hetero-dodecameric MCC from Pseudomonas aeruginosa (A, pdb: 
3U9S) and hetero-dodecameric chimeric PCC from Ruegeria pomeroyi and Roseobacter 
denitrificans (B, pdb: 3N6R). Color-coding according to the sequence scheme. Same 
domains are labeled and the molecules are to scale. 
 
While structures of bacterial biotin-dependent carboxylases58-60,86 and of 
individual domains from eukaryotic ACCs are known79,87,88, there is no insight into 
the architecture or assembly mode of full-length eukaryotic ACC and this cannot 
be deduced from the already available structures. Additionally, there is only little 
understood on the function and positioning of the CD. 
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1.9! Biological role, regulation and domain structures of 
acetyl-CoA carboxylase 
1.9.1! Biological role of ACC 
ACC was discovered in 1958 due to its involvement in fatty acid biosynthesis89. 
There are two isoforms of ACC in mammals, ACC1 and ACC2. While ACC1 is 
mostly expressed in lipogenic tissues, such as liver, adipose and lactating 
mammary gland, ACC2 is predominantly expressed in heart and skeletal muscle. 
ACC1 catalyzes the committed and rate-limiting step of long-chain fatty acid 
biosynthesis44,90-92, as the produced malonyl-CoA is mainly used as two-carbon 
donor by FAS (Figure 1.8). ACC2 shares 73% sequence identity to ACC1, but 
contains an N-terminal anchoring sequence that locates it to the outer 
mitochondrial membrane. Malonyl-CoA produced by ACC2 is a potent regulator 
of fatty acid oxidation in these tissues by inhibiting the carnitine 
palmitoyltransferase I (CPT-I, Figure 1.8)93. CPT-I is responsible for the 
conversion of long chain fatty acids into acylcarnitine, a conversion that is 
essential for the fatty acids in order to cross the mitochondrial membrane and to 
enter !-oxidation94-96. Mice deficient in ACC2 have continuous !-oxidation, 
reduced level of body fat and are protected against diabetes and obesity induced 
by high-fat diets97,98.  
Single nucleotide polymorphism in human ACC is linked to hypertriglyceridemia 
and hypercholesterolemia in patients taking antipsychotics99. Also, human ACC is 
overexpressed in cancer cells and chemical inhibition or RNAi knockdown of 
ACC have been shown to lead to increased levels of apoptosis and growth 
inhibition in cancerous cells100-104. 
Fungi contain only one cytosolic ACC isoform and it is essential (Figure 1.8). 
Mutants lacking ACC arrest in G2/M phase105, while mutants lacking FAS can 
survive if long-chain fatty acids are provided in the medium106. Adding long-chain 
fatty acids does not restore viability of ACC- mutants107 and this indicates that 
ACC may also be involved in the synthesis of very long-chain fatty acids. Yeast 
mitochondria also encode an isoform of ACC, called HFA1, crucial for fatty acid 
and lipoic acid biosynthesis in mitochondria108-110.  
In some bacteria, such as Streptomyces coelicolor, the produced malonyl-CoA is 
additionally used for polyketide biosynthesis111, and in archae, ACC is thought to 
be involved in CO2 fixation83. 
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1.9.2! Regulation of acetyl-CoA carboxylase 
ACCs are tightly regulated on the level of expression, by binding of proteins and 
small molecules and by post-translational modification. The features and 
differences of regulation between human ACC and the simpler model organism 
S. cerevisiae will be discussed in this section. 
Long-term regulation is achieved by changing the number of active enzymes in a 
cell or compartment. Several transcription factors regulate gene expression of 
human ACC, including sterol regulatory element binding proteins (SREBP1a and 
SREBP1c) and carbohydrate response element binding protein (ChREBP). High-
carbohydrate diets lead to elevated levels of insulin, which in turn upregulates 
expression of SREBP1c and ChREBP, while high levels of polyunsaturated fatty 
acids decrease the expression of SREBP1112-114. In addition, the effects of these 
transcriptional factors can be further increased by PGC-1" and PGC-1!, 
peroxisome proliferator-activated # coactivator 1115,116.  
The use of different promoters leads to alternative splicing at the 5’ of human 
ACC1. The shortened N-termini lack phosphorylation sites that are normally 
recognized by AMP-activated protein kinase (AMPK)117-120. Phosphorylation in 
these regions is linked to activity, and it is proposed that the shortened isozymes 
are constitutively active. Similarly, ACC2 also has a shortened transcript, and the 
encoded protein is believed to lack the N-terminal anchoring sequence, 
rendering the enzyme cytosolic 117. 
In yeast, steady state transcription is decreased by the phospholipid precursors 
inositol and choline105,121,122. Adding inositol and choline to the growth medium 
leads to a 50-75% reduced activity level of ACC, based on decreased levels of 
mRNA123. 
Short-term regulation of human ACC is achieved by feedforward and feedback 
regulation (Figure 1.10A). Citrate, a precursor of acetyl-CoA, serves as allosteric 
activator, while long-chain acyl-CoA, the product of fatty acid biosynthesis, acts 
as an inhibitor45,93,124. The most active forms of animal ACCs are large, linear 
polymers with a molecular weight of up to 8 MDa, consisting of ACC dimers as 
building blocks45,125 (Figure 1.10C). Citrate and long-chain acyl-CoA are either 
driving or perturbing this polymerization process, respectively (Figure 1.10A). 
Binding of the small protein MIG12 to ACC is further promoting polymerization of 
both mammalian ACC isoforms84. However, an N-terminally truncated construct 
for ACC2, lacking the mitochondrial membrane anchoring sequence, was used in 
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this study, and it was not shown whether ACC2 also polymerizes when it is 
membrane-bound.  
 
Figure 1.10 Regulation of ACC in mammals and fungi.  
Feed-forward and feedback regulation of ACC is indicated by arrows. A. ACC1 and 
ACC2 are activated by citrate and MIG12, which leads to polymerization in ACC1. 
Phosphorylation by AMPK leads to inactivation of ACC, as does binding of palmitoyl-
CoA. B. The fungal AMPK homologue Snf1 inhibits ACC by phosphorylation, while the 
acetyl-CoA precursor citrate is an activator of activity. Malonyl-CoA produced by 
mitochondrial HFA1 is used for the biosynthesis of mitochondrial fatty acids and lipoic 
acids. C. Negative stain EM micrograph of Homo sapiens ACC1 polymers (unpublished 
results). Scale bar is indicated. 
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While long-chain acyl-CoA has no inhibitory effect on the activity of yeast ACC, 
citrate has also been identified to induce activity45. However, no spontaneous or 
inducible polymerization has been observed for yeast ACC (Figure 1.10B). 
Human ACC is also regulated by reversible phosphorylation (Figure 1.10A) by 
AMPK and cAMP-dependent protein kinase (PKA). AMPK phosphorylates ACC1 
in vitro at Ser80, Ser1201, and Ser1216 and PKA at Ser78 and Ser1201. Direct 
regulatory effects, however, have only been observed for phosphorylation of 
Ser80 and Ser1201126,127. Ser222 in ACC2 aligns to Ser80 in ACC1, and is also 
phosphorylated by AMPK. Ser80 is highly conserved in higher eukaryotes and 
presumably binds, upon phosphorylation, into the Soraphen A (an antifungal and 
antibiotic compound) binding pocket128. Ser1201 is only moderately conserved 
among higher eukaryotes, while Ser1216 is highly conserved among all 
eukaryotes. However, no effect of Ser1216-phosphorylation on activity has been 
reported.  
Breast cancer susceptibility gene 1 (BRCA1) binds to phosphorylated Ser1263 
and this binding decreases ACC1 activity and establishes a further direct link 
between ACC and cancer129,130. Phosphorylation of Ser1263 is controlled by the 
cell cycle, possibly through cyclin-dependent kinase (CDK).  
The situation presents itself less complex in yeast (Figure 1.10). Several 
phosphosites were identified in phosphoproteomics studies, namely Ser2, 
Ser735, Ser1148, Ser1157, and Ser1162. Of these phosphorylation sites, only 
Ser1157 is highly conserved among all fungi and it aligns to Ser1216 in human 
ACC. Phosphorylation of Ser1157 by the AMPK homologue Snf1 leads to 
strongly reduced activity in vitro and in vivo80,131,132.  
Many of the phosphorylation sites and also the binding site for BRCA are located 
in the central domain of yeast and human ACC, respectively. This domain, 
however, lacks structural description and the mechanisms underlying regulation 
through phosphorylation are not understood, neither in humans nor in fungi. 
1.9.3! Structures of eukaryotic acetyl-CoA carboxylase 
ACC holo-enzymes are difficult to study. In prokaryotes, the multi-domain 
enzyme is a transient complex that readily dissociates during purification while 
eukaryotic ACCs are large polypeptides and a flexible quaternary structure has to 
be expected, at least for the mobile carrier protein. Thus, no structural data is 
available for the complete assembly of eukaryotic ACCs and the structure of the 
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CD is unknown and has no homologs in structural databases. Crystal structures 
of the individual domains, however, have been solved. 
 
 
Figure 1.11 Structure of the biotin carboxylase domain.  
A. Crystal structure of the monomeric S. cerevisiae BC domain (pdb: 1W93). The A-, B-, 
C- and AB-linker domains are colored and labeled with different shades of red. The active 
site is marked with an asterisk, and the closing movement of the B-domain is indicated 
with a dashed arrow. B. Crystal structure of the dimeric BC domain from E. coli (pdb: 
3G8C) in complex with ADP, biotin and carbonate (shown as sticks). The subdomains 
labeled as in A. C. Close up on the active site of E. coli BC, illustrating the positioning of 
ADP, biotin and carbonate (as sticks). The subdomains are labeled as in B. 
 
The BC domain of eukaryotic ACC is monomeric in solution while prokaryotic BC 
is dimeric (Figure 1.11A,B). It is suggested, that conformational differences in the 
respective dimerization area (compared to E. coli) prevents dimerization 133. 
However, eukaryotic BC is inactive in solution, and it remains concealed whether 
BC requires the proximity of other domains in the complex for activity or a 
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whether specific conformational change has to occur. Apart from that, the overall 
structure clearly resembles the BC subunit of E. coli ACC, consisting of three 
domains (A, B and C). Eukaryotic BC contains several inserted segments, 
especially the linker segment between the A- and the B-domain (AB-linker). 
Residues from the A- and C-domain contribute to the active site and the flexible 
B-domain potentially acts as a lid that closes over the active site during catalysis 
134. The positioning of the substrates can be derived from a comparison with E. 
coli BC and is shown in Figure 1.11B,C.  
During catalysis, a nucleophilic attack by one of the oxygen atoms of carbonate 
on ATP leads to formation of a carboxyphosphate intermediate, which 
decomposes and releases orthophosphate. Orthophosphate acts as general 
base and extracts a proton from the N1’ atom of biotin, and the resulting enolate 
biotin is then stabilized by a positively charged arginine during the carboxylation 
reaction. 
A crystal structure of yeast CT was reported in 200388 (Figure 1.12A). As in their 
prokaryotic counterparts, the CT domain is a head-to-tail dimer consisting of two 
subdomains (N-lobe and C-lobe) of which each shows a crotonase fold. In the 
structure, CoA is bound and it can be seen that residues from both protomers 
are required for binding and recognition (Figure 1.12B). The pantetheine arm 
wedges into a cavity between the two protomers and places the thiol group in a 
pocket formed by both protomers. Since the active site is situated exactly 
between the protomers, CT requires dimerization in order to be active and is 
consequently not stable as a monomer in solution. Interestingly, it is proposed 
that the C-terminal helical regions are incompatible with a hexameric assembly, 
as it was observed for CT domains of bacterial acyl-CoA carboxylases 135. This 
strongly suggests that eukaryotic ACC show a completely unrelated assembly to 
the bacterial counterparts. 
The CD is a completely unique feature of eukaryotic ACCs and is predicted to 
consist of an "-helical part, which accounts for roughly half of the CD, followed 
by one or more domains with mixed "-helix and !-sheet predictions. It has no 
homologs in other proteins, no other carboxylase incorporates a similar domain 
and no biochemical or structural data is available, except for the fact that it is 
implicated in regulation through phosphorylation. 




Figure 1.12 Structure of the carboxyl transferase.  
A. Crystal structure of the dimeric S. cerevisiae CT domain (pdb: 1OD2). The N- and C-
lobes are labeled and one of the active sites is marked with an asterisk. Bound CoA is 
shown as sticks. Coloring of one protomer according to the sequence scheme, the 
protomer is in gray for clarity. Visible N- and C-termini are labeled. B. Zoom-in on the 
active site (marked area in A), situated between the N-lobe of the first protomer and the 
C-lobe of the second protomer. The bound CoA and the coordinating residues, from both 
protomers, are shown as sticks. The expected site of catalysis is marked with an asterisk. 
ACC as target for drug development 
1.10! ACC as target for drug development 
Due to their pivotal role in fatty acid metabolism, ACCs are a potent target for 
drug development against type 2 diabetes, atherosclerosis, cancer, and microbial 
and fungal infections90,124. Many of these diseases are manifestations of the 
metabolic syndrome, which in turn is linked to obesity136. It has been projected 
that by the year 2030 approximately 50% of the adult population in the US will be 
obese137. 
The potency of ACC as a drug target was first demonstrated by the observation 
that ACC2 knock-out mice exhibit elevated !-oxidation, reduced body fat and 
weight and improved insulin sensitivity97,98. A complete knock-out of ACC1, on 
the other hand, leads to embryonic lethality in mice138, while a liver-specific 
knock-out of ACC1 in mice results in reduced lipid accumulation without 
disturbing glucose homeostasis139. Recent reports, however, failed to observe 
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these effects140-142, and it is suggested that differences in the strategies that were 
used to produce the knock-out mice are responsible for this discrepancy34. 
Many potent inhibitors of human ACC are known100,143-148. Some of them do not 
discriminate between the two isoforms, while others show increased selectivity 
towards ACC2. In rodent models, these inhibitors show similar effects as it was 
seen in the knock-out mice studies: increased !-oxidation, decreased body fat 
mass and improved insulin sensitivity. Although long-term treatment using 
isoform non-selective inhibitors leads to increased !-oxidation, it does not 
sustainably reduce hepatic triglyceride levels in rodent models149. Prolonged 
inhibition of ACC1 reduces glucose-stimulated insulin secretion. ACC2-selective 
inhibitors may thus be more suited as potential drugs against diabetes150.  
ACC is overexpressed in different cancers, such as liver, breast and prostate 
cancer, rendering the enzyme an attractive target for the development of new 
anti-cancer compounds. RNAi knockdowns and chemical inhibition lead to 
growth arrest, apoptosis and decreased tumor cell invasion100,103,104,151,152.  
Two commercially available herbicides, in use for over 20 years, are inhibitors of 
plastid ACC: aryloxyphenoxypropionate and cyclohexanedione44. Not all plants, 
however, are sensitive to these herbicides and the widespread use lead to the 
emergence of new resistant weeds. The two compounds are only weakly active 
against mammalian and yeast ACCs153. The macrocyclic antifungal and antibiotic 
compound Soraphen A is a potent inhibitor of eukaryotic BC, but does not target 
the prokaryotic counterpart87,133. 
Inhibiting one of the two half-reactions occurring in ACC is sufficient to inhibit the 
overall reaction and most available inhibitors target the CT, while only soraphen A 
is targeting the BC. Inhibition of polymerization could be an additional route for 
potential drugs in higher eukaryotes, while selective targeting of the CD could 
potentially work on all eukaryotes. For this task, however, more knowledge is 
needed concerning the structure and function of the CD. 
1.11! Bacterial single-chain acyl-CoA carboxylases 
A novel group of bacterial acyl-CoA carboxylases was recently discovered but 
not characterized biochemically34. Even though they are denoted as PC or 
carbamoyl-phosphate synthetase in the NCBI database, sequence homology to 
acyl-CoA carboxylases clearly identifies them as members of the latter. These 
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carboxylases, denoted as YCCs here, consist of a single polypeptide chain 
comprising all three functional domains in the same order as eukaryotic ACCs 
but they, however, lack the large CD (Fig 2D). The monomer weight is 
approximately 120 kDa but no extensive studies concerning the oligomerization 
state or the architecture have been conducted. The domain arrangement on a 
single polypeptide is exceptional as they are the only true bacterial acyl-CoA 
multienzyme carboxylases. YCCs are present in a diverse set of unrelated 
bacteria, such as Pseudomonas aeruginosa, Cupriavidus metallidurans, 
Deinococcus metallidurans and Mycobacterium avium subspecies 
paratuberculosis. For most YCCs neither substrate specificity, which could differ 
vastly, nor cellular function have been studied. Recently, a crystal structure and 
initial substrate characterization has been reported for an YCC from 
Mycobacterium avium, which was termed long-chain acyl-CoA carboxylase 
(MapLCC, Figure 1.13). Again, this structure shows a new overall architecture: 
The CT domains form a trimer of dimers, as it has been seen in other acyl-CoA 
carboxylases (Figure 1.9A,B), but the dimeric BCs are attached laterally. Further 
structural studies of these enzymes could shed light on the dynamic architecture, 




Figure 1.13!Crystal structure of MapLCC.  
MapLCC consists of a hexameric CT ring with dimeric BC domains laterally attached. 
Views correspond to top view and side views focusing on the BC dimer or the CT dimer. 
Domains form one polypeptide chain are labeled and colored according to the sequence 





1.12! Aims of the thesis 
As outlined so far, there is profound knowledge on the biochemistry of multi-
domain acyl-CoA carboxylases available, especially ACC, gathered over the last 
60 years. ACCs are of outstanding importance in primary and intermediary 
metabolism and they are established as important drug targets. However, 
structural information is limited to individual domains and insights into the 
molecular mechanisms of regulation, substrate shuttling, domain interactions and 
dynamic architecture of these multienzymes are sparse. Structure determination 
was precluded due to the size and flexibility of these fascinating enzyme 
complexes and without structural details it remains elusive how exactly the 
enzymes operate on a molecular level. 
Therefore, the main aim of this thesis was to analyze the structure and function of 
eukaryotic acetyl-CoA carboxylases, in particular the currently uncharacterized 
central domain. I wanted to understand the biological role of the CD, especially 
how it can mediate regulation through phosphorylation and what implications this 
may have for other carrier protein-dependent enzymes. In addition, I strived to 
gain knowledge on the architecture and function of the full assembly and domain 
dynamics, in order to understand how multienzymes work.  
At the beginning of the project, D. radiodurans YCC was a completely 
uncharacterized enzyme that was misannotated in all databases. The work on 
YCC was conducted in order to characterize this particular prokaryotic multi-
domain acyl-CoA carboxylase functionally and structurally and to provide 
insights into active site architecture, domain interactions and dynamics that may 
hold true not only for this enzyme but also for a larger class of carrier protein-
dependent multienzymes. 
To achieve this, a variety of methods were used, based on x-ray crystallography 
as a main tool, supplemented with electron microscopy (EM), small angle x-ray 
scattering (SAXS) and additional methods for biophysical characterization. 
Chapter 2 of this thesis covers our findings on eukaryotic ACC and is based on a 
manuscript in revision. Several crystal structures of full-length and truncated 
eukaryotic ACCs will be presented and a link will be made on how this enzyme 
can be regulated by phosphorylation of a single site in the central domain. This 
novel mechanical regulation mechanism gives rise to new possibilities in 
synthetic biology. 
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Chapter 3 outlines what we learned from structural analyses of the prokaryotic 
YCC from D. radiodurans concerning large conformational flexibility in multi-
domain carboxylases. This part is based on a manuscript in preparation. A hybrid 
structure and quantitative analysis of domain flexibility reveal a highly flexible 
architecture and demonstrate that biotin-dependent multienzymes can exhibit 
large conformational freedom. 
In addition, I was involved in crystal optimization, data collection and structure 
refinement in an unrelated side-project, which will be introduced below. The 
findings of this work are presented in chapter 4, which is reproduced from 
manuscript publication in J. Biol. Chem.154. It will provide insights into the 
structure and function of the bacterial extracellular foldase PrsA using a 
combination of crystallographic, enzymatic and NMR spectroscopic analyses.  
1.13! The bacterial extracellular foldase PrsA 
The rate-limiting step in the folding of proteins containing cis-prolines is 
catalyzed by peptidyl prolyl cis/trans isomerases (PPIases). PPIases are foldases 
that occur in all types of cells155. These proteins are ubiquitous and can be 
divided into three classes: Cyclophilins, FK506-binding proteins (FKBP) and 
parvulins156. Cyclophilins and FKBPs are targets for immunosuppressants and 
are thus also called immunophilins. The name-giving prototype for the parvulin 
family is an enzyme from E. coli157. This small cytoplasmic protein consists 
essentially of only the PPIase domain. In other cases, a homologous PPIase 
domain can be flanked by additional protein stretches either N- or C-terminally or 
on both termini158. Based on functional and structural differences, at least three 
subfamilies can be defined, that are discussed below. 
The first class of the Pin1-type contains, except in plants, an N-terminal WW-
domain159 (Figure 1.14A). WW domains are known to bind to proline-rich protein 
stretches and to phosphoserine- or phosphothreonine-containing motifs160. A 
crystal structure of the human Pin1 protein reveals that the PPIase domain 
consists of a four-stranded antiparallel !-sheet surrounded by four "-helices 
(!"3!"!2)159. The WW domain is shown to indeed bind together with the PPIase 
domain to phosphorylated residues located N-terminally to a proline161. Pin1-type 
PPIases are involved in mitosis and chromatin remodeling162,163.  
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In the second subclass, hPar14-type, the first "-helix and the preceding loop (s1-
H1 loop) are shorter than in Pin1-type PPIases and the exact biological function 
is unknown164 (Figure 1.14A,B).  
 
 
Figure 1.14 PrsA is an extracellular foldase belonging to the parvulin family.  
A. Crystal structures of representatives of the three classes of parvulins: hPar14 (orange, 
pdb: 3UI4), human Pin1 (cyan, pdb: 2Q5A) and E. coli SurA (blue, pdb: 1M5Y). All 
structures are to scale and aligned on the PPIase domain. The secondary structure 
elements are labeled for hPar14, as well as all domains. Pin1 contains an additional WW 
domain and SurA contains two PPIase domains and an additional chaperone domain. B. 
Structural overlay of the PPIase domains from hPar14 and Pin1 and the core PPIase 
domain from SurA, illustrating the common fold and the extended S1-H1 loop of Pin1. C. 
Schematic representation of extracellular folding, mediated by the membrane-anchored 
foldase PrsA. SecYEG is the main protein-conducting channel in gram-positive bacteria. 
 
In the third subclass, the PPIase domain is most similar to the E. coli parvulin and 
it is occurring mostly in prokaryotes, required for maturation and folding of 
exctracytoplasmic proteins165. The periplasmic chaperone SurA, for example, 
belongs to this class (Figure 1.14A).  
Parvulins, in general, assist the maturation of intracellular proteins, and a large 
network of periplasmic PPIases support the folding of periplasmic and outer 
membrane proteins in Gram-negative bacteria166,167. In Gram-positive bacteria, 
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folding and maturation of most secreted proteins is dependent on a single 
parvulin-type PPIase, PrsA168,169. 
PrsA is an essential protein in Bacillus subtilis under normal growth conditions170 
and depletion of PrsA from cells leads to increased osmotic shock 
susceptibility171, decreased cell wall integrity172,173 and increased antibiotic 
sensitivity174,175. PrsA is anchored to the outer leaflet of the cell membrane at the 
interface between plasma membrane and cell wall168,169. It is crucial for proper 
folding of proteins that are protruding from the protein-conducting channel 
SecYEG during co-translational or post-translational protein translocation (Figure 
1.14C). PrsA is a potential target for drug development due to its important role 
as folding factor of secreted proteins168, toxins176 and virulence factors174,177. On a 
sequence level, 155 N-terminal and 70 C-terminal amino acid residues flank a 
parvulin-like domain. These flanking regions are not homologous to any other 
parvulin-like PPIase169. So far, the function of these flanking regions remained 
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Acetyl-CoA carboxylases (ACCs) catalyze the committed step in fatty acid 
biosynthesis, the ATP-dependent carboxylation of acetyl-CoA to malonyl-CoA. 
They are important regulatory hubs for metabolic control and relevant drug 
targets for the treatment of the metabolic syndrome and cancer. Eukaryotic 
ACCs are single-chain multienzymes characterized by a large, non-catalytic 
central domain (CD), whose role in ACC regulation remains poorly characterized. 
The crystal structure of the yeast ACC CD reveals a unique dynamic four-domain 
organization. A regulatory loop, which is phosphorylated at the key functional 
phosphorylation site of fungal ACC, wedges into a crevice between two domains 
of CD. Combining the yeast CD structure with intermediate and low-resolution 
data of larger fragments up to intact ACCs provides a comprehensive 
characterization of the dynamic fungal ACC architecture. In contrast to related 
carboxylases, large-scale conformational changes are required for substrate 
turnover, and are mediated by the CD under phosphorylation control.    
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2.2! Introduction 
Biotin-dependent acetyl-CoA carboxylases (ACCs) are essential enzymes that 
catalyze the ATP-dependent carboxylation of acetyl-CoA to malonyl-CoA. This 
reaction provides the committed activated substrate for the biosynthesis of fatty 
acids via fatty acid synthase 45,89. By catalyzing this rate-limiting step in fatty acid 
biosynthesis, ACC plays a key role in anabolic metabolism. ACC inhibition and 
knock-out studies show the potential of targeting ACC for treatment of the 
metabolic syndrome 90,97,98. Furthermore, elevated ACC activity is observed in 
malignant tumors 178,179. A direct link between ACC and cancer is provided by 
cancer-associated mutations in the breast cancer susceptibility gene 1 (BRCA1), 
which relieve inhibitory interactions of BRCA1 with ACC 129,130. Thus, ACC is a 
relevant drug target for type 2 diabetes and cancer 44,180,181. Microbial ACCs are 
also the principal target of the antifungal and antibiotic compound  
Soraphen A 87,133.  
The principal functional protein components of ACCs have been described 
already in the late 1960’s for Escherichia coli (E. coli) ACC 182,183: Biotin 
carboxylase (BC) catalyzes the ATP-dependent carboxylation of a biotin moiety, 
which is covalently linked to the biotin carboxyl carrier protein (BCCP). 
Carboxyltransferase (CT) transfers the activated carboxyl group from carboxy-
biotin to acetyl-CoA to yield malonyl-CoA. Prokaryotic ACCs are transient 
assemblies of individual BC, CT and BCCP subunits 184. Eukaryotic ACCs, 
instead, are multienzymes, which integrate all functional components into a 
single polypeptide chain of approx. 2300 amino acids 45. Human ACC occurs in 
two closely related isoforms, ACC1 and 2, located in the cytosol and at the outer 
mitochondrial membrane, respectively 185,186. In addition to the canonical ACC 
components, eukaryotic ACCs contain two non-catalytic regions, the large 
central domain (CD) and the BC-CT interaction domain (BT). The CD comprises 
one third of the protein and is a unique feature of eukaryotic ACCs without 
homologs in other proteins. The function of this domain remains poorly 
characterized, although phosphorylation of several serine residues in the CD 
regulates ACC activity 80,93,187. The BT domain has been visualized in bacterial 
carboxylases, where it mediates contacts between !- and "-subunits 58,59. 
Structural studies on the functional architecture of intact ACCs have been 
hindered by their huge size and pronounced dynamics, as well as the transient 
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assembly mode of bacterial ACCs. However, crystal structures of individual 
components or domains from prokaryotic and eukaryotic ACCs, respectively, 
have been solved 79,88,188-190. The structure determination of the holoenzymes of 
bacterial biotin-dependent carboxylases, which lack the characteristic CD, such 
as the pyruvate carboxylase (PC) 60, propionyl-CoA carboxylase (PCC) 59, 3-
methyl-crotonyl-CoA carboxylase (MCC) 58 and a long-chain acyl-CoA 
carboxylase (LCC) 86 revealed strikingly divergent architectures despite a general 
conservation of all functional components. In these structures, the BC and CT 
active sites are at distances between 40 # and 80 #$%&'()%*)+*%&',&*-+*.%*-+/&0.-%
(1'23%,.%4.35+*.3%&12.26%,6%*).%41,525*6%10%*).%02.75,26%*.*).-.3%899:; 
Human ACC1 is regulated allosterically, via specific protein-protein interactions, 
and by reversible phosphorylation. Dynamic polymerization of human ACC1 is 
linked to increased activity and is regulated allosterically by the activator citrate 
and the inhibitor palmitate 93,187 or by binding of the small protein MIG-12 84. 
Human ACC1 is further regulated by specific phosphorylation-dependent binding 
of BRCA1 to Ser1263 in the CD. BRCA1 binds only to the phosphorylated form of 
ACC1 and prevents ACC activation by phosphatase-mediated dephosphorylation 
129,191. Furthermore, phosphorylation by AMP-activated protein kinase (AMPK) and 
cAMP-dependent protein kinase (PKA) leads to a decrease in ACC1 activity. 
AMPK phosphorylates ACC1 in vitro at Ser80, Ser1201, and Ser1216 and PKA at 
Ser78 and Ser1201. However, regulatory effects on ACC1 activity are mainly 
mediated by phosphorylation of Ser80 and Ser1201, respectively 126,127. 
Phosphorylated Ser80, which is highly conserved in higher eukaryotes, 
presumably binds into the Soraphen A binding pocket 128. The regulatory Ser1201 
shows only moderate conservation across higher eukaryotes, while the 
phosphorylated Ser1216 is highly conserved across all eukaryotes. However, no 
effect of Ser1216 phosphorylation on ACC activity has been reported in higher 
eukaryotes. 
For fungal ACC, neither spontaneous nor inducible polymerization has been 
detected despite considerable sequence conservation to human ACC1. The 
BRCA1-interacting phosphoserine position is not conserved in fungal ACC, and 
no other phospho-dependent protein-protein interactions of fungal ACC have 
been described. In yeast ACC, phosphorylation sites have been identified at 
Ser2, Ser735, Ser1148, Ser1157 and Ser1162. Of these, only Ser1157 is highly 
conserved in fungal ACC and aligns to Ser1216 in human ACC1. Its 
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phosphorylation by the AMPK homologue Snf1 results in strongly reduced ACC 
activity 80,131,132.  
Despite the outstanding relevance of ACC in primary metabolism and disease, 
the dynamic organization and regulation of the giant eukaryotic, and in particular 
fungal ACC, remain poorly characterized. Here, we provide the structure of 
SceACC CD, intermediate- and low-resolution structures of human (Hsa) ACC 
CD and larger fragments of fungal ACC from Chaetomium thermophilum (Cth) 
(Figure 2.1a). Integrating these data with small-angle X-ray scattering (SAXS) and 
electron microscopy (EM) observations yields a comprehensive representation of 
the dynamic structure and regulation of fungal ACC. 
2.3! Results 
2.3.1! The organization of the yeast ACC central domain 
First, we focused on structure determination of the 82 kDa CD. The crystal 
structure of the CD of SceACC (SceCD) was determined at 3.0 $ resolution by 
experimental phasing and refined to Rwork/Rfree= 0.20/0.25 (Supplemental Table 
2.1). The overall extent of the SceCD is 70 by 75 #% (Figure 2.1b, Supplemental 
Figure 2.1a, b)$% +/3% *).%+**+()4./*%<15/*&%10% *).%=>*.-45/+2%?@>-.&53'.% 25/A.-% *1%
*).%899:%314+5/%+/3%*).%9>*.-45/+2%9B%314+5/%+-.%&.<+-+*.3%,6%C@%#%D*).%=>%
+/3%9>*.-45/5%+-.% 5/35(+*.3%E5*)%&<).-.&% 5/%Figure 2.1,F;%SceCD comprises four 
distinct domains, an N-terminal !-helical domain (CDN), and a central four-helix 
bundle linker domain (CDL), followed by two !-"-fold C-terminal domains 
(CD9GH9I9?). CDN adopts a letter C shape, where one of the ends is a regular 
four-helix bundle (N!3-6), the other end is a helical hairpin (N!8,9) and the 
bridging region comprises six helices (N!1,2,7,10-12). CDL is composed of a 
small, irregular four-helix bundle (L!1-4) and tightly interacts with the open face 
of CDC1 via an interface of 1300 $2 involving helices L!3 and L!4. CDL does not 
interact with CDN apart from the covalent linkage and forms only a small contact 
to CDC2 via a loop between L!2/!3 and the N-terminal end of L!1 with an 
interface area of 400 $2. CD9GH9I9?%share a common fold; they are composed of 
six-stranded !-sheets flanked on one side by two long, bent helices inserted 
between strands "3/"4 and "4/"5. CDC2 is extended at its C-terminus by an 
additional !-strand and an irregular !-hairpin.  
 

































Figure 2.1 The phosphorylated central domain of yeast ACC.  
(a) Schematic overview of the domain organization of eukaryotic ACCs. Crystallized 
constructs are indicated. (b) Cartoon representation of the SceCD crystal structure. CDN 
is linked by a four-helix bundle (CDL) to two !-" fold domains (CDC1 and CDC2). The 
regulatory loop is shown as bold cartoon and the phosphorylated Ser1157 is marked by a 
red triangle. The N- and C-termini are indicted by spheres. (c) Superposition of CDC1 and 
CDC2 reveals highly conserved folds. (d) The regulatory loop with the phosphorylated 
Ser1157 is bound into a crevice between CDC1 and CDC2, the conserved residues 
Arg1173 and Arg1260 coordinate the phosphoryl-group. (e) Structural overview of 
HsaBT-CD. The attachment points to the N-terminal BCCP domain and the C-terminal 
CT domain are indicated with spheres. All coloring is according to scheme (a). 
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Based on an rmsd of main chain atom positions of 2.2 #, CD9GH9I9?% are 
structurally more closely related to each other than to any other protein (Figure 
2.1c); they may thus have evolved by duplication. Close structural homologs 
could not be found for the CDN or the CDC domains. 
2.3.2! A regulatory loop mediates interdomain interactions 
To define the functional state of insect-cell expressed ACC variants, we 
employed mass spectrometry (MS) for phosphorylation site detection. In insect-
cell expressed full-length SceACC, the highly conserved Ser1157 is the only fully 
occupied phosphorylation site with functional relevance in S. cerevisiae. 
Additional phosphorylation was detected for Ser2101 and Tyr2179, however 
these sites are neither conserved across fungal ACC nor natively phosphorylated 
in yeast. MS analysis of dissolved crystals confirmed the phosphorylated state of 
Ser1157 also in SceCD crystals. The SceCD structure thus authentically 
represents the state of SceACC, where the enzyme is inhibited by Snf1-
dependent phosphorylation.  
In the SceCD crystal structure, the phosphorylated Ser1157 resides in a 
regulatory 36-amino acid loop between strands "2%+/3%"3 of CDC1 (Figure 2.1b, 
d), which contains two additional less conserved phosphorylation sites (Ser1148, 
Ser1162) confirmed in yeast 192, but not occupied here. This regulatory loop 
wedges between the CDC1 and CDC2 domains and provides the largest 
contribution to the interdomain interface. The N-terminal region of the regulatory 
loop also directly contacts the C-terminal region of CDC2 leading into CT. 
Phosphoserine 1157 is tightly bound by two highly conserved arginines (Arg1173, 
Arg1260) of CDC1 (Figure 2.1d). Already the binding of phosphorylated Ser1157 
apparently stabilizes the regulatory loop conformation, the accessory 
phosphorylation sites Ser1148 and Ser1162 in the same loop may further 
modulate the strength of interaction between the regulatory loop and the CDC1 
and CDC2 domains. Phosphorylation of the regulatory loop thus determines 
interdomain interactions of CDC1 and CDC2 suggesting that it may exert its 
regulatory function by modifying the overall structure and dynamics of the CD.  
The functional role of Ser1157 was confirmed by an activity assay based on the 
incorporation of radioactive carbonate into acid non-volatile material 193. 
Phosphorylated SceACC shows only residual activity (kcat = 0.4 J 0.2 s-1), which 
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increases 16-fold (kcat = 6.5 J 0.3 s-1) after dephosphorylation with K protein 
phosphatase. The values obtained for dephosphorylated SceACC are 
comparable to earlier measurements of non-phosphorylated yeast ACC 
expressed in E. coli 194. 
2.3.3! The variable CD is conserved between yeast and human  
To compare the organization of fungal and human ACC CD, we determined the 
structure of a human ACC1 fragment that comprises the BT and CD domains 
(HsaBT-CD), but lacks the mobile BCCP in between (Figure 2.1a). An 
experimentally-phased map was obtained at 3.7 # resolution for a cadmium-
derivatized crystal and was interpreted by a poly-alanine model (Figure 2.1e, 
Tab.1). Each of the four CD domains in HsaBT-CD individually resembles the 
corresponding SceCD domain; however, human and yeast CDs exhibit distinct 
overall structures. In agreement with their tight interaction in SceCD, the relative 
spatial arrangement of CDC1 and CDL is preserved in HsaBT-CD, but the human 
CDL/CDC1 didomain is tilted by 30° based on a superposition of human and yeast 
CDC2 (Supplemental Figure 2.1c). As a result, the N-terminus of CDL at helix L"1, 
which connects to CDN, is shifted by 12 $. Remarkably, CDN of HsaBT-CD 
adopts a completely different orientation compared to SceCD. With CDL/CDC1 
superposed, CDN in HsaBT-CD is rotated by 160° around a hinge at the 
connection of CDN/CDL (Supplemental Figure 2.1d). This rotation displaces the N-
terminus of CDN in HsaBT-CD by 51 $ compared to SceCD resulting in a 
separation of the attachment points of the N-terminal linker to the BCCP domain 
and the C-terminal CT domain by 67 $ (the attachment points are indicated with 
spheres in Figure 2.1e). The BT domain of HsaBT-CD consists of a helix that is 
surrounded at its N-terminus by an anti-parallel eight-stranded !-barrel. It 
resembles the BT of PCC 59, only the four C-terminal strands of the !-barrel are 
slightly tilted.  
Based on MS analysis, insect-cell expressed human full-length ACC Ser80 
shows the highest degree of phosphorylation (90%). Ser29 and Ser1263, 
implicated in insulin-dependent phosphorylation and BRCA1 binding, 
respectively, are phosphorylated at intermediate levels (40%). The highly 
conserved Ser1216 (corresponding to S. cerevisiae Ser1157), as well as Ser1201, 
both in the regulatory loop discussed above, are not phosphorylated. However, 
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residual phosphorylation levels were detected for Ser1204 (7%) and Ser1218 
(7%) in the same loop. MS analysis of the HsaBT-CD crystallization sample 
reveals partial proteolytic digestion of the regulatory loop. Accordingly, most of 
this loop is not represented in the HsaBT-CD crystal structure. The absence of 
the regulatory loop might be linked to the less restrained interface of CDC2 and 
CDL/CDC1 and altered relative orientations of these domains. Besides the 
regulatory loop, also the phosphopeptide target region for BRCA1 interaction is 
not resolved presumably due to pronounced flexibility.  
At the level of isolated yeast and human CD, the structural analysis indicates the 
presence of at least two hinges, one with large-scale flexibility at the CDN/CDL 
connection, and one with tunable plasticity between CDC2 and CDL/CDC1, 
plausibly affected by phosphorylation in the regulatory loop region.  
2.3.4! The integration of CD into the fungal ACC multienzyme 
To further obtain insights into the functional architecture of fungal ACC, we 
characterized larger multi-domain fragments up to the intact enzymes. Using 
molecular replacement based on fungal ACC BC, CD and CT models, we 
obtained structures of a variant comprising CthCT and CDC1/CDC2 in two crystal 
forms at resolutions of 3.6 # and 4.5 #%DCthCD-CTCter1/2), respectively, as well as 
of a CthCT linked to the entire CD at 7.2 #%-.&12'*51/%DCthCD-CT) (Figure 2.1a, 2, 
Tab. 1). No crystals diffracting to sufficient resolution were obtained for larger 
BC-containing fragments, or for full-length Cth or SceACC. To improve 
crystallizibility, we generated LBCCP variants of full-length ACC, which based on 
SAXS analysis preserve properties of intact ACC (Supplemental Figure 2.2a-c). 
For CthLBCCP, crystals diffracting to 8.4 # resolution were obtained. However, 
molecular replacement did not reveal a unique positioning of the BC domain. Due 
to the limited resolution the discussion of structures of CthCD-CT and 
CthLBCCP is restricted to the analysis of domain localization. Still, these 
structures contribute considerably to the visualization of an intrinsically dynamic 
fungal ACC.  
In all these crystal structures, the CT domains build a canonical head-to-tail 
dimer 190, with active sites formed by contributions from both protomers (Figure 
2.2, Supplemental Figure 2.3a). The connection of CD and CT is provided by a 
10-residue peptide stretch, which links the N-terminus of CT to the irregular "- 


































Figure 2.2 Architecture of the CD-CT core of fungal ACC.  
Cartoon representation of crystal structures of multi-domain constructs of CthACC. One 
protomer is shown in color and one in gray. Individual domains are labeled, the active site 
of CT and the position of the conserved phosphoserine site (Ser1157 in S. cerevisiae 
ACC) are indicated by an asterisk and a triangle, respectively. 
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hairpinH"-strand extension of CDC2 DSupplemental Figure 2.3bF;% B).% (1//.(*5/M%
-.M51/%5&%-.4+-A+,26%&5452+-%5/%5&12+*.3%9I%+/3%!"#9I>9B9*.-%&*-'(*'-.&$%5/35(+*5/M%
5/).-./*%(1/01-4+*51/+2%&*+,525*6;%CD/CT contacts are only formed in direct vicinity 
of the covalent linkage and involve the ">)+5-<5/ extension of CDC2 as well as the 
loop between strands "2/"3 of the CT N-lobe, which contains a conserved 
N77O7=% 41*50;% Bhe neighboring loop on the CT side (between CT "G/"?F is 
displaced by 2.5 #% (14<+-.3% *1% 5&12+*.3% 9B% &*-'(*'-.&% DSupplemental Figure 
2.3c);% Based on an interface area of around 600 #?% +/3% 5*&% .3M.>*1>.3M.%
(1//.(*51/%()+-+(*.-5&*5(&$% *).% 5/*.-0+(.%,.*E../%9B%+/3%9I%45M)*%,.%(2+&&505.3%
+&%(1/01-4+*51/+226%P+-5+,2.; Indeed, the comparison of the positioning of eight 
instances of the C-terminal part of CD relative to CT in crystal structures 
determined here, reveals flexible interdomain linking (Figure 2.3a): The CDC2/CT 
interface acts as a true hinge with observed rotation up to 16Q, which results in a 
translocation of the distal end of CDC2 by 8 #.  
The interface between CDC2 and CDL/CDC1, which is mediated by the 
phosphorylated regulatory loop in the SceCD structure, is less variable than the 
CD-CT junction, and permits only limited rotation and tilting (Figure 2.3b).%
R/+26&5&% 10% *).% 54<+(*% 10% <)1&<)1-62+*51/% 1/% *).% 5/*.-0+(.% ,.*E../% CDC2 and 
CDL/CDC1%5/%!"#R99%P+-5+/*%&*-'(*'-.&%5&%<-.(2'3.3%,6%*).%2545*.3%(-6&*+221M-+<)5(%
-.&12'*51/;% S1E.P.-$% TU% +/+26&5&% 10% !"#9I>9B% +/3% 9*)L899:% (1/&*-'(*&%
-.P.+2.3% ,.*E../% @V% +/3% WVX% <)1&<)1-62+*51/% 10% U.-GGWV% D(1--.&<1/35/M% *1%
$%&R99% U.-GGYWF;% B).% 9I=% 314+5/% <1&5*51/5/M% -.2+*5P.% *1% 9IZH9I9G% 5&% )5M)26%
P+-5+,2.%E5*)%*)-..%4+5/%1-5./*+*51/&%1,&.-P.3%5/%*).%&*-'(*'-.&%10%$%&9I and the 
larger CthACC fragments[%9I=%*52*&$%-.&'2*5/M% 5/%+%35&<2+(.4./*%10% 5*&%=>*.-45/'&%
,6%?\%#%DFigure 2.4+$%1,&.-P.3%5/%,1*)%<-1*14.-&%10%!"#9I>9B%+/3%1/.%<-1*14.-%
10% !"#L899:F;% ]/% +335*51/$% 9I=% (+/% -1*+*.% +-1'/3% )5/M.&% 5/% *).% (1//.(*51/%
,.*E../% 9I=H9IZ% ,6% WVQ% DFigure 2.4,$% 1,&.-P.3% 5/% *).% &.(1/3% <-1*14.-% 10%
!"#L899:F%+/3%G@VQ%DFigure 2.4($%1,&.-P.3% 5/%$%&9IF% 2.+35/M%*1%35&<2+(.4./*%
10%*).%+/()1-%&5*.%01-%*).%899:%25/A.-%,6%'<%*1%\\%#%+/3%CV%#$%-.&<.(*5P.26;%%
91/01-4+*51/+2%P+-5+,525*6% 5/%*).%9I%*)'&%(1/*-5,'*.&%(1/&53.-+,26%*1%P+-5+*51/&%5/%
*).% &<+(5/M% ,.*E../% *).% 89% +/3% 9B% 314+5/&$% +/3% 4+6% .7*./3% *1% 35&*+/(.%
P+-5+*51/&%,.61/3%*).%41,525*6%-+/M.%10%*).%02.75,26%*.*).-.3%899:;%8+&.3%1/%*).%
1(('--./(.% 10% *).% 35&*5/(*% (1/01-4+*51/&% ,.*E../% 0'/M+2% +/3% )'4+/% R99%
0-+M4./*&$% *).6%4+6%E.22% -.<-.&./*% M./.-+2% (1/01-4+*51/+2% &*+*.&% <-.&./*% 5/% +22%
.'A+-61*5(%R99&;%%%
%





















Figure 2.3 Structural variability of the CD-CT connection in fungal ACC.  
(a) Hinge properties of the CD-CT connection analyzed by a CT-based superposition of 
eight instances of the CDC1/CDC2-CT segment. For clarity, only one protomer CthCD-
CTCter1 is shown in full color as reference. For other instances, CDC2 domains are shown in 
transparent tube representation with only one helix each highlighted. The range of hinge 
bending is indicated and the connection points between CDC2 and CT (blue) as well as 
between CDC1 and CDC2 (green and gray) are marked as spheres. (b) The interdomain 
interface of CDC1 and CDC2 exhibits only limited plasticity. Representation as in (a), but the 
CDC1 and CDC2 are superposed based on CDC2. One protomer of CthLBCCP is shown in 
color, the CDL domains are omitted for clarity and the position of the phosphorylated 
serine is indicated with a red triangle. The connection points from CDC1 to CDC2 and to 
CDL are represented with green spheres.!
2.3.5! Large-scale conformational variability of fungal ACC  
B1% 1,*+5/% +% (14<-.)./&5P.% P5.E% 10% 0'/M+2% R99% 36/+45(&% 5/% &12'*51/$% E.% )+P.%
.4<216.3%UR^U%+/3%_T;%UR^U%+/+26&5&%10%!"#R99%+M-..&%E5*)%+%354.-5(%&*+*.%
+/3% +/% .21/M+*.3% &)+<.%E5*)% +%4+754'4%.7*./*% 10% \YV%#% DU'<<2.4./*+2% B+,2.%
?;?F;% B).% &411*)% +<<.+-+/(.% 10% &(+**.-5/M% ('-P.&% +/3% 3.-5P.3% 35&*+/(.%
35&*-5,'*51/&% 45M)*% 5/35(+*.% &',&*+/*5+2% 5/*.-314+5/% 02.75,525*6% G`Y% DSupplemental 
Figure 2.2+>(F;% I5-.(*% 1,&.-P+*51/% 10% 5/35P53'+2% 0'22>2./M*)% 9"#R99% <+-*5(2.&$%
+((1-35/M% *1%TU% -.&'2*&% <-.3145/+/*26% 5/% +% <)1&<)1-62+*.3% 21E%+(*5P5*6% &*+*.$% 5/%



















Figure 2.4 The conformational dynamics of fungal ACC.  
(a)-(c) Large-scale conformational variability of the rotation of the CDN domain relative to 
the CDL/CDC1 domain. CthCD-CT1 (in color) serves as reference, the compared structures 
(as indicated) are shown in gray. Domains other than CDN and CDL/CDC1 are omitted for 
clarity. The domains are labeled and t).%35&*+/(.&%,.*E../%*).%=>*.-45/5%10%CDN (spheres) 
in the compared structures +-.%5/35(+*.3; D"F%U().4+*5(%413.2%10%0'/M+2%R99%&)1E5/M%*).%
5/*-5/&5($% -.M'2+*.3% 02.75,525*6% 10% 9I% 5/% *).% <)1&<)1-62+*.3$% 5/)5,5*.3% +/3% *).% /1/>
<)1&<)1-62+*.3% +(*5P+*.3% &*+*.;% b2.75,525*6% 10% *).% 9I9?H9B% +/3% 9I=H9IZ% )5/M.&% 5&%
522'&*-+*.3% ,6% +--1E&;% B).% U.-GGYW% <)1&<)1-62+*51/% &5*.% +/3% *).% 3.<)1&<)1-62+*.3%
-.M'2+*1-6%211<%+-.%(121-.3%5/%4+M./*+;!
%
92+&&% +P.-+M.&$% 1,*+5/.3% ,6% 4+754'4>25A.25)113>,+&.3% ?I% (2+&&505(+*51/$% +-.%
01('&.3%1/%*).%354.-5(%9B%314+5/%+/3%*).%0'22%89>899:>9I%314+5/%10%1/26%1/.%
<-1*14.-$% 3'.% *1% *).% /1/>(11-35/+*.3% 41*51/&% 10% *).% 2+*.-+2% 89H9I% -.M51/&%
-.2+*5P.% *1% *).% 9B% 354.-;% B).6% 53./*506% *).% (1//.(*51/&% ,.*E../% 9I=H9IZ% +/3%
,.*E../% 9I9?H9B% +&% 4+c1-% (1/*-5,'*1-&% *1% (1/01-4+*51/+2% ).*.-1M./.5*6%
DSupplemental Figure 2.4+$% ,F;% B).% 02.75,525*6% 5/% *).% 9I9?H9B% )5/M.% +<<.+-&%
&',&*+/*5+226% 2+-M.-% *)+/% *).% P+-5+*51/&% 1,&.-P.3% 5/% *).% &.*% 10% (-6&*+2% &*-'(*'-.&;%
B).%89%314+5/%5&%/1*%(14<2.*.26%35&1-3.-.3$%,'*%2+*.-+226%+**+().3%*1%8BH9I=%5/%+%
M./.-+226%(1/&.-P.3%<1&5*51/$%+2,.5*%E5*)%5/(-.+&.3%02.75,525*6;%U'-<-5&5/M26$% 5/%,1*)%
*).% 25/.+-% +/3%a>&)+<.3% (1/01-4+*51/&$% *).% +<<-1754+*.% 35&*+/(.&% ,.*E../% *).%
89% +/3% 9B% +(*5P.% &5*.&% E1'23% -.4+5/% 2+-M.-% *)+/% GGV% #;% B).&.% 1,&.-P.3%
35&*+/(.&% +-.% (1/&53.-+,26% 2+-M.-% *)+/% 5/% &*+*5(% &*-'(*'-.&% 10% +/6% 1*).-% -.2+*.3%
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,51*5/>3.<./3./*% (+-,1762+&.;% b'-*).-41-.$% ,+&.3% 1/% +/% +P.-+M.% 2./M*)% 10% *).%
899:>9I% 25/A.-% 5/% 0'/M+2% R99% 10% ?@% +45/1% +(53&$%41,525*6% 10% *).% 899:% +21/.%
E1'23% /1*% ,.% &'005(5./*% *1% ,-53M.% *).% +(*5P.% &5*.&% 10% 89% +/3% 9B;% 91/&.d'./*26$%
5/(-.+&.3% 02.75,525*6% 1-% +335*51/+2% 413.&% 10% (1/01-4+*51/+2% ()+/M.&% 4+6% ,.%
-.d'5-.3% 01-%<-13'(*5P.%(+*+26&5&;%B).%41&*% -.2.P+/*% (+/353+*.%&5*.% 01-%4.35+*5/M%













*).% -.M'2+*1-6% 211<% (1/*+5/5/M% U.-GGYW% E.3M.&% ,.*E../% 9I9GH9I9?% +/3%
<-.&'4+,26% 2545*&% *).% (1/01-4+*51/+2% 0-..314% +*% *)5&% 5/*.-314+5/% 5/*.-0+(.;%
S1E.P.-$% 02.75,525*6% +*% *)5&% )5/M.% 4+6% ,.% -.d'5-.3% 01-% 0'22% R99% +(*5P5*6$% +&% *).%
35&*+/(.&% ,.*E../% *).%899:% +/()1-% <15/*&% +/3% *).% +(*5P.% &5*.&% 10% 89% +/3%9B%
1,&.-P.3%).-.%+-.%&'()%2+-M.$%*)+*%41,525*6%10%*).%899:%+21/.%5&%/1*%&'005(5./*%01-%
&',&*-+*.%*-+/&0.-;%B).%('--./*%3+*+%*)'&%&'MM.&*%*)+*%-.M'2+*51/%10%0'/M+2%R99%5&%
4.35+*.3% ,6% (1/*-1225/M% *).% 36/+45(&% 10% *).% '/5d'.% 9I$% -+*).-% *)+/% 35-.(*26%
+00.(*5/M% (+*+26*5(% *'-/1P.-% +*% *).% +(*5P.% &5*.&% 10% 89% +/3% 9B;% R% (14<+-5&1/%
,.*E../% 0'/M+2% +/3% )'4+/% R99% E522% ).2<% *1% 0'-*).-% 35&(-545/+*.% 4.()+/5&*5(%





+/3% +&&.4,2.&% 5/% +% *-5+/M'2+-% +-()5*.(*'-.% E5*)% 354.-5(% 89% 314+5/&%
DSupplemental Figure 2.5+F;%]/%*).5-%&*'36$%4'*+*51/+2%3+*+%5/35(+*.%+%-.d'5-.4./*%
01-%89%354.-5f+*51/% 01-% (+*+26*5(% +(*5P5*6;% B).% *-+/&5*51/% 0-14% *).% .21/M+*.3% 1<./%





4+c1-% (1/*-5,'*1-% *1% (1/01-4+*51/+2% 02.75,525*6% DSupplemental Figure 2.5,$% (F;% ]/%
02R99$%9I9?%-1*+*.&%+<<-1754+*.26%G?VQ%E5*)%-.&<.(*%*1%*).%9B%314+5/;%R%&.(1/3%
)5/M.% (+/% ,.% 53./*505.3% ,.*E../%9I9GH9I9?;%8+&.3%1/% +% &'<.-<1&5*51/% 10%9I9?$%
9I9G%10%*).%<)1&<)1-62+*.3%$%&9I%5&%-1*+*.3%,6%\VQ%-.2+*5P.%*1%9I9G%10%*).%/1/>
<)1&<)1-62+*.3% 02R99% DSupplemental Figure 2.53F$% &5452+-% *1% E)+*% E.% )+P.%
1,&.-P.3% 01-% *).% /1/><)1&<)1-62+*.3% 0./8B>9I% DSupplemental Figure 2.13F;%
g)./% 5/&<.(*5/M% +22% 5/35P53'+2% <-1*14.-% +/3% 0-+M4./*% &*-'(*'-.&% 5/% *).5-% &*'36$%
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522'&*-+*5/M% *).% 5/(-.+&.3% 02.75,525*6% 3'.% *1% *).% +,&./(.% 10% *).% <)1&<)1-62>M-1'<;%
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.21/M+*.3% +/3% a>&)+<.3% (1/01-4+*51/&% +/3% -.P.+2% /1% +<<+-./*% 3500.-./(.&% 5/%
<+-*5(2.% &)+<.% 35&*-5,'*51/&% DSupplemental Figure 2.7F;% B)5&% 54<25(+*.&% *)+*% *).%
*-5+/M'2+-%&)+<.%E5*)%354>.-5(%89%314+5/&%)+&%+%21E%<1<'2+*51/%+2&1%5/%*).%+(*5P.%
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Z+-M.>&(+2.% (1/01-4+*51/+2% P+-5+,525*6% )+&% +2&1% ,../% 1,&.-P.3% 5/% 41&*% 1*).-%
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5/01-4+*51/% &'MM.&*&% *)+*% P+-5+,2.% (+--5.-% <-1*.5/% *.*).-5/M% 5&% /1*% &'005(5./*% 01-%
.005(5./*% &',&*-+*.% *-+/&0.-% +/3% (+*+26&5&% 5/% +/6% 10% *).&.% &6&*.4&;% B).%
3.*.-45/+*51/% 10% +% &.*% 10% (-6&*+2% &*-'(*'-.&% 10% $%&R99% 5/% *E1% &*+*.&$%
'/<)1&<)1-62+*.3% G`C% +/3% <)1&<)1-62+*.3% +*% *).% 4+c1-% -.M'2+*1-6% &5*.% U.-GGYW$%
<-1P53.&% +% '/5d'.% 3.<5(*51/% 10% 4'2*5./f64.% -.M'2+*51/% ,6% <1&*>*-+/&2+*51/+2%
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2.5! Methods 
2.5.1! Protein Expression & Purification 
All proteins were expressed in the Baculovirus Expression Vector System. The 
MultiBac™ insect cell expression plasmid pACEBACI (Geneva Biotech) was 
modified to host a GATEWAY® (LifeTechnologies) cassette with an N-terminal 
10xHis-tag, named pAB1GW-NH10 hereafter. Full-length HsaACC (Genebank 
accession #U19822), SceACC (#NC_001146), CthACC (#XM_006692575) were 
cloned into pAB1GW-NH10 using GATEWAY® according to manufacturers 
manual. Truncated variants were constructed by PCR amplification, digestion of 
the template DNA with DpnI, phosphorylation of the PCR-product and religation 
of the linear fragment to a circular plasmid. The following constructs were used 
for this study: SceACC (1–2233), CthACC (1–2297), Cth%BCCP (1–2297, %700–
765), CthCD-CT (788–2297), CthCD-CTCter (1114–2297), SceCD (768–1494), 
HsaBT-CD (622–1584, %753–818). Bacmid and virus production was carried out 
according to MultiBac™ instructions 199. Baculovirus generation and amplification 
as well as protein expression were performed in Sf21 cells (Expression Systems) 
in Insect-Xpress medium (Lonza). The cells were harvested between 68-96h post 
infection by centrifugation and stored at -80 °C until being processed. 
Cells were lysed by sonication and the lysate was cleared by ultracentrifugation. 
Soluble protein was purified using Ni-NTA (Genscript) and size exclusion 
chromatography (Superose 6, GE Healthcare). The affinity tag was removed by 
TEV-cleavage overnight at 4°C. TEV-protease and uncleaved protein were 
removed by orthogonal Ni-NTA purification prior to size exclusion 
chromatography. SceACC, CthACC and Cth%BCCP were further purified by 
high-resolution anion exchange chromatography prior to size exclusion 
chromatography. Purified SceCD, CthCD-CTCter, CthCD-CT, Cth%BCCP, SceACC 
were concentrated to 10 mg ml-1 in 30 mM MOPS pH 7, 200 mM ammonium 
sulfate, 5% glycerol and 10 mM dithiothreitol and purified HsaBT-CD was 
concentrated to 20 mg ml-1 in 20 mM bicine pH 8.0, 200 mM NaCl, 5% glycerol, 
and 5 mM TCEP. Proteins were used directly or were stored at –80°C after flash-
freezing in liquid nitrogen. 
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2.5.2! Protein Crystallization 
All crystallization experiments were conducted using sitting drop vapour 
diffusion. SceCD crystals were grown at 19 °C by mixing protein and reservoir 
solution (0.1 M BisTrisPropane pH 6.5, 0.05 – 0.2 M di-sodium malonate, 20 – 
30% polyethylene glycol (PEG) 3350, 10 mM trimethylamine or 2% benzamidine) 
in a 1:1 or 2:1 ratio. Crystals appeared after several days and continued to grow 
for 20 to 200 days. Crystals were cryo-protected by short incubation in mother 
liquor supplemented with 22% ethylene glycol and flash-cooled in liquid nitrogen. 
For heavy metal derivatization the crystals were incubated in stabilization solution 
supplemented with 1 mM Thimerosal or 10 mM EuCl2, respectively, and then 
backsoaked for 15 seconds in stabilization solution without heavy metal. 
Initial crystals of HsaBT-CD grew in 0.1 M Tris pH 8.5, 0.35 M tri-potassium 
citrate and 2 – 3.5% PEG10000 at 19 °C. After several rounds of optimization 
good quality diffraction crystals were obtained at 19 °C in 0.1M MES pH 6, 0.25 – 
0.35 M tri-potassium citrate, 2 – 5% PEG10000, 0.01 – 0.04 M cadmium chloride. 
The protein drop contained a 1:1 ratio of protein and reservoir solution. Crystals 
grew immediately and stopped growing after 3 days. They were dehydrated and 
cryoprotected in several steps in artificial mother liquor containing incrementally 
increasing concentrations of tri-potassium citrate, PEG10000 and ethylene glycol 
and then flash-cooled in liquid nitrogen. The final solution was composed of 0.1 
M MES pH6, 0.5 M tri-potassium citrate, 6.75% PEG10000, 0.01 M cadmium 
chloride.  
CthCD-CTCter crystals were grown at 19°C by mixing protein and reservoir 
solution (0.1 M Hepes pH 7.5, 2 – 7% Tacsimate pH 7, 7.5 – 15% PEGMME5000) 
in a 1:1 ratio. Crystals appeared after several days and continued to grow for up 
to two weeks. Crystals were cryo-protected by short incubation in mother liquor 
supplemented with 22% ethylene glycol. 
CthCD-CT ACC crystals were grown at 19 °C by mixing protein and reservoir 
solution (0.1 M Bicine pH 8.5 – 9.5, 4 – 8% PEG8000) in a 1:1 or 1:2 ratio. 
Crystals grew 8 to 10 days and were cryo-protected by short incubation in 
mother liquor supplemented with 22% ethylene glycol before flash-cooling in 
liquid nitrogen. 
Cth%BCCP ACC crystals were grown at 19 °C by mixing protein and reservoir 
solution (0.1 M morpheus buffer 3, 7 – 12% Morpheus ethylene glycols mix, 8 – 
12% PEG4000, 17 – 23% glycerol) in a 1:1 or 1:2 ratio. Crystals grew up to three 
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weeks and were cryo-protected in reservoir solution before flash cooling in liquid 
nitrogen. 
2.5.3! Structure Determination and Analysis of Phosphorylation 
All X-ray diffraction data were collected at beamlines X06SA (PXI) and X06DA 
(PXIII) at the Swiss Light Source (SLS, Paul Scherrer Institute, Villigen, 
Switzerland) equipped with PILATUS detectors, respectively. The wavelength of 
data collection was 1.000 $ for native crystals, and 1.527 $ and 1.907 $ for 
crystals derivatized with europium and cadmium, respectively. Raw data were 
processed using XDS 200. Molecular replacement was carried out using Phaser 
2.5.7 and 2.6.0, density modification was done using Parrot 201,202 and resolve, 
multi crystal averaging 203 was carried out using phenix. All model building was 
conducted using Coot 204 and figures were prepared using PyMOL (Schrödinger 
LLC).  
Diffraction of initial SceCD crystals in space group P43212 with unit cell 
dimensions of a = b = 110.3 $ and c = 131.7 $ was limited to 3.5 $. The 
resolution was improved to 3 $ by addition of trimethylamine or benzamidine to 
the reservoir solution without significant changes in unit cell dimensions. Crystals 
derivatized with thimerosal and europium were used for initial SAD phase 
determination using the SHELXC/D package 205. Two mercury and four europium 
sites were located and an initial model was placed in the resulting maps. Since 
crystals derivatized with europium were slightly non-isomorphous with a c-axis 
length of 127 $, multi crystal averaging was used for density modification and 
provided directly interpretable maps. Iterative cycles of model building and 
refinement in Buster (version 2.10.2; Global Phasing Ltd.) converged at Rwork/Rfree 
of 0.20/0.25. The final model lacks the disordered N-terminus (amino acids 768 – 
789), an extended loop in the CDC1 domain (1204 – 1215) and a short stretch 
(1147 – 1152) preceding the regulatory loop. Based on temperature factor 
analysis, the start and end of the regulatory loop show higher disorder than the 
region around the interacting phosphoserine 1157. MS analysis of dissolved 
crystals detected quantitative phosphorylation of the regulatory Ser1157, as also 
found for full length SceACC, and additionally albeit with much lower occurrence, 
phosphorylation of Ser790, Ser1137, Ser1148 and Ser1159. A modeled 
phosphoryl-position for Ser1159 could overlap with the one of Ser1157, and 
might be represented in the crystal. For all other phosphorylation sites no 
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difference density could be observed, probably due to very low occupancy. 
PDBeFold 206 was used to search for structural homologues. The thresholds for 
lowest acceptable percentage of matched secondary structure elements were 
70% for the search query and 20% for the result. 
Initial HsaBT-CD crystals were obtained in space group I4122 with a = b = 240.1 
$ and c = 768.9 $ and diffracted to only 7.5 $. Optimized and dehydrated 
crystals also belonged to space group I4122 but with unit cell parameters a = b = 
267.3 $ and c = 210.6 $ and diffracted up to a resolution of 3.7 $. Phase 
information was obtained from SAD based on bound cadmium ions from the 
crystallization condition. Six cadmium positions were located in a 4.0 $ resolution 
dataset at 1.9 $ wavelength using SHELXC/D 205 via the HKL2MAP interface 207. 
Density modification and phasing based on this anomalous dataset, a 3.7 $ 
resolution data set at 1.0 $ wavelength, and additional non-isomorphous lower 
resolution datasets led to a high-quality electron density map. At the intermediate 
resolution obtained, the map was interpreted by a poly-alanine model, which was 
guided by predicted secondary structure as well as sequence and structural 
alignment with SceCD. The final model refines against experimental data with 
with Rwork/Rfree of 0.38/0.41, as expected for a poly-alanine model 203. Two HsaBT-
CD monomers are packed in the asymmetric unit via the CDN and BT domains. 
Density on top of the !-barrel of one BT most likely representing parts of the BT-
CD linker guided the assignment of this BT to its linked CD partner domain. This 
BT-to-CD assignment was further supported by the analysis of an additional 
lower resolution crystal form. Cadmium ions were found to participate in crystal 
packing.  
In HsaACC. phosphorylation at regulatory sites was detected as provided in the 
main text. No phosphorylation was detected for other phosphosites previously 
identified in large-scale phosphoproteomics studies, namely serines 5, 23, 25, 
48, 53, 78, 488, 786, 1273 208-210. 
Two different crystal forms were obtained for CthCD-CTCter (denoted as CthCD-
CTCter1 and CthCD-CTCter1), diffracting to 3.6 $ and 4.5 $, respectively. Both forms 
packed in space group P212121 with unit cell constants of a = 97.7 $, b = 165.3 $ 
and c = 219.2 $ or a = 100.2 $, b = 153.5 $ and c = 249.2 $, respectively. 
Phases were determined by molecular replacement using a homology model 
based on SceCT (pdb 1od2) as search model in Phaser 202,211,212, multi crystal 
averaging was applied in density modification. The CT domain was rebuilt and an 
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initial homology model based on the SceCD structure was fitted into difference 
density for CthCD-CTCter1. Iterative cycles of rebuilding and refinement in Buster 
converged at Rwork/Rfree of 0.20/0.25. The refined CD fragment served as a starting 
model for rebuilding CthCD-CTCter2 at lower resolution. Coordinate refinement in 
Buster was additionally guided by reference model restraints and converged at 
Rwork/Rfree of 0.26/0.30. Residues 1114 – 1188, 1213 – 1252, 1380 – 1385 and 
2188 – 2195 were disordered in both crystal forms and are not included in the 
models. Conservation was mapped onto the CthCD-CTCter1 crystal structure using 
al2co 213 based on a sequence alignment of 367 fungal ACC sequences 
calculated by Clustal Omega 214. MS analysis of purified protein detected 7% 
phosphorylation at Ser1170 (corresponding to Ser1157 in SceCD). 
CthCD-CT crystallized in P31212 with unit cell constants of a = b = 195.0 $ and c 
= 189.5 $ and crystals diffracted to a resolution of 7.2 $. The structure was 
solved by molecular replacement using a model composed of CthCT and CDC2 as 
search model in Phaser. CDC1 and CDN were placed manually into the resulting 
maps and the model was refined using rigid-body, domain-wise TLS and B-
factor refinement and NCS- and reference model restrained coordinate 
refinement in Buster to Rwork/Rfree of 0.26/0.28. Residues 1033 – 1035, 1134 – 
1152, 1214 – 1252, 2188 – 2195 and 2260 – 2297 were not included in the 
models. Conservation was mapped onto the CthCD-CT crystal structure as for 
CthCD-CTCter. MS analysis of purified protein detected 60% phosphorylation at 
Ser1170 (corresponding to Ser1157 in SceCD). 
Cth%BCCP ACC crystallized in P6422 with unit cell constants of a = b = 462.2 $ 
and c = 204.6 $, resolution was limited to 8.4 $. Structure determination and 
refinement was performed as for CthCD-CT. Final Rwork/Rfree were 0.31/0.34. 
Although substantial difference density is observed, in accordance with the lack 
of the BT and BC domains in the model, no defined positioning of these domains 
could be derived. Additionally, residues 1033 – 1035, 1134 – 1152, 1214 – 1252, 
2188 – 2195 and 2260 – 2297 were not included in the models. MS analysis of 
purified protein detected 70% phosphorylation at Ser1170 (corresponding to 
Ser1157 in SceCD). 
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2.5.4! Small-angle X-ray Scattering 
Proteins were thawed on ice and dialyzed overnight against 30 mM MOPS pH 7, 
200 mM ammonium sulfate, 5% glycerol and 10 mM dithiothreitol. Raw 
scattering data were measured at SAXS beamline B21 at Diamond Light Source. 
The samples were measured at concentrations of 2.5, 5 and 10 mg ml-1. Data 
were processed using the ATSAS package 215 according to standard procedures 
216,217. A slight increase in scattering in the very low-resolution range was 
observed with increasing protein concentrations, which may be due to 
interparticle attraction or minor aggregation. Scattering intensities were thus 
extrapolated to zero concentration using point-wise extrapolation implemented in 
Primus 218. Direct comparison of raw scattering curves demonstrates the 
similarity of CthACC and Cth%BCCP, and the derived values such as Rg and 
Porod Volume match within expected error margins. Molecular mass estimations 
based on the SAXS-MOW method 219 derive values of 534.7 kDa and 534.0 kDa 
for CthACC and Cth%BCCP, respectively. The relative discrepancies to the 
theoretical weights of 516.8 kDa (CthACC) and 503.0 kDa (Cth%BCCP) are 3.5% 
and 6.2%, which is in a typical range for this method 219. 
2.5.5! Electron Microscopy 
Full-length CthACC was diluted to 0.01 mg ml-1 in 30 mM MOPS pH 7.0, 200 mM 
ammonium sulphate, 5% glycerol, and 10 mM dithiothreitol. Protein sample was 
adsorbed to a 200 µm copper grid and stained with 2% uranyl acetate. Grids of 
CthACC were imaged on a CM-200 microscope (Philips) equipped with a TVIPS 
F416 4k CMOS camera (Tietz Video and Image Processing Systems). The voltage 
used was 200 kV; and a magnification of 50000 x results in a pixel size of 2.14 $. 
Initial image processing and particle picking was carried out using Xmipp 220,221. 
22309 particles were picked semi-automatically from 236 micrographs with a box 
size of 300x300 pixels. After extraction, particles with a z-score of >3 were 
discarded and 22257 particles were aligned and classified into 48 2D class 
averages using maximum-likelihood target function in Fourier space (MLF2D). 
After 72 iterations, 4226 additional particles were discarded and the remaining 
18031 particles were re-aligned and classified into 36 classes using MLF2D with 
a high-resolution cutoff of 30 $. After 44 iterations the alignment converged and 
class averages were extracted. 
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2.5.6! In vitro Biotinylation and Activity Assay 
To ensure full functionality, SceACC was biotinylated in vitro using the E. coli 
biotin ligase BirA. The reaction mixture contained 10 µM ACC, 3.7 µM BirA, 50 
mM Tris-HCl, pH 8, 5.5 mM MgCl2, 0.5 mM biotin, 60 mM NaCl, 3 mM ATP, 10% 
glycerol and the reaction was allowed to proceed for 7 h at 30 °C. 
The catalytic activity of phosphorylated and dephosphorylated SceACC was 
measured following the incorporation of radioactive 14C into acid-stable non-
volatile material 193. Dephosphorylated ACC was prepared by over-night 
treatment with & protein phosphatase (New England Biolabs) of partially purified 
ACC before the final gel filtration step. The removal of the phosphoryl group from 
Ser1157 was confirmed by MS. The reaction mixture contained 0.5 µg 
recombinant ACC in 100 mM potassium phosphate, pH 8, 3 mM ATP, 5 mM 
MgCl2, 50 mM NaH14CO3 (specific activity 7.4 MBq mmol-1) and 1 mM acetyl-CoA 
in a total reation volume of 100 µl. The reaction mixture was incubated for 15 min 
at 30 °C, stopped by addition of 200 µl 6 M HCl and subsequently evaporated to 
dryness at 85 °C. The non-volatile residue was redissolved in 100 µl of water, 1 
ml Ultima Gold™ XR scintillation medium (Perkin Elmer) was added and the 14C 
radioactivity was measured in a Packard Tricarb 2000CA liquid scintillation 
analyzer. Measurements were carried out in five replicates and catalytic activities 
were calculated using a standard curve derived from measurements of varying 
concentrations of NaH14CO3 in reaction buffer. 
2.6! Accession codes 
Atomic coordinates and structure factors have been deposited in the Protein 
Data Bank with accession codes 5i6e (SceCD), 5i87 (HsaBT-CD), 5i6f/5i6g 
(CthCD-CTCter1/2), 5i6h (CthCD-CT), and 5i6i (CthLBCCP). 
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data, all authors contributed to manuscript preparation.  
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2.10!Supplemental Data 
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Supplemental Table 2.2%Small angle x-ray scattering data collection and processing 
  full length CthACC Cth%BCCP 
Instrument B21 at Diamond Light Source B21 at Diamond Light Source 
Beam size (mm) 1 x 5  1 x 5  
Wavelength ($) 1 1 
q range ($-1) 0.005 - 0.4 0.005 - 0.4 
Detector distance (m) 3.92 3.92 
Temperature (K) 293 293 
Protein concentration (mg/ml) 2.5, 5, 10 2.5, 5, 10 
Scan repeats 30 30 
Total exposure time (s) 300 300 
Capillary diameter (mm) 1.6 1.6 
I(0) (A-1) [from P(r)] '  0.023 0.024 
Rg ($) [from P(r)] ' 94 97 
Rg ($) (from Guinier) 89 ± 2 92 ± 3 
Porod volume estimate ($3) 1176290 1174390 
Dmax ($) 350 350 
 
  


















Supplemental Figure 2.1!Structure of SceCD and comparison to HsaBT-CD.  
(a) Stereo view of SceCD accompanying Fig 1b. (b) Stereo view of a representative part 
of the electron density in CDC2 of SceCD. Shown is a 2Fo-Fc map contoured at 1 (. (c) 
30° rotation of CDC1 in SceCD and HsaBT-CD visualized based on CDC2 superposition. 
SceCD is shown in color and HsaBT-CD is shown in gray. Both CDN domains and the 
HsaBT domain were omitted for clarity. The "-helix L"1 of both structures, the domain 
rotation and the distance between N-termini (shown as spheres) is indicated. (d) A 160° 
rotation relates CDN in SceCD to HsaBT-CD, visualized by CDL/CDC1 superposition. 
HsaBT domain was removed for clarity. Spheres indicate the N-termini and the coloring is 
as in (c). 




Supplemental Figure 2.2 SAXS analysis of fungal ACC.  
Scattering curves (a), distance distribution (b) and Kratky plots (c) of full-length CthACC 
(orange) and Cth%BCCP (black) demonstrating that BCCP-deletion has no impact on the 
overall solution structure. For clarity, scattering curves are shown with a y-axis offset. 
 
  




(a) Cartoon representation of CthCD-CT with one protomer colored according to 
conservation in a gradient from high (red) to low (blue). The second protomer is colored in 
gray. Contact regions of CDN and CDC1/CDL (asterisk), CDC1 and CDC2 (triangle) and CDC2 
and CT (square) are surrounded by regions of higher conservation. (b) Close-up on the 
edge-like hinge between CDC2 and CT. Highly conserved residues of RxxGxN motif are 
indicated as well as important strands of CDC1 and CT. The second CT protomer is 
omitted for clarity. (c) Superposition of nine isolated CT crystal structures (gray) onto the 
CT domain of CthCD-CTCter1 (red). The loop preceding the conserved RxxGxN motif is 
displaced in the CD-CT contact by 2.5 $ compared to isolated crystal structures. Pdb 
accession codes of structures used for superposition: 1od2, 1uys, 1uyt, 1w2x, 3h0j, 
3h0q, 3k8x, 3pgq, 3tv5. 




Supplemental Figure 2.4! Negative stain electron microscopy class averages of 
CthACC illustrating its flexibility.  
(a) 18031 particles were 2D-classified into 36 classes using the MLF2D method. Classes 
are sorted by number of particles per class, with the highest number at the top left and 
the lowest number at the bottom right. Scale bar 200 $. (b) 2D-class averages from 
negative stain EM analysis depict the ensemble of solution conformations of the intrinsic 
flexibility of CthACC. Scale bar 200 $. 
 
 
2 The Dynamic Organization of Fungal Acetyl-CoA Carboxylase 
 75 
 
Supplemental Figure 2.5!Conformational variability in fungal ACC.  
(a) Cartoon representation of triangular flACC (pdb accession code: 5csl). The domains 
are labeled according to the color scheme in (b). (b) Cartoon representation of Cth)BCCP 
colored according to the given color scheme. The orientations of (a) and (b) are based on 
a superposition of the CT domains. Fields of view for subpanels (c) and (d) are indicated 
with boxes and eyes. (c) Left: Detailed view of the CDC2/CT 120° hinge motion viewed 
along the rotation axis. Cth)BCCP is colored and flACC is shown in gray for clarity. 
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Corresponding ends of CDC2 helices are colored in yellow and magenta. The rotation axis 
is indicated and the view for the right subpanel is indicated with an eye. Right: View onto 
the rotation axis. (d) Conformational states of the CDC1-CDC2 hinge in the non-
phosphorylated flACC and in the phosphorylated SceCD crystal structures when 
superimposed on CDC2 domains. L"1, the first N-terminal helix of the CDL domain, is 
labeled to illustrate the conformational differences. The left panel shows the view along 
the rotation axis, the right panel corresponds to a view onto the axis. The position of the 





Supplemental Figure 2.6! Conformation of phosphorylated CDC1-CDC2 hinge is 
incompatible with BT/CDN conformation in flACC.  
(a) Detailed view on flACC (PDB accession code: 5csl) with CT and CDC2 domains shown 
as surface and BT, BCCP, CDN, CDL and CDC1 domains shown as cartoon. (b) flACC 
model with the CDC1-CDC2 hinge conformation as observed in the SceCD crystal 
structure. Clashes of BT/CDN with CT and CDN with CDC2, that are caused by the 30° 
rotation of CDC1 relative to CDC2 (rotation axis shown in (a)), are indicated with white 
circles. For orientation, the first helix of CDL is labeled in both panels. 
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Supplemental Figure 2.7!Negative stain electron microscopy of phosphorylated and 
dephosphorylated SceACC shows similar degree of conformational flexibility. 
Micrographs of phosphorylated (left) and dephosphorylated SceACC (right) are shown 
side by side. Selected particles representing elongated molecules and U-shaped 
molecules are indicated with black and orange arrows, respectively. The scale bar is 200 
nm.   
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3.1! Abstract 
Biotin-dependent acyl-Coenzyme A (CoA) carboxylases (aCCs) are involved in 
key steps of anabolic pathways and comprise three distinct functional units; 
biotin carboxylase (BC), biotin carboxyl carrier protein (BCCP) and carboxyl 
transferase (CT). YCC multienzymes are a poorly characterized family of 
prokaryotic aCCs of unidentified substrate specificity, which integrate all 
functional units into a single polypeptide chain. We employed a hybrid approach 
to study the dynamic structure of Deinococcus radiodurans (Dra) YCC: crystal 
structures of isolated domains reveal a hexameric CT core with extended 
substrate binding pocket and a dimeric BC domain. Negative stain electron 
microscopy provides an approximation for the variable positioning of the BC 
dimers relative to the CT core. Small-angle X-ray scattering yields quantitative 
information on the ensemble of Dra YCC structures in solution. Comparison to 
other carrier protein-dependent multienzymes highlights a characteristic range of 











Biotin-dependent carboxylases are ubiquitous enzymes catalyzing ATP-
dependent carboxylation in fatty acid, carbohydrate and amino acid metabolism, 
as well as in urea utilization and microbial polyketide biosynthesis 42,43,222-224. 
Based on their substrate specificity, biotin-dependent carboxylases are classified 
into three families: urea carboxylases (UCs), pyruvate carboxylases (PCs) and the 
general family of acyl-CoA carboxylases (aCCs) 57,62,225. The aCC family includes 
acetyl-CoA carboxylase (ACC), which catalyzes the key committed step in fatty 
acid biosynthesis, propionyl-CoA carboxylase (PCC) and 3-methylcrotonyl-CoA 
carboxylase (MCC) 42,226-229. Despite their diverse substrate specificities, all biotin-
dependent carboxylases share a common enzymatic mechanism and domain 
organization. Carboxylation is carried out in two half reactions and involves three 
functional components. First, a biotin carboxylase (BC) catalyzes the ATP-
dependent carboxylation of a biotin cofactor, which is covalently linked to a 
conserved lysine of the biotin carboxyl carrier protein (BCCP). Then, BCCP 
translocates to the carboxyl transferase (CT), where the carboxyl group of the 
carboxybiotin intermediate is transferred to the respective substrate 10,230. In this 
reaction scheme, the BC and BCCP are conserved components, while the CT 
varies in active site structure depending on the substrate. The structural 
organization differs vastly between various aCCs, despite their conserved 
reaction logic. aCCs either occur as multi-subunit enzymes, where the enzymatic 
functions are provided by distinct protein subunits, or as single-chain 
multienzymes, which integrate all enzymatic domains into one polypeptide chain 
(Figure 3.1A). The group of multi-subunit aCC comprises most prokaryotic forms, 
which consist of two, three or four subunits as exemplified by Streptomyces 
coelicolor PCC, Metallosphaera sedula ACC or Escherichia coli ACC, 
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respectively, as well as the eukaryotic PCC and MCC. Single-chain aCCs are 
represented by eukaryotic ACCs, which comprise a large, non-catalytic central 
domain in addition to the canonical enzymatic domains. Strikingly different 
oligomeric assemblies are observed for aCCs: Bacterial PCC and MCC are 
hetero-dodecamers with (BC-BCCP)6(CT)6 stoichiometry 228,229. Bacterial ACCs 
have a (BC)2(BCCP)4(CT"CT!)2 stoichiometry 34 and the archaeal ACC holoenzyme 
forms a (BC)4(BCCP)4(CT)4 hetero-dodecamer 83. Eukaryotic ACCs function as 
dimers or higher oligomeric filaments 85,194,231,232. 
Recently, in bacteria, a group of single-chain aCCs of yet unknown substrate 
specificity was identified. These enzymes, denoted as YCCs, encompass all 
functional domains in a single polypeptide chain of ~1200 amino acids. They 
share the domain order with eukaryotic ACCs, but lack the large central domain 
(Figure 3.1A). YCCs occur in a diverse set of unrelated bacterial species, 
including Pseudomonas aeruginosa, Cupriavidus metallidurans and 
Deinococcus radiodurans. For most YCCs, neither the substrates nor their 
physiological function or structure have been identified. The only exceptions are 
Mycobacterium avium LCC (Map LCC) and Rhodopseudomonas palustris LCC 
(Rpa LCC), for which a crystal structure and an initial substrate characterization, 
respectively, have been obtained recently 233. Based on high-resolution crystal 
structures of the CT and BC subunits and solution structural data, we report a 
hybrid model of the D. radiodurans YCC (Dra YCC), which provides insights into 
active site architectures, domain interactions and the dynamic organization of a 
complex YCC multienzyme. 




Dra YCC was overexpressed in Sf21 insect cells and purified in biotinylated form 
with a yield of ~30 mg per liter of culture. It forms a hexamer of ~680 kDa in 
solution, as confirmed by size exclusion chromatography coupled to multi-angle 
light scattering (SEC-MALS) (Supplemental Figure 3.1A). Size exclusion 
chromatography and SDS-PAGE analysis of the protein confirmed homogeneity 
and purity of the sample (Supplemental Figure 3.1B and C). We employed a 
hybrid approach of determining high-resolution crystal structures of the individual 
enzymatic domains in combination with analyzing the overall assembly structure 
and flexibility in solution by small-angle X-ray scattering (SAXS) and electron 
microscopy (EM). 
3.3.1! Crystal structure of a ring-shaped hexameric CT domain 
assembly  
We overexpressed the CT domain of Dra YCC (amino acids 556 – 1091) in Sf21 
cells. The protein forms a hexamer of ~330 kDa in solution based on SEC-MALS 
analysis (Supplemental Figure 3.1D). The CT domain was crystallized in space 
group P212121 and its structure was determined by molecular replacement using 
the transcarboxylase 12S subunit 82 as search model. The final model comprising 
residues 573 – 1091 was refined to Rwork/Rfree at 20.2%/24.1% at 2.4 $ 
resolution (Supplemental Table 3.1). The CT domain consists of two subdomains, 
the N-lobe (residues 554 - 832) and the C-lobe (residues 833 – 1091). Consistent 
with the oligomeric state in solution, the CT domain forms a hexameric ring with 
D3 symmetry, consisting of a trimer of dimers with an outer diameter of ~140 $ 
and a height of ~67 $ (Figure 3.1B and C). Dimerization of CT is mediated by 
head-to-tail interaction of two protomers with an interface area of ~3900 $2. Both 
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subdomains contribute to trimerization of CT dimers via an interface area of 
~2800 $2 per dimer.  
 
Figure 3.1 Dra YCC domain organization and hexameric CT domain structure.  
A. Schematic domain organization of eukaryotic ACC, PCC, E. coli ACC, Map LCC, and 
Dra YCC. Domain boundaries of Dra YCC are indicated. BC is shown in ruby, BCCP in 
dark gray, CT in blue, BT in red and CD domains in light gray. B. Top view of the 
hexameric CT domain organized as trimer of dimers. One dimer is depicted in light and 
dark blue, the remaining structure in gray, the D3 symmetry is indicated. N- and C-termini 
of the colored dimer are indicated with spheres. C. Side view of one CT dimer, as 
indicated in B. The dimer exhibits an antiparallel arrangement with a central 2-fold axis 
and active sites located at its distal interfaces. Disordered regions are indicated in dotted 
lines and N- and C-lobe are indicated by brackets. D. Dra YCC CT dimer with stabilizing 
C-terminal extensions highlighted as bold loops. Beginning of extensions and C-terminus 
are indicated by spheres. View is the same as in C, only one dimer is shown for clarity.  
E. Interactions of the conserved C-terminal DXW motif. View as indicated by a rectangle 
in D, top protomer is clipped for clarity. Salt bridges are shown as black dashed lines. 
See also Supplemental Figure 3.1 and 3.2. 
3.3.2! A conserved C-terminal peptide extends the CT dimer interface  
A comparison of the Dra YCC and Map LCC CT structures 233 shows 
conservation of oligomeric interaction and overall assembly shape. However, a 
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major difference is observed in the inter-subunit dimer interface: Dra YCC 
features a 15 amino acid C-terminal extension (Figure 3.1D), which enlarges the 
dimer interface by ~700 $2 relative to Map LCC. The C-terminal extension 
protrudes into the dimer interface from the inside of the hexameric ring, while 
Map LCC already terminates at the end of a conserved helix (Supplemental 
Figure 3.2A). Based on sequence alignment, a C-terminal extension of ~10 to 20 
amino acids with a highly conserved aspartate-X-tryptophan (DXW) motif at the 
very C-terminus is present in 20 out of 29 YCC sequences (Supplemental Figure 
3.2B). The C-terminal DXW motif mediates Dra YCC intersubunit interactions: the 
motif’s aspartate 1089 and the C-terminal carboxyl group are both engaged in 
bidentate interactions with the conserved arginine 957 of the neighboring 
protomer (Figure 3.1E). Arginine 957 is also found in Map LCC, which lacks a C-
terminal extension, and there forms a salt bridge to aspartate 919 in a 
neighboring helix from the same subunit. The tryptophan of the DXW motif, 
stacks with histidine 955, which is conserved in all but one of the examined 
YCCs. 
C-terminal core fold extensions of similar length and with distinct conserved 
C-terminal motifs are also present in the two other families of structurally 
characterized hexameric CT domains, namely PCCs and MCCs (Supplemental 
Figure 3.2C and D) 229,234. In PCC, these extensions extend into the same region 
of the hexameric CT assembly and terminate at the equivalent position of the Dra 
YCC C-terminal extension. However, in PCC the extensions are not crossed over 
(Supplemental Figure 3.2C). In MCC, which is characterized by a domain-
swapped organization of the CT N- and C-lobe relative to YCC and PCC, the C-
terminal extensions adopt a completely different topology and protrude into the 
interface responsible for dimer trimerization (Supplemental Figure 3.2D) 229. As in 
YCC and PCC, the extension only spans about 2/3 of the interface. Overall, C-
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terminal core fold extensions are observed in all structurally characterized 
hexameric CT domains, except for the Map LCC-like subclass of YCCs. In these 
systems, the C-terminal extensions are located in intersubunit or interdomain 
interfaces. However, their topology and the interactions of their distinct 
conserved C-terminal motifs are strikingly divergent. 
 
Figure 3.2 Active site of Dra YCC CT.  
A. The extended substrate binding cleft of the Dra YCC CT domain is lined with 
conserved residues. Color gradient from blue to red indicates increasing conservation; for 
visualization, a CoA moiety is modeled according to its positioning in the related MCC 
holoenzyme (PDB ID: 3U9R 228) and the carboxybiotin and palmitoyl are docked into 
active site pockets. B. Overlay of the CT active sites of M. tuberculosis (Mtb) ACC, Map 
LCC and Dra YCC. Dra YCC CT is shown surface representation (light and dark blue for 
two protomers), loops occluding the binding site tunnel of Mtb ACC and Map LCC are 
shown in yellow and red, respectively 233,235. See also Supplemental Figure 3.3. 
3.3.3! The active site cleft in Dra YCC CT is extended 
The CT active site is formed at the dimer interface between the N-lobe of one 
protomer and the C-lobe of its dimer partner (Figure 3.1C). It consists of a biotin- 
and a substrate specific binding pocket. The substrate binding pocket of Dra 
YCC is an elongated and narrow cleft of ~20 $ length (Figure 3.2A) and a volume 
of ~2000 $3, which is lined by conserved residues and sufficient in length for 
enclosing a C16 acyl chain with possible space for accommodation of longer or 
branched substrates. The binding groove is much more extended than in ACCs 
with their small acetyl substrate, e.g. M. tuberculosis ACC CT 235 (Figure 3.2B and 
S3A). The active site region of Dra YCC is rather conserved at the sequence level 
to Rpa LCC, which is active towards C2 to C16 substrates, but with a preference 
for long-chain acyl chain substrates 233. However, in the crystal structure of the 
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related Map LCC, the substrate binding cleft is occluded by a loop formed by 
residues 715 – 732 (Figure 3.2B and S3B), such that a requirement for 
conformational changes during substrate accommodation has been suggested 
233. The corresponding loop glycine 716 – proline 732 in Dra YCC adopts a 
different conformation, which results in an opening of the substrate binding 
groove. Dra YCC may thus represent a substrate-binding competent form of the 
active site. In Map LCC, a helix spanning residues 781-787 occludes the CoA 
binding region of the active site 233. Although the positioning of the corresponding 
helix (residues 781 – 788) is well conserved in the Dra YCC CT structure, already 
a slight shift of the CoA moiety relative to its position observed in the crystal 
structure of MCC, would be sufficient for accommodating CoA in an equivalent 
pocket also in Dra YCC CT. The respective regions are not constrained by crystal 
contacts in either the Dra YCC CT or Map LCC CT crystal structures. A helical 
hairpin flap (amino acids 1005 – 1046) with increased flexibility is positioned 
above the active site of Dra YCC. In the structure of the homologous P. 
aeruginosa MCC CT domain in complex with CoA, the corresponding flap acts as 
a lid helix by closing down onto the bound CoA moiety 229, suggesting a similar 
role in CoA and substrate accommodation also in Dra YCC (Figure 3.1C).  
3.3.4! Limited proteolysis enables structure determination of dimeric 
BC 
Initial expression screening failed to yield a solubly expressed construct of the Dra 
YCC BC domain. However, a stable BC domain fragment was obtained by limited 
proteolysis of full-length Dra YCC. Initial crystals of the fragment were affected by 
merohedral twinning with a twin fraction close to 50%, which precluded structure 
determination. Through extensive screening, a crystal with a twin fraction of ~30% 
in space group P65 with two molecules in the asymmetric unit was obtained and 
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the Dra YCC BC domain structure solved using molecular replacement with the 
BC domain of PC 236. The final model consists of two almost identical monomers 
(RMSD of 0.14 Å) (Supplemental Figure 3.4A) including residues 1 - 464 and was 
refined to Rwork/Rfree of 14.9%/18.4% at 1.7 Å resolution using twin refinement 
in REFMAC5 237. 
 
Figure 3.3 Dimerization and active site structure of the BC domain.  
A. Cartoon representation of the dimeric BC domain structure, one protomer is shown in 
red, the other in orange, the two-fold symmetry dimer axis is indicated. The three 
subdomains are shown in shades of red in one protomer. The lid in the B subdomain is in 
an open conformation and partially disordered. The active site location is marked in one 
protomer. B. The active site structure of the Dra YCC BC domain superimposed onto E. 
coli ACC (PDB ID: 3G8C 238) in gray and R. pomeroyi PCC (PDB ID: 3N6R 228) in black. 
Catalytic residues are labeled; residue numbering is according to Dra YCC BC. 
Conservation of the BC active site indicates a conserved reaction mechanism of Dra 
YCC. See also Supplemental Figure 3.4. 
 
The BC domain consists of the rigid A and C subdomains and the small 
interspersed B subdomain (Figure 3A) 239. The B subdomain is flexibly tethered by 
two irregular linkers and exhibits increased disorder in the crystal (Supplemental 
Figure 3.4B). Based on homology to the BC domains of E. coli or Haemophilus 
influenzae ACC, this B subdomain may undergo a hinge-bending motion during 
substrate binding to act as a lid to the BC active site 240,241. Particularly the highly 
conserved glycine-rich loop (lysine 157 – methionine 167) in the B subdomain 
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might be involved in direct ligand contacts, with lysine 157 presumably interacting 
with one of the !-phosphoryl oxygens of MgATP (Figure 3A).  
The BC active site is located at the interface of the A and C subdomains. Active 
site residues are well conserved between YCC, ACC 239 and PCC BC 228 (Figure 
3B). Structural homology suggests that residues glutamic acid 273 and glutamic 
acid 286 in Dra YCC BC coordinate magnesium ions, which are presumably 
involved in binding of the ATP substrate. Arginine 290, glutamic acid 294 and 
arginine 342 are directly implicated in binding of biotin and ATP 228,239,241. 
Carboxybiotin-interacting residues have been identified in the crystal structure of 
the H. influenzae ACC BC 241 and are structurally conserved in Dra YCC (lysine 
235, arginine 290 and arginine 342) (Figure 3B), in agreement with a generally 
conserved BC mechanism.  
The BC domains form dimers with an interface area of ~900 $2 and a maximum 
extent of 100 $, analogous to the E. coli and H. influenzae ACC BC as well as the 
BC domain of the Map LCC 233,238,241. Contrastingly, the BC domains of eukaryotic 
ACC are monomers in isolation, but they may form a permanent or transient 
dimer in context of the full-length ACC multienzyme 194,232,242.  
3.3.5! Negative stain electron microscopy reveals variable BC domain 
positioning  
To gain insight into the overall Dra YCC assembly, we employed negative stain 
electron microscopy (EM). Dra YCC particles are characterized by a central 
triangular shape, which corresponds to the hexameric CT domain (Figure 3.4A). 
9477 particles were picked and used for the generation of 24 2D class averages 
(Supplemental Figure 3.5). 16 of these 24 classes represent top views of the CT 
hexamer with laterally positioned dimeric BC domains (Figure 3.4B), only one 
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class provides a side view along a twofold symmetry axis, the remaining classes 
are projections showing the CT domain tilted to ~45°. Projections of the CT 















Figure 3.4 Negative stain EM analysis of BC domain mobility.  
A. Cropped raw negative stain EM micrograph. Three Dra YCC particles are indicated 
with white arrows. Scale bar is 500 $. B. Representative negative stain EM 2D class 
averages of Dra YCC in top view (left), tilted view (middle) and side view (right). In the top 
view, the hexameric CT ring is clearly visible; the BC dimers are positioned laterally to the 
ring. C. Projections of the Dra YCC CT crystal structure, filtered to 20 $ resolution, as well 
as images of the structure, corresponding to the class averages in B, are shown.  
D. Histogram of measured BC-CT distance in distance classes of 5 $ increments 
demonstrating the variable positioning of the BC domains relative to the CT domain 
hexamer. See also Supplemental Figure 3.5. 
 
Whilst the CT hexamer is preserved in all classes, significant variability is 
observed in positioning of the BC domains. To further analyze BC positioning, we 
measured the pixel distances between the center of the CT hexamer and the 
respective BC dimers in particles of top view classes as an approximation of CT-
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BC distance. ~1600 distance measurements were sorted into classes of 5 $ 
increments (Figure 3.4D). The resulting distance histogram demonstrates that BC 
dimer positioning is highly variable and covers the total range from less than 80 
$, which corresponds to the BC dimer resting on the CT ring as observed in the 
Map LCC crystal structure 233, to more than 135 $ from the center of the CT ring, 
which roughly corresponds to maximally extended interdomain linker 
conformation. Only about 12% of all BC domains were detected in close 
proximity with the CT domains at distances to the CT center of < 85 $. The 
distance distribution has a maximum at an intermediate distance of 105 $. 
However, due to measurement in projection images, this value probably still 
underestimates the real BC-CT distance.  
3.3.6! Small-angle X-ray scattering provides an ensemble model of 
Dra YCC  
Negative stain EM indicates a considerable flexibility of the BC domains relative 
to the CT ring in Dra YCC (Supplemental Figure 3.5). To assess this flexibility 
under physiological conditions in solution, we subjected Dra YCC to SAXS 
measurements (Supplemental Table 3.2). Interatomic distance distributions 
derived from raw scattering data yielded Dmax=256 $, while the corresponding 
value for a Dra YCC model with the BC domains in close proximity of the CT 
hexamer would only be ~200 $. A theoretical scattering curve calculated for a 
symmetrical Dra YCC assembled based on the crystal structure of Map LCC 
does not provide a good fit to the experimental data (*2=3.7, Figure 3.5A). The 
solution scattering ensemble data thus reinforce the results of the single-particle 
EM analysis, which suggested a highly variable BC positioning. It was therefore 
unlikely, that a single, symmetrical Dra YCC model would be sufficient to fit the 
SAXS data. Therefore, we applied the ensemble optimization method (EOM) for 
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SAXS data interpretation 243,244: First, a pool of 10 000 random models was 
generated by keeping the CT domain fixed while BC dimers were allowed to 
move freely, only restrained by the approximate linker length. This was achieved 
by assembling a hexameric Dra YCC model from rigid CT and BC domain dimers 
linked by a single artificial linker. This linker represents the N- and C-terminal 
BCCP linkers and was allowed to adopt random, native-like conformations. Then, 
a minimal ensemble of models with optimal fit to the experimental data was 
selected 243,245. This ensemble comprised three models (Figure 3.5B) and yields 
an improved quality of fit to experimental data as documented by a *2 value of 
1.45. The Dmax of 255 $ for the calculated combined scattering curve 
corresponds well to experimental data. Each of the three models individually 
exhibits asymmetric BC positioning with variable distances and angles between 
BC dimers and the CT hexamer. 
 
Figure 3.5 SAXS analysis of Dra YCC.  
A. Comparison of an experimental scattering curve (red) with calculated scattering curves 
for a symmetrical Dra YCC model based on Map LCC (green), the EOM-derived three 
model Dra YCC ensemble (blue) and of a single reconstituted asymmetric Dra YCC model 
(black, as shown in C). B. Ensemble of Dra YCC models generated by EOM.  
C. Reconstructed Dra YCC model featuring asymmetric placement of BC domains. The 
BCCP domains were modeled according to the crystal structure of the MCC BCCP (PDB 
ID: 3U9S 229). The BC dimer is colored in orange and red, the CT monomers in light and 
dark blue. The BCCP domains are colored in black and the linkers in gray. See also 
Supplemental Table 3.2. 
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The EOM derived models only contain an artificial single-stranded linker between 
a BC dimer and the CT. To obtain a most realistic representation of Dra YCC, we 
reconstructed a complete Dra YCC model with all linkers and BCCP based on 
the asymmetric model with largest weight in EOM (Figure 3.5C): The linkers were 
modeled in stereochemically plausible conformations incorporating the native 
domain swap suggested for Map LCC (Figure 3.5C) 233, although also non-
swapped linker arrangements would be plausible. The BCCP domain was 
modeled according to the crystal structure of MCC BCCP (PDB ID: 3U9S 229). 
Scattering curves calculated from the resulting model provided a good fit to 
experimental data at a *2 value of 0.65 (Figure 3.5A). In the reconstituted Dra YCC 
full-length model, two of the three BC dimers are in distal positions outside the 
plane defined by the CT hexamer, while one lies in the same plane. One of the 
dimers is located inside the ring diameter, outside of the ring plane, while the 
other two are located at center-to-center distances of 103 $ and 125 $ to the CT 
hexamer. Altogether, the EOM-based SAXS model is highly consistent with 
individual particles and class averages visualized in EM and demonstrates that a 
single symmetric model is not sufficient to provide an adequate representation of 
the solution conformation of Dra YCC. 
3.4! Discussion 
The structural analysis of Dra YCC establishes a classification of bacterial single-
chain carboxylases into two subfamilies based on the presence of a C-terminal 
extension that contributes to inter-subunit interactions. Although the cognate 
physiological substrate of Dra YCC remains unknown, the CT extended active 
site cleft hints towards a long-chain acyl substrate. This hypothesis is further 
substantiated by the specific genomic organization of the Dra YCC coding gene 
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Dra_A0310 into one operon with gene Dra_A309, annotated as a long-chain fatty 
acid CoA ligase. When examining the genetic context for 21 identified YCCs, ten 
of them also contain a related ligase in their operon, amongst them M. avium, of 
which the Map LCC structure is known 233. These organisms are not 
phylogenetically related, however, the genetic synteny of the YCC and the ligase 
points towards a common specialized, yet unidentified substrate and metabolic 
pathway. Genetic and functional linking between a biotin-dependent carboxylase 
(AccD4) and a protein from the long-chain fatty acid CoA ligase family (FadD32) 
is for example also observed in operon mtu-Rv3801c of Mycobacterium 
tuberculosis. There, AccD4, a putative carboxyltransferase, carboxylates acyl-
CoA substrates in cooperation with AccD3, a biotin carboxylase, not localized on 
the operon. FadD32 is required for the activation of a meromycolic acid 246. The 
third enzyme on the operon, Pks13, then catalyzes the condensation of the 
meromycolic acid and the carboxylated long-chain fatty acid into a mycolic acid 
membrane lipid. Speculatively, the YCC or LCC in cooperation with the ligase 
could be part of a system for activation of long-chain fatty-acid precursors for 
condensation in the course of the biosynthesis of complex membrane lipids.  
By combining negative stain EM to analyze individual particles and SAXS as an 
ensemble technique, we have obtained a consistent quantification of the 
remarkable mobility of the Dra YCC BC domain. Large-scale conformational 
dynamics have been observed in other carrier protein-based enzymatic systems, 
such as animal fatty acid synthase (FAS), microbial modular polyketide synthases 
(PKS), and the pyruvate dehydrogenase complex (PDC) (Figure 3.6) 247-249. Still, 
substrate transfer in these even more complex systems has commonly been 
discussed only in terms of the mobility of a flexibly tethered carrier protein. The 
recognition of the conformational dynamics of BC in single-chain carboxylases 
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with only two types of enzymatic subunits suggests a more general role of overall 
assembly dynamics for carrier protein-mediated substrate transfer.  
 
Figure 3.6 Dynamics of carrier protein-dependent multienzyme families.  
Rigid regions are shown in light and dark blue, while variable regions are shown in orange 
and red. Transparent domains show the approximate range of motion of the domains. 
Arrows represent example modes of domain motion. A. Schematic representation of Dra 
YCC showing only a single instance of BCCP and BC dimer. B. Schematic representation 
of E. coli PDC. Only three E3 subunits are shown for clarity. Distances according to 
Murphy et al 20. C. Schematic representation of mammalian FAS with acyl carrier protein 
(ACP), thioesterase (TE) domain and the linker tethering them to the enzyme 250. Only one 
ACP and TE are shown for clarity. 
 
The mode of carrier linkage of the Dra YCC BCCP resembles those of other 
carrier protein-dependent enzymes: The BCCP-CT linker has a length of 21 
amino acids and no preferential sequence composition, it resembles linkers in 
animal FAS and PKS, with lengths of 12 amino acids in FAS and 15 to over 40 
residues in PKS 251. The BC-BCCP linker is 22 amino acids long and rich in 
alanine and proline residues. Similar linker compositions are observed in PDC 8 
and fungal FAS 18,248 and results in an increased linker stiffness 8,252,253, which may 
prevent linker entanglement or guide motion paths of carrier proteins. The 
efficiency of substrate transfer by a carrier protein results from the interplay of its 
own motion with the conformational dynamics of its enzymatic target sites. 
Considerable conformational dynamics have been observed in most other carrier 
protein-based multienzyme systems, and are now well-characterized for Dra 
YCC (Figure 3.6A), PDC (Figure 3.6B) and animal FAS (Figure 3.6C) 250,254. A 
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comparison of these systems reveals that in all of them domain motions on the 
100 $ scale complement the mobility of carrier proteins, whose linkers have 
maximal lengths below 45 $. Electron cryo-tomography demonstrates that in the 
E. coli PDC the E2 core stays rigid, while the surrounding E1 and E3 subunits, 
bound to the E2 core, adopt a variety of conformations, with a maximal range of 
motion of ~150 $ 20. For animal FAS, cryo-electron microscopy confirmed a 
rotation, twisting and bending around a central hinge, which leads to domain 
displacement of more than 120 $ and an almost unrestrained motion of the C-
terminal thioesterase domain, which is linked via a 30-residue linker to the acyl 
carrier protein 250.  
Altogether, although many aspects of the interplay between catalysis and 
dynamics remain unknown, these data indicate a crucial and general role of 
large-scale dynamics in multienzyme systems employing tethered carrier 
proteins. Such systems include highly relevant assembly lines for the production 
of bioactive compounds and drug candidates, such as non-ribosomal 
polypeptide synthetases and PKS. Understanding and considering general 
principles of substrate transfer aided by structural dynamics in systems ranging 
from YCC to PKS is a crucial prerequisite for efficiently engineering versatile 
carrier protein-based biosynthetic factories.  
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3.5! Experimental Procedures 
3.5.1! Protein expression and purification 
Full-length (Genebank accession: NP_285633) and CT domain (residues 554-
1091) of YCC were amplified from genomic Dra R1 DNA (DSMZ205309) by PCR 
and cloned into vector pAB1GN-his10, a Gateway® (Thermo Fisher Scientific) 
compatible derivative of the MultiBac™ insect cell expression plasmid pACEBACI 
(Geneva Biotech) coding for an additional N-terminal 10 x His-tag. Protein was 
overexpressed in Sf21 insect cells at 27°C according to the baculovirus 
expression system manual. Cells were lysed by sonication in 50 mM TrisHCl (pH: 
7.5); 200 mM NaCl; 5 mM MgCl2; 20 mM imidazole; 10% (w/v) glycerol; 5 mM !-
mercaptoethanol (BME). Soluble protein was purified by metal affinity 
chromatography using a Ni-NTA column and elution with a linear gradient to 500 
mM imidazole. Full-length YCC was diluted with dilution buffer (50 mM TrisHCl 
(pH: 7.5); 10% (w/v) glycerol; 5 mM BME) to 70 mM NaCl and subjected to anion 
exchange chromatography using PL-SAX 4000 $ resin (Agilent) and eluted with a 
linear gradient to 500 mM NaCl in the same buffer. Both, the full length Dra YCC 
and Dra YCC CT domain were subjected to size exclusion chromatography on a 
Superose 6 and Superdex 200 (GE Healthcare) column, respectively, equilibrated 
in crystallization buffer (30 mM TrisHCl (pH: 7.5); 150 mM NaCl; 5% (w/v) 
glycerol; 10 mM dithiothreitol (DTT)). Proteins were concentrated to 10 mg/ml 
using centrifuge concentrators (Millipore) and flash frozen in liquid nitrogen. 
3.5.2! Protein characterization by SEC-MALS 
For size exclusion chromatography coupled with multi-angle light scattering 
(SEC-MALS) measurements, 20 +l or 100 +l samples of 4 mg/ml protein were 
applied to a GE Healthcare Superdex 200 5/150 GL SEC column equilibrated 
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overnight in crystallization buffer at 4 °C, using an Agilent 1100 series HPLC 
system. Light-scattering and differential refractive index measurements were 
made using Wyatt miniDawn TriStar detector and a Wyatt Optilab rRex detector, 
respectively. The inter-detector delay volumes, band broadening, and the light-
scattering detector normalization, were calibrated according to the 
manufacturer’s protocol using a 2 mg/ml BSA solution (Thermo Pierce) run in the 
same buffer. The absolute refractive index of the buffer was measured using the 
refractive index detector. The data were collected and processed using the Wyatt 
Astra software. The molar mass was calculated from a global fit of the light 
scattering signals from three detectors at different angles, and the differential 
refractive index signal, using algorithms in the Astra 5 software. 
3.5.3! Limited proteolytic digest to obtain a stable BC domain 
Full-length Dra YCC (10 mg/ml) was treated with 1:1000 subtilisin protease 
(Sigma), incubated for 2 h at 20 °C, and quenched with 
phenylmethylsulfonylfluoride. The BC containing fragment was purified on a 
Superdex 200 (GE Healthcare) column equilibrated in crystallization buffer. 
Protein was concentrated to 10 mg/ml using centrifugal concentrators (Millipore) 
and flash frozen in liquid nitrogen. 
3.5.4! Crystallization and crystallographic data collection 
The Dra YCC CT domain was crystallized at 25 °C using the sitting drop vapor 
diffusion method at 9 mg/ml and a reservoir (26% polyethylene glycol 3350; 0.08 
M DL-malic acid) to protein ratio of 2:1 in a total drop volume of 1.5 µl. Crystals 
appeared after 7 days and continued to grow for 42 days to size of 130 x 130 x 
25 µm. Crystals were transferred into cryoprotecant (reservoir solution containing 
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32% polyethylene glycol 3350 and 20% ethylene glycol) and vitrified in liquid 
nitrogen. BC domain was crystallized at 17 °C using the sitting drop vapor 
diffusion method at 10 mg/ml and a reservoir (0.03 M MgCl2; 0.1 M HEPES (pH 
7.5); 24% w/v poly(acrylic acid sodium salt) 5,100) to protein ratio of 1:1 in a total 
drop volume of 1.5 µl. Crystals appeared after 1 day and continued to grow for 7 
days to a size of 170 x 170 x 100 µm. Crystals were transferred into 
cryoprotecant (reservoir solution containing 30% w/v Poly(acrylic acid sodium 
salt) 5,100 and 20% ethylene glycol) and vitrified in liquid nitrogen. All 
crystallographic data were collected at the Swiss Light Source (Paul Scherrer 
Institute) at beam line X06DA at 100 K using a Pilatus 2M detector (Dectris). Dra 
YCC CT data were collected at a wavelength of 1.0 $ with an exposure time of 
0.25 seconds, a rotation angle of 0.25° and a detector distance of 0.245 m. YCC 
BC data were collected at a wavelength of 1.0 $ with an exposure time of 0.15 
seconds, a rotation angle of 0.1° and a detector distance of 0.17999 m. 
3.5.5! Structure determination of Dra YCC CT and twinned Dra YCC 
BC 
Dra YCC CT data were processed using XDS 255,256. Phases were obtained by 
molecular replacement using PHASER (CCP4 suite) 257-259. The initial model was 
refined by iterative cycles of manual model building and real space refinement in 
Coot and refinement in phenix.refine 260-262. The final model includes residues 
574-1091 for chain A, 573-1091 for chain B, 572-1091 for chain C, 556-1091 as 
well as 7 residues of the TEV-cleavage site for chain D, 575-1091 for chain E and 
572-1091 for chain F. Residues 1011-1032 show increased disorder and could 
only be modeled in chain B and D. Density around the loop from residue 720-730 
is indicative of disorder or partial binding of a non-natural ligand. The Dra YCC 
BC data were processed using XDS. Molecular replacement was done using 
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Molrep 263. The model was rebuilt using Coot and refined in REFMAC5 in iterative 
cycles 237. Twin refinement, as implemented in REFMAC5, was used. MolProbity 
was used to assess final model quality 264. The final model includes residues 2-
464 for chain A and B. The B subdomain shows increased disorder and residues 
ranges 156-167 and 184-197 in chain A and residue ranges 159-168 and 183-
194 in chain B have not been modeled. The loop 346-355 in chain A and 346-358 
in chain B shows increased disorder or flexibility and could not be modeled.  
3.5.6! Negative stain electron microscopy and image processing 
Dra YCC samples used for EM were thawed on ice and diluted in crystallization 
buffer to 0.05 mg/ml. 200 "m copper grids were glow discharged for 20 s, sample 
was adsorbed for one minute and blotted using Whatman filters. The grid was 
washed three times using crystallization buffer, two times using H2O and once 
using 2% uranyl acetate, followed by a 20 s staining with 2% uranyl acetate. Grids 
of Dra YCC were imaged on a CM-100 microscope (Philips) equipped with a 
Veleta 2k x 2k camera (Olympus) at 80 kV and a magnification of 130000 x. The 
pixel size was 0.37 x 0.37 nm. 9819 Particles were picked from 82 images using 
standard procedures in XMIPP 265. All particles were normalized and bad particles 
from the semi-automated particle picking procedure were discarded manually. 
The remaining particles were windowed in 120 x 120 pixel images. After 
extraction, particles with a z-score of >3 were discarded and 9477 particles were 
aligned and classified into 24 2D class averages using maximum-likelihood target 
function in Fourier space (MLF2D) in 100 iterations 266. Distances were measured 
manually from single picked particles out of top view 2D class averages in 
ImageJ 267. Only distances of clearly visible BC domains were measured and 
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binned into classes of 5 $ increments. 2D projections of Dra CT domain were 
generated using EMAN2 268. 
3.5.7! Small angle X-ray scattering 
Dra YCC was thawed on ice and dialyzed against 20 mM HEPES (pH 7.4), 150 
mM NaCl, 5% Glycerol, 2 mM TCEP. Samples were measured at the Swiss Light 
Source (Paul Scherrer Institut) at the X12SA beamline at 3 mg/ml. Measurements 
were done in a 1 mm capillary at 10 positions, for 0.04 sec exposure per position 
and 10 acquisitions with 8 scan repeats. Data were processed, scaled and 
merged using the ATSAS package 244. The ensemble analysis was done using 
ensemble optimization method (EOM) 243. The three models contribute ~38, ~38 
and ~25% to the ensemble and the model with highest contribution was selected 
for reconstitution of native-like linkers in Coot. Scattering curves of Dra YCC 
models were calculated using CRYSOL 269. The BCCP model was generated 
using SWISS-MODEL 270.  
3.5.8! Structure analysis 
Interfaces of proteins were analyzed by PISA 271; alignments of sequences were 
done using MUSCLE 272. Active site of Dra YCC CT was analyzed using  
SiteMap 273,274. Conservation was plotted using AL2CO, with the entropy-based 
algorithm 275 and figures were generated using The PyMOL Molecular Graphics 
System, Version 1.7 Schrödinger, LLC. 
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3.9! Supplemental Data 
Supplemental Table 3.1 Crystallographic data collection and refinement statistics for 
Dra YCC CT and BC 
   Dra YCC CT   Dra YCC BC 
Wavelength ($) 
Resolution range ($) 
Space group 
Unit cell ($) 






Wilson B-factor ($2) 










RMS (°, angles) 
RMS ($, bonds) 
Ramachandran favored (%) 





P 21 21 21 
111.47, 149.57, 189.3 


























138.02, 138.02, 97.81 
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Supplemental Table 3.2 SAXS data statistics for Dra YCC 
 Dra YCC 
Instrument cSAXS at SLS 
Beam size (µm) 200 x 200 
Wavelength ($) 1.0000 
Detector distance (m) 2.1368 
Temperature (K) 293 
Protein concentration (mg/ml) 3 
Total exposure time (s) 240 
Single exposure time (s) 0.04 
Capillary diameter (mm) 1 
I(0) (cm-1) [from P(r)] ' 0.06-0.21 
Rg ($) [from P(r)] ' 84.31 ± 3.02 
Rg ($) (from Guinier)  80.03 ± 3.80 
Porod volume estimate ($3)  1274980.00 
I(0) (cm-1) (from Guinier)  3.10 ± 1.09 










Supplemental Figure 3.1 SEC-MALS analysis of Dra YCC constructs and quality of 
full-length Dra YCC.  
A. SEC-MALS analysis of full-length Dra YCC. Measured molecular weight of Dra YCC is 
680 kDa. Raleigh ratio is shown in red, differential refractive index in blue. B. Size 
exclusion chromatogram of Dra YCC. Absorption at 280 nm is shown in blue, showing a 
symmetric peak, indicating a homogeneous sample. C. SDS-PAGE analysis of peak 
fractions of Dra YCC size exclusion chromatography showing purity of over 95%.  
D. SEC-MALS analysis of Dra YCC CT. Experimentally determined molecular weight of 
Dra YCC CT is 360 kDa. Raleigh ratio is shown in red, differential refractive index in blue. 
Figure related to Figure 3.1. 
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Supplemental Figure 3.2 C-terminal extension and alignment of 29 YCCs.  
A. Superposition of Dra YCC (light and dark blue) onto Map LCC (gray). C-termini of both 
proteins are indicated. Relative to Map LCC, Dra YCC contains a C-terminal extension 
shown as bold loop. B. Alignment of 29 YCC sequences shaded according to identity 
level. C-terminal core fold helices in Dra YCC CT and Map LCC structures are indicated 
in blue, the C-terminal extension with conserved DXW motif is indicated in red. C. Left 
panel: Ribbon representation of S. coelicolor PCC (Arbolaza et al., 2010). Right panel: 
Alignment of 21 PCC sequences. D. Left panel: Ribbon representation of P. aeruginosa 
MCC (Huang et al., 2011)). Right panel: Alignment of 20 MCC sequences. In C) and D), C-
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terminal extensions are shown as bold loops. The C-terminal core fold helix is indicated 
in blue; further C-terminal extensions are indicated in red. Sequence alignments are 





Supplemental Figure 3.3 Active site cleft of ACC and LCC.  
Surface representation of the active site of A. Mtb ACC and B. Mal LCC276,277. Coloring 
according to conservation from blue to red. Biotin and CoA moiety are modeled 
according to their positioning in the MCC holoenzyme (PDB ID: 3U9R228). Figure related 
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Supplemental Figure 3.4 BC protomers in the asymmetric unit and B-factors 
A. Overlay of the two BC protomers of the asymmetric unit. One protomer is shown in 
red, the other in orange. RMSD of 0.142 $ is indicated. B. B-factor plot of one BC 
protomer. Scale bar from 0 to 100 is shown going from dark blue to dark red. Increased 
B-factor values in the B-domain can be observed, likely due to the absence of a bound 
substrate. Figure related to Figure 3.3. 
  




Supplemental Figure 3.5 Negative stain EM 2D class averages of Dra YCC.  
9477 particles were classified into 24 2D class averages using the MLF2D method 
(Scheres et al., 2007). Classes are shown with decreasing number of particles per class, 
from top left (592 particles) to bottom right (179 particles). Scale bar is 200$. Figure 
related to Figure 3.4. 
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Secretion of proteins into the membrane-cell wall space is essential for cell wall 
biosynthesis and pathogenicity in Gram-positive bacteria. Folding and maturation 
of many secreted proteins depend on a single extracellular foldase, the PrsA 
protein. PrsA is a 30 kDa protein, lipid-anchored to the outer leaflet of the cell 
membrane. The crystal structure of Bacillus subtilis PrsA reveals a central 
catalytic parvulin-type prolyl isomerase domain, which is inserted into a larger 
composite NC domain formed by the N- and C-terminal regions. This domain 
architecture resembles, despite a lack of sequence conservation, both trigger 
factor, a ribosome-binding bacterial chaperone, and SurA, a periplasmic 
chaperone in Gram-negative bacteria. Two main structural differences are 
observed in that the N-terminal arm of PrsA is substantially shortened relative to 
trigger factor and SurA and in that PrsA is found to dimerize in a unique fashion 
via its NC domain. Dimerization leads to a large, bowl-shaped crevice, which 
might be involved in vivo in protecting substrate proteins from aggregation. NMR 
experiments reveal a direct, dynamic interaction of both the parvulin and the NC 
domain with secretion propeptides, which have been implicated in substrate 
targeting to PrsA.  
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4.2! Introduction 
Protein folding is assisted by molecular chaperones and by foldases. Peptidyl-
prolyl cis-trans isomerases (PPIases) constitute a class of foldases that occur in 
all types of cells and cell compartments155. They catalyze the isomerization of 
peptide bonds preceding proline residues158, which is often a rate-limiting step 
during protein folding278. Three families of PPIases are known: the cyclophilins279, 
the FK506-binding proteins (FKBP)280, and the parvulins157. Parvulins are 
ubiquitous globular proteins or protein domains of about 100 residues 
characterized by the parvulin fold161, a four-stranded antiparallel !-sheet, 
surrounded by four "-helices (!"3!"!2). Human Pin1 is the most prominent 
member of the parvulin family and is involved in phosphorylation-dependent 
signal transduction pathways, in transcriptional regulation, and cell cycle 
control281. In prokaryotes, parvulins assist in the maturation of intracellular 
proteins, e.g. nitrogenase reductase282 and various virulence factors283,284. A 
network of periplasmic PPIases, including SurA, FkpA, CypB and Par10, 
supports the folding of periplasmic and outer membrane proteins in Gram-
negative bacteria166,167. In Gram-positive bacteria, the parvulin-type PPIase PrsA 
is the only general factor mediating folding of secreted proteins, which are 
essential for bacterial pathogenicity and cell wall biosynthesis.   
PrsA is a ubiquitous 30 kDa lipoprotein localized to the space between plasma 
membrane and cell wall. It is tethered to the outer leaflet of the cell membrane by 
a lipid anchor, which is attached to its N-terminal cysteine residue168,169. PrsA is 
essential under normal growth conditions in B. subtilis 170 and PrsA depleted cells 
are affected by decreased cell wall integrity172,173, osmotic shock susceptibility171 
and increased sensitivity to antibiotics174,175. Overexpression of PrsA improves the 
recombinant overproduction of biotechnologically important proteins163,285. PrsA 
plays an important role as a folding factor of secreted proteins286 including 
enzymes involved in cell wall biogenesis173, toxins176, and virulence factors174,177. 
Due to its general role for the maturation of pathogenicity factors, PrsA is a 
potential target for novel antimicrobial drugs. 
At the sequence level, PrsA consists of three regions: a large N-terminal part with 
unknown function, followed by a parvulin-type PPIase domain287 and a small C-
terminal region169. Despite its importance for protein secretion and pathogenicity 
in Gram-positives, the structural basis for PrsA function has so far remained 
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unknown. Here, we determine the crystal structure of PrsA from B. subtilis and 
characterize its functional properties. Our data reveal a didomain architecture, in 
which the catalytically active parvulin domain is inserted into a composite N- and 
C-terminal chaperone-like domain. Dimerization of a soluble PrsA variant at high 
concentrations and presumably of membrane-tethered PrsA is mediated by the 
chaperone-like domain and creates a bowl-shaped crevice, which may be 
required for in vivo chaperone activity of PrsA. NMR spectroscopic experiments 
provide initial insights to substrate interactions of PrsA. 
4.3! Experimental Procedures 
4.3.1! Expression and purification of PrsA 
For the expression of full length PrsA (residues 21–292) and C-terminal truncated 
version (residues 21–280) the gene fragments were amplified by PCR from B. 
subtilis (strain 168) and cloned into the expression plasmid pNIC28-Bsa4288, 
where they are N-terminally linked to hexa-Histag followed by a TEV-site. The 
proteins were overexpressed in E. coli BL21(DE3). After lysis of the cells in 50 
mM Hepes/NaOH, 500 mM NaCl, pH 7.4, 40 mM imidazol with a sonicator and 
centrifugation, both proteins were found in soluble form. The proteins were 
purified by immobilized metal-affinity chromatography on a Ni-NTA column, TEV 
digested overnight followed by an orthogonal Ni-NTA column step and then 
subjected to size exclusion chromatography in 20 mM Hepes/NaOH pH 7.4 on a 
Superdex S75 column (GE Healthcare). The protein-containing fractions were 
pooled and concentrated in Amicon Ultra units (Millipore). [U-15N]-PrsA was 
obtained by growing E. coli BL21(DE3) cells in M9 minimal medium 
supplemented with 1g/l (15NH4)Cl (Cambridge Isotope Labs) at 37 °C until an  
OD600 = 0.8 was reached. Expression was induced by addition of 1 mM 
isopropyl-!-D-thiogalacto-pyranosid (IPTG). Se-Methionine-derivatized PrsA was 
produced in M9 minimal medium. Cells were grown at 37 °C. At an OD600 of 0.6 
100 mg/L lysine, 100 mg/L Phenylalanine, 100 mg/L threonine, 50 mg/L 
isoleucine, 50 mg/L leucine, 50 mg/L valine, 100 mg/L DL-Selenomethionine 
were added, and after 30 min of incubation, protein expression was induced by 
addition of 1 mM IPTG. Cells were harvested 6 h after induction and purified in 
the same manner as the unlabelled protein. Yields were about 15 – 30 mg/l. 
RCM-T1 was expressed and purified as described289. 
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4.3.2! Prolyl isomerase and chaperone activity assays 
The prolyl isomerase activities were measured by a protease-free fluorescence 
assay, as described290. The kinetics of the decrease in cis-content was measured 
by the change in fluorescence at 416 nm (5 nm bandwidth) after excitation at 316 
nm (3 nm bandwidth) in 100 mM K-phosphate 7.4 at 15 °C. Under these 
conditions, the cis-to-trans isomerization of the prolyl bond was a mono-
exponential process, and its rate constant was determined by using GraFit 5.0 
(Erithacus Software, Staines, UK). The folding experiments of RCM-T1 were 
performed as described289. The citrate synthase aggregation assay was 
measured as described291. Citrate synthase was unfolded in 50 mM Tris–HCl (pH 
8.0), 20 mM dithioerythritol, 6 M GdmCl for 1 h and then diluted 200-fold to a 
final concentration of 0.15 +M (monomer) in 50 mM Tris–HCl (pH 8.0), 0.1 mM 
dithioerythritol, 30 mM GdmCl, and various concentrations of prolyl isomerase at 
25 °C. Spontaneous aggregation was monitored by measuring the increase in 
light-scattering at 360 nm. 
4.3.3! Thermal induced unfolding transitions 
The heat-induced unfolding transitions were measured by CD at protein 
concentrations of 0.5 – 4.0 µM in 100 mM K phosphate (pH 7.4). Samples were 
heated at a rate of 60 K h,1. The transitions were monitored by the increase of the 
CD signal at 222 nm with 1 nm bandwidth and 10 mm path length with a JASCO 
J710A spectropolarimeter (JASCO, Tokyo, Japan). The experimental data were 
analyzed on the basis of a three-state approximation with a fixed heat capacity 
change %Cp of 6000 J mol, 1 K, 1 for the first transition and a %Cp of 6000 J mol, 1 
K, 1 for the second transition292,293. 
4.3.4! NMR spectroscopy 
NMR experiments of PrsA were performed in NMR buffer containing 25 mM 
MES, 150 mM NaCl, pH 6.5. The measurements were recorded at 298 K on a 
Bruker AscendII 700 MHz spectrometer equipped with a cryogenically cooled 
triple-resonance probe. For the titration with AmyE–(ETANKSNELTA)–peptide 2D 
[15N,1H]-TROSY-HSQC294 spectra of 0.5 mM [U-95% 2H,15N]–PrsA at different 
peptide concentration titrated from a 50 mM stock solution were collected. NMR 
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data were processed using PROSA295 and analyzed with CARA296. The chemical 
shift changes of the amide moiety were normalized according to equation 1. 
Δ𝛿= Δ𝛿(%𝐻)(+0.2	  Δ𝛿(%.𝑁)(   (1) 
          
The  chemical  shift  changes  observed  upon increasing  AmyE-peptide 
concentrations were analyzed by non-linear regression to equation 2, 
∆𝛿123=∆𝛿456 789	  :;:<=>;?9	  @A3B?C (789	  :;:<=>;?9	  @A3B?)
DC(E@A3B?:;:<=>;?)
([@A3B]?   (2) 
by using standard software. 
4.3.5	  SEC-MALS 
For size  exclusion chromatography  coupled  with  multi-angle light  scatering 
(SEC-MALS) measurements, 20 µl or 100 µl  samples  of  1-4  mg/ml  protein were 
applied to a  GE  Healthcare  Superdex  200  5/150  GL SEC  column  equilibrated 
overnight in  20  mM  Hepes  pH  7.4  at  5 °C,  using an  Agilent  1100  series HPLC 
system.  Light-scatering  and  diferential refractive index  measurements  were 
made using Wyat miniDawn TriStar detector and a Wyat Optilab rRex detector, 
respectively.  The inter-detector  delay volumes,  band  broadening,  and the light-
scatering  detector  normalization,  were calibrated  according to the 
manufacturer’s protocol using a 2 mg/ml BSA solution (Thermo Pierce) run in the 
same bufer. The absolute refractive index of the bufer was measured using the 
refractive index detector. The data were colected and processed using the Wyat 
Astra  5 software.  The  molar  mass  was calculated from  a  global fit  of the light 
scatering  signals from three detectors  at  diferent  angles,  and the  diferential 
refractive index signal, using algorithms in the Astra 5 software. 
4.3.6	  Protein crystalization and structure determination 
Initial ful-length PrsA crystals difracted only to 6 Å resolution. After truncation of 
the twelve  C-terminal residues (SNSTSSSSSNSK)  PrsA∆C  crystalized  under 
identical  conditions  as the ful-length  protein,  but  crystals  difracted to  higher 
resolution. Best difracting crystals were grown at 30 °C in 17% PEG2000MME, 
0.1  M  Hepes-NaOH  pH  7.5  within 4  days.  The  crystals  were  dehydrated  and 
cryo-preserved by successively increasing the PEG2000MME to 50%. Difraction 
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data were collected at Swiss Light source X06DA beamline and processed using 
XDS200. The crystals belong to space group C2221 with cell dimensions 
a = 71.5 $, b = 88.4 $, and c = 233.4 $, "=!=#= 90° and contain two molecules 
per asymmetric unit. The structure of PrsA was determined by SeMet-SAD 
phasing and refined to 2.63 $. All expected 2 x 4 selenium sites were identified in 
the Se-Met dataset by Phenix-HySS297. Initial automated model building was 
carried out with Phenix298 and Buccaneer299. Manual model building and structure 
refinement were performed with Coot300 and PHENIX301. The final model includes 
residues 3–259 of mature PrsA. 
4.4! Results 
4.4.1! PrsA is a stable two-domain protein that dimerizes at high 
concentrations 
In Gram-positive bacteria, PrsA-like lipoproteins have an N-terminal cysteine that 
is enzymatically modified upon signal sequence cleavage with a diacylglycerol 
residue to promote membrane association302. We produced a recombinant 
soluble variant of the PrsA protein that comprises residues 21–292 excluding the 
signal peptide and the aminoterminal residue Cys20. The circular dichroism 
spectrum shows a maximum near 190 nm and minima near 208 and 222 nm, as 
expected for a protein with a high content of helical secondary structure (Figure 
4.1A). Thermal unfolding of PrsA was monitored via the increase of the helical CD 
signal at 222 nm. The resulting curve can be decomposed into two transitions 
with midpoints (TM1) at 46.5°C and (TM2) at 62.8°C and unfolding enthalpies (%HD) 
of 247 kJ mol,1 and 211 kJ mol,1, respectively (Figure 4.1B). To distinguish 
whether these transitions involve an oligomerization process, we set out to 
characterize the oligomeric state of soluble PrsA as a function of the protein 
concentration. The two thermal unfolding transitions are independent of the 
protein concentration in the range between 0.5 and 4 +M (Figure 4.1C). 
Furthermore, at a concentration of about 25 µM, PrsA elutes in a single peak with 
monomer molecular weight from size exclusion chromatography coupled to 
multiangle light scattering (SEC-MALS) (Figure 4.2A). These data thus indicate 
that PrsA is monomeric in the concentration range up to at least 25 µM and that 
the two concentration-independent transitions observed during thermal unfolding 
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(Figure 4.1B) represent conformational unfolding reactions of individual domains 
of monomeric PrsA.  
 
 
Figure 4.1 Circular dichroism spectra and thermal stability of PrsA.  
A Far-UV CD spectrum of PrsA at 15°C. The spectrum was measured with 2 +M protein 
in 10 mM potassium phosphate (pH 7.0), at a path length of 1 mm and a band width of 1 
nm. B Thermal stability of PrsA. Thermal transition measured by CD at 222 nm for the 
wild-type protein. The change of the CD signal is shown as a function of temperature. 
The three-state analysis (continuous line) resulted in TM1 = 46.5 ± 0.4°C, %HD1 = 247 ± 15 
kJ mol,1 and TM2 = 62.8 ± 0.4°C, %HD2 = 211 ± 15 kJ mol,1. TM1 and TM2 are indicated as 
red dots. The transition was measured with 2 +M protein in 100 mM potassium 
phosphate (pH 7.0), at a path length of 10 mm. C Thermal stability of PrsA at different 
protein concentrations. The fractional change after a three-state analysis is shown as a 
function of the temperature. The transitions were measured with 0.5 +M (red; TM1 = 46.7 ± 
0.2°C, %HD1 = 259 ± 12 kJ mol,1, TM2 = 62.4 ± 0.2°C, %HD2 = 201 ± 13 kJ mol,1), 2 +M 
(green) and 4 +M (blue; TM1 = 46.2 ± 0.3 °C, %HD1 = 233 ± 14 kJ mol,1, TM2 = 67.0 ± 0.3 
°C, %HD2 = 218 ± 18 kJ mol,1) protein in 100 mM potassium phosphate (pH 7.0), at a path 
length of 10 mm. 
 
While SEC-MALS is an ideal tool to study oligomeric protein states at 
intermediate and low concentrations, it is not suited for measurements at high 
protein concentrations. However, increased concentrations best represent the in 
vivo situation of a membrane-anchored protein, where high local concentrations 
and molecular pre-orientation increases the likelihood of dimer formation by up 
to 106-fold303. Thus, PrsA oligomerization was also analyzed at high protein 
concentrations by lateral diffusion and relaxation analyses of 15N-labelled protein 
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by NMR spectroscopy. The TRACT and BPP–LED NMR experiments 
demonstrate that at 750 µM PrsA is dimeric (Figure 4.2B, C), pointing to an 
inherent propensity of PrsA to dimerize based on direct interactions of its soluble 
regions. Lipid anchoring will further promote self-association, indicating that a 
dimer is the most likely physiological state of PrsA, in agreement with earlier in 
vivo data173,174.   
 
 
Figure 4.2 Molecular weight and biophysical molecular parameters of PrsA.  
A. Size exclusion chromatography coupled to static multi angle light scattering and 
refractive index measurements (SEC-MALS) of PrsA. The molecular mass was calculated 
throughout the eluting peaks and is indicated in green. The calculated mass of 36.0 kDa 
is in good agreement with the 33.4 kDa for N-terminal His and TEV tagged 
(MHHHHHHSSGVDLGTENLYFQ*SM (*, TEV cleavage site) PrsA protein (residues 21–
292). B. [15N,1H]-TRACT experiment304 for the determination of the effective rotational 
correlation time constant -c. The 1D proton signal intensity, Iref, of a sample of 750 µM 
PrsA at 25°C was integrated between 10 and 8.5 ppm and plotted vs. the relaxation 
period T. The transverse relaxation rates of the TROSY component (blue; black: least-
squares fit) and the anti-TROSY component (red; black: least-squares fit) were 
determined to be R" = 18 Hz and R! = 77 Hz, resulting in -c = 23 ns, that is typical for a 
globular protein of about 60 kDa size305. C. Measurement of the molecular diffusion 
constant in aqueous solution by the 15N-filtered diffusion BPP–LED NMR experiment306 
for 750 µM PrsA (green). The logarithm of the signal intensity, integrated between 10 and 
8.5 ppm, is plotted vs. the gradient strength of the pulsed field gradients. The black line 
represents the linear fit to the measured data. This measurement yielded the self-
diffusion constants D0 = 6.11*10-11 m2s-1, that corresponds under the assumption of a 
spherical molecule and by using the Stokes-Einstein-equation to an estimated molecular 
weight of 58 kDa. 
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4.4.2! Catalysis of prolyl isomerization by PrsA in peptides and 
proteins 
To characterize the activity of PrsA as a prolyl isomerase and to map its 
substrate specificity, we used a fluorimetric protease-free assay and a set of 
proline-containing tetrapeptides, which carry an aminobenzoyl (Abz) group at the 
aminoterminus and a para-nitroanilide (pNA) group at the carboxyterminus290,307. 
In the peptides of the general formula Abz-Ala-Xaa-Pro-Phe-pNA, the Xaa 
position was occupied by either charged (Glu, Lys), aliphatic (Ala, Leu), or 
aromatic (Phe) residues. PrsA catalyzes peptide isomerization very well when 
hydrophobic residues such as Leu precede the proline (Abz-Ala-Leu-Pro-Phe-
pNA), and 16 nM PrsA sufficed to double the isomerization rate (Figure 4.3A). 
From the increase of the isomerization rate as a function of the PrsA 
concentration (Figure 4.3C), the catalytic efficiencies (kcat/KM) of PrsA towards 
peptides with six different Xaa-Pro sequences were derived (Table 4.1).  
Table 4.1 Catalytic efficiencies of Bacillus subtilis PrsA for prolyl isomerization in 
peptide and protein substrates  
 BsPrsAa BsPrsAb SaPrsA(140–245)c 







Abz-Ala-Ala-Pro-Phe-pNA 52 6 17 
Abz-Ala-Glu-Pro-Phe-pNA 450 7 33 
Abz-Ala-Leu-Pro-Phe-pNA 3.103 n.d. d n.d. 
Abz-Ala-Lys-Pro-Phe-pNA 300 15 5 
Abz-Ala-Phe-Pro-Phe-pNA 500 n.d. n.d.  
Abz-Ala-Asn-Pro-Phe-pNA n.d. 0.5 3  
Protein folding    
RNase T1 8.7 e 25 f n.d. 
a Catalytic activities towards peptides of full-length PrsA from B. subtilis from protease-
free experiments as described in Figure 4.3. The confidence limits of the kcat/KM values 
were between 5% and 10%.  
b Catalytic activities towards peptides of full-length PrsA from B. subtilis derived with a 
protease-coupled assay. Data taken from 169,308.  
c Catalytic activities of the isolated parvulin domain of S. aureus SaPrsA(140–245). Data 
taken from 169,308.  
d n.d., not determined.  
e Catalytic activity was determined using the refolding of reduced and carboxymethylated 
RNase T1 (RCM-T1) in 2 M NaCl, 100 mM Tris-HCl, pH 7.8, and 1 mM EDTA. 
f Catalytic activity was determined using the refolding of urea denaturated RNase T1 in 
0.28 M urea, 100 mM Tris-HCl, pH 7.8, and 1 mM EDTA. 
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Figure 4.3 Characterization of enzymatic activity of PrsA.  
A. Kinetics of cis-trans isomerization of 3 +M Abz-Ala-Leu-Pro-Phe-pNa followed by 
fluorescence at 416 nm, without enzyme (black), with 12 nM (blue), 16 nM (green) and 20 
nM (red) PrsA. B. Refolding kinetics of RCM-T1 in the presence of increasing 
concentrations of PrsA, 0 nM (black), 300 nM (blue), 500 nM (green) and 1000 nM (red). 
Catalytic efficiencies of PrsA for C. the cis-trans isomerization of Abz-Ala-Leu-Pro-Phe-
pNA and D. the refolding of RCM-T1. The measured rate constants kapp are shown as a 
function of the prolyl isomerase concentration. The kcat/KM values derived from the slopes 
are given in Table 4.1. 
 
The highest catalytic efficiency was observed for Leu-Pro. For Phe-Pro the 
efficiency was 6-fold, for Ala-Pro, 60-fold lower. Peptides with charged residues 
such as Glu or Lys preceding the proline resembled the peptide with the Phe-Pro 
sequence in their kcat/KM values (Table 4.1). Our kcat/KM values are about 10-to 20-
fold higher than those obtained previously for PrsA with a protease-coupled 
activity assay using N-terminally succinylated Suc-Ala-Xaa-Pro-pNA peptides 
(Table 4.1)169. The protease-coupled peptide assay can be used only for enzymes 
that are resistant to proteolysis, and therefore is unsuitable for most multi-domain 
prolyl isomerases. Possibly, PrsA is sensitive to proteolysis and inactivated 
during the assay as found for trigger factor309 and SlyD310. With its kcat/KM value of 
3 x 103 mM-1s-1 for the Leu-Pro peptide, PrsA shows an activity that is 1000-fold 
and 10-fold higher than the activities of human parvulin14 and E. coli SurA, 
respectively, and only 10-fold lower than the activity of E. coli parvulin 10, which 
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is the most active parvulin known to date311. In its substrate specificity with 
preference for hydrophobic residues preceding proline, PrsA resembles other 
bacterial parvulin homologues312,313. 
The efficiency of PrsA as a catalyst of proline-limited protein folding (the protein 
folding activity) was determined by using reduced and carboxymethylated 
ribonuclease T1 (RCM-T1) as a substrate protein. This variant cannot form 
disulfide bonds because the cysteine residues are modified. RCM-T1 is 
permanently unfolded in the absence of salt, but refolds spontaneously in 2 M 
NaCl, where electrostatic repulsion between negatively charged groups is 
decreased. In unfolded proteins, most of the proline residues adopt the trans 
conformation. Proline 39 is in cis conformation in folded RCM-T1, but in the 
unfolded state 85% of the molecules contain a trans-proline 39. As a 
consequence, the refolding of 85% of all molecules is limited in rate by trans!cis 
isomerization at Pro39, which shows a time constant of 530 s (at 15 °C, pH 8.0). 
The major part of the fluorescence change during RCM-T1 refolding reflects this 
isomerization and makes RCM-T1 an excellent substrate for assaying the folding 
activity PPIases314-317. Relatively high PrsA concentrations were necessary to 
accelerate the refolding of RCM-T1 (Figure 4.3B). The apparent rate constant of 
catalyzed folding increased in a linear fashion with PrsA concentration 
suggesting that the affinity of PrsA for refolding RCM-T1 is rather low (Figure 
4.3D). A kcat/KM value of 8.7 mM-1s-1 is derived from Figure 4.3D. This value is 
similar to previously determined values (Table 4.1)169 and also similar to the 
kcat/KM values obtained for the RCM-T1 refolding catalyzed by parvulin10 or SurA 
from E. coli311,318. In its properties as a catalyst of protein folding, PrsA thus 
resembles other parvulins. 
4.4.3! Crystal structure of PrsA 
PrsA (21–292) crystallized under various conditions, but diffraction was always 
limited to 6 $ resolution. At their C-termini, many PrsA orthologs contain serine-
rich stretches of five to fifteen residues. In PrsA, this sequence region was shown 
to be dispensable for function, in vivo and in vitro169. The targeted deletion of the 
respective twelve C-terminal residues (SNSTSSSSSNSK) from PrsA improved 
diffraction to about 3.5 $ resolution under similar conditions as for the full-length 
protein. Crystal dehydration by successive addition of long chain polyethylene 
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glycols (up to 50% PEG 2000 MME) led to a further improvement. Finally, the X-
ray crystal structure of PrsA (21–280) was solved by single-wavelength 
anomalous dispersion (SAD) for crystals of Se-Methionine-derivatized PrsA at  
3.2 $ resolution. The structure of native PrsA was refined to R/Rfree of 22/25% at 
2.63 $ resolution. Data collection and refinement statistics are given in 
Supplemental Table 4.1.  
 
Figure 4.4 Crystal structure of PrsA.  
A. Schematic representation of the PrsA primary structure. B. PrsA monomer. The N-
terminal domain, PPIase and C-terminal domain are colored in blue, green and red, 
respectively. C. Superimposition of the parvulin domain of PrsA (gray) to the closest 
homologue human Pin1 (1pin, green). Secondary structure elements as well as the 
substrate interacting loop (S1-H1) of Pin1 are indicated. D. Comparison of the two PrsA 
molecules A and B in the asymmetric unit. PrsA molecule A is colored as in (B). PrsA 
molecule B is shown in gray, superimposed on molecule A based on the parvulin domain. 
The tilt of secondary elements is indicated. E. Dimeric structure of PrsA. PrsA molecules 
A and B are colored as in (D). The estimated position of membrane and membrane 
anchor are indicated in schematic representation. 
 
PrsA consists of two domains in a discontinuous arrangement (Figure 4.4A): The 
central parvulin domain (Leu115–Glu207) (Figure 4.4B) is connected via short 
linkers to a composite domain formed by the N-terminal region Ser4–Gly114 
together with the C-terminal region Arg208–Ser260. This domain, which we call 
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the NC domain, is almost exclusively "-helical, except for two short strands in 
the N-terminal region, which form an antiparallel !-sheet.  
The PrsA parvulin domain consists of a four-stranded antiparallel !-sheet 
surrounded by four "-helices (!"3!"!2 topology) and superimposes well with 
other parvulin-type PPIase domains159,164,167,287,308,319-324. Structurally, it is most 
closely related to human Pin1159, although PrsA is of prokaryotic origin and 
exhibits a different substrate specificity. The strongest differences locate to the 
S1–H1 loop (Figure 4.4C). In Pin1, this loop contains seventeen residues 
including a cluster of positively charged residues, which determine the specificity 
of Pin1 for phosphorylated Ser/Thr-Pro substrates. In PrsA, this loop is shortened 
to only a two-residue turn. The proline-binding pocket of PrsA is lined 
predominantly by hydrophobic residues. It also includes the highly conserved 
residues His123, Asp155, Thr195, and His200, which form an extended hydrogen 
bonding network325 similar to the active sites of other parvulins (Figure 4.5).  
PrsA crystallizes with two monomers in the crystallographic asymmetric unit, 
which superimpose with an overall root-mean-square deviation (rmsd) of 1.9 $. 
The isolated domains are structurally very similar with rmsd values of 0.7 $ for 
the PPIase and 1.2 $ for the NC domains; the larger overall rmsd results from a 
slight hinge bending motion between the domains (Figure 4.4D). The dimer 
interface involves 47 mainly N-terminal residues, it extends over an area of 1830 
$2 and is classified as stable326. In the PrsA dimer, the N-terminal ends are in 
close proximity, in agreement with dimer formation of the full-length protein 
anchored via its lipid-linked N-terminal cysteine to the membrane anchors in B. 
subtilis (Figure 4.4E).  
4.4.4! Relation of NC domains to chaperone domains of SurA and 
trigger factor 
In addition to their catalytic domains, foldases often contain domains for 
transient and dynamic interactions with their substrates. The N-terminal region of 
PrsA starts with a pair of short antiparallel !-strands (Val9-Thr13 and Asp16-
Thr19) followed by five "-helices before entering the parvulin domain. The C-
terminal region is arranged into two long "-helices that tightly interact with the N-
terminal helices. Together with the parvulin domain, the N- and C-terminal 
helices form an extended crevice (Figure 4.4E).  
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Figure 4.5 Active site structure of PrsA.  
A. PrsA in comparison to B. Pin1, C. SurA and D. Par10. Residues that contribute to the 
active site of the parvulin enzyme family are shown in stick representation and labeled. E. 
Comparison of the sequences that define the active site of PPIase domains. 
 
Interestingly, despite a lack of sequence homology, the NC domain is structurally 
related to the chaperone domains of trigger factor, which assists the folding of 
newly synthesized proteins at the ribosome327,328 and of SurA322, a foldase for 
outer membrane proteins in Gram-negative bacteria. A related fold is also found 
in the less well-characterized leptospiral protein LIC12922. Figure 4.6 highlights 
the common structural elements of these four proteins. The 110 residues of PrsA 
(Met27–Leu115; Asp229–250) that build the central region of the NC domain 
superimpose well with SurA (Asp62–Ala161; Phe406–Ser427), trigger factor 
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(Ser280–Lys361) and LIC12922 (Ser89–Val184; Glu322–Leu351) with rmsd values 
of 3.3 $, 3.6 $ and 3.1 $323, respectively. The “arms” and “body” structure 
described initially for trigger factor329 is present in all four proteins (Figure 4.6A), 
but arm1 is significantly shortened in PrsA.  
 
Figure 4.6 A common chaperone domain fold of the NC domain.  
A. Cartoon representation of the PrsA NC domain (cyan) with the “body” and “arms” 
modules, in comparison with the chaperone domains of SurA (red) and trigger factor 
(yellow), both from E. coli and LIC12922 from Leptospira interrogans (green). Structurally 
non-conserved regions are represented in gray whereas conserved ones are highlighted. 
B. Orientation of the PPIase (parvulin) domains (orange), relative to the NC domain. The 
color code is the same as in (A). SurA contains two parvulin domains (ppiase1 and 
ppiase2). Trigger factor shows a FKBP-type PPIase and a ribosome binding domain (dark 
gray). 
 
The linkers to the parvulin domain are relatively short (five amino acids) in PrsA, 
and therefore the prolyl isomerase site is located in close proximity to the NC 
domain, such that helix "2 of the NC domain is in close proximity (5 $) to helix 
"3' of the parvulin domain (Figure 4.6B). The orientation of the two domains is 
similar in LIC12922, although the parvulin domain is tilted relative to its position 
in PrsA by about 25°, but differs from the organization of the well-characterized 
trigger factor and SurA chaperones. In trigger factor, an FKBP-type PPIase is 
inserted into the chaperone domain, and the linkers between the two domains 
are much longer. SurA consists of a chaperone domain and two parvulin-type 
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PPIase domains. In SurA, parvulin domain 1 is inactive and tightly associated 
with the chaperone (NC) domain, while the functionally active parvulin domain 2 
is tethered to the NC domain also via a long, and presumably flexible linker322 
similar to the FKBP-type PPIase in trigger factor (Figure 4.6B). 
4.4.5!  Monomeric PrsA in solution does not prevent protein 
aggregation 
Many periplasmic folding factors are known to have dual functions as PPIases 
and chaperones330. As the NC domain of PrsA shows structural similarity to 
chaperones we examined whether PrsA interacts with an unfolded protein. We 
performed citrate synthase (CS) aggregation and inactivation assays. GdmCl-
unfolded CS aggregates spontaneously after dilution with refolding buffer, and 
this is accompanied by a strong increase in light scattering, unless aggregation is 
suppressed by a chaperone. PrsA was unable to inhibit the aggregation of CS 
(Figure 4.7), while 3.0 µM SlyD from E. coli completely abolished aggregation of 
CS331. Similar results have been previously obtained in a rhodanese aggregation 
assay169. Importantly, under the assay conditions, non-membrane tethered PrsA 
is monomeric and does not self-associate into its presumably native dimeric form. 
As a distinct chaperone activity has been observed for PrsA in vivo, these results 
strongly suggest that dimerization – in line with our structural data – may be a 
pre-requisite for chaperone function of PrsA, although we cannot rule out that 
PrsA may only be active towards a limited set of substrates different from CS. 
 
 
Figure 4.7 Monomeric PrsA in solution has no generic chaperone function.  
Citrate synthase chaperone assay. Influence of PrsA on the aggregation of chemically 
denatured citrate synthase at 25 °C. Denatured citrate synthase was diluted to a final 
concentration of 0.15 µM (monomer) in 100 mM Tris-HCl (pH 8.0), 1 mM EDTA, 30 mM 
GdmCl, 50 mM NaCl, and 0.1 mM DTE. Light scattering at 360 nm was monitored in the 
absence of enzyme (!) and in the presence of 3.0 µM SlyD* (.), in the presence of 3.0 µM 
PrsA (!). 
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4.4.6! Binding to presequence involves residues from parvulin and NC 
domains 
In Gram-positive organisms, exported proteins commonly contain a propeptide 
sequence, which follows the export signal sequence and increases export 
efficiency285. The AmyE propeptide from the alpha-amylase of B. subtilis is eleven 
amino acids long (ETANKSNELTA) and contains no proline residues. When 
attached to other proteins, it improves their export285,332. If PrsA is overexpressed 
in addition to AmyE attachment, the protein export is further increased285, 
suggesting functional interplay and possibly a direct interaction of PrsA and the 
AmyE propeptide.  
To examine how PrsA interacts with the AmyE propeptide, we recorded two-
dimensional [15N,1H]-TROSY spectra of 15N-labeled PrsA in the presence of the 
AmyE-peptide at increasing concentrations. The [15N,1H]-TROSY cross peaks of 
[1H,15N]-PrsA were well resolved and enabled a detailed analysis of the chemical 
shift changes upon addition of the AmyE-propeptide (Figure 4.8A). The 
resonances of the isolated parvulin domain of PrsA (residues 116–206,287) closely 
match corresponding resonances of full length PrsA. This indicates that most 
amide moieties of the parvulin domain in isolation and in full length PrsA are in 
similar chemical environments and allows a direct transfer of sequence-specific 
resonance assignments for the analysis of chemical shift changes induced by 
binding of the AmyE propeptide to full length PrsA. 
Addition of 5.0 mM of the AmyE propeptide to 0.5 mM PrsA (final ligand to 
protein ratio 10:1) led to chemical shifts larger than 0.05 ppm for the amide 
moieties of 18 residues in the parvulin and 37 residues in the NC domain (Figure 
4.8B). In all cases, the resonances changed their positions continuously during 
the titration (Figure 4.8C, D), indicating that exchange kinetics between bound 
and unbound form are occurring in the fast exchange limit of the NMR chemical 
shift timescale (> 1000 s-1). The residues in the PPIase domain with the largest 
chemical shift changes are located around the active site (Figure 4.8E). From the 
concentration dependence of the chemical shift change we derived dissociation 
constants for the interaction between the propeptide and individual residues in 
the PPIase or NC domain (Table 4.2; Table 4.3; Figure 4.8C, D). With the caveat 
that substrate saturation was not reached for all residues in this experiment, the 
data are well suited to establish an overall estimate of the binding constant of the 
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substrate peptide to the PPIase (in the range of 1.5 to 4.5 mM) and NC domain 
(in the range of 1.2 mM to 4.9 mM). 
 
Figure 4.8 Mapping of PrsA residues involved in AmyE-propeptide binding.  
A. Left hand panel: [15N,1H]-TROSY spectra of 0.5 mM [U-2H,15N]-PrsA in 25 mM MES pH 
6.5 with increasing AmyE-peptide concentrations, as indicated. The protein to ligand 
ration is given in parentheses. Right hand panels: Enlargement of two regions with the 
assignment derived from the NMR-structure of the PPIase-domain alone (287; BMRB 
6601) as well as peaks belonging to the NC-domain, that were analyzed (Table S1). All 
spectra were measured at 25°C with eight scans and 1024 x 200 complex points. B. 
NMR peak shift analysis of AmyE-peptide to PrsA titration. Combined chemical shift 
changes of the amide moiety upon titration with a 10-fold excess of AmyE-peptide (blue) 
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vs. the residue number. The broken line indicates a significance level of 0.05 ppm. ‘*’ 
denotes unassigned residues as well as Pro192. C. Backbone chemical shift 
perturbations for residues located in the parvulin domain of 0.5 mM PrsA upon titrating 
increasing AmyE-peptide. D. Backbone chemical shift perturbations for residues located 
in the NC domain of 0.5 mM PrsA upon titrating increasing AmyE-peptide. The solid lines 
in B, C represent nonlinear least square best fits of the normalized changes of the 1H and 
15N chemical shifts to all of the titration data simultaneously, using a bimolecular 
equilibrium binding model. E. Surface representation of the PrsA dimer (monomer A in 
dark gray and monomer B in light gray). PrsA residues of the parvulin domain involved in 
AmyE-propeptide binding identified by NMR are shown in red. The dimensions of the 
PrsA cavity are indicated. 
 
These dissociation constants are identical within the experimental precision. 
Overall, the NMR experiments thus demonstrate that PrsA directly interacts with 
the AmyE propeptide and that both the NC and the parvulin domain contribute to 
the interaction, even though the propeptide does not contain proline residues. 
Table 4.2 Interaction of the AmyE-peptide with PrsA. Dissociation constants for the 
interaction of PrsA with the AmyE-peptide for selected PrsA residues of the parvulin 
domain, as determined by NMR spectroscopy titrations. 
Residue AmyE  
KD [mM] 
Thr131 3.9 ± 0.5 
Ala132 3.7 ± 1.3 
Lys194 4.8 ± 0.7 
Ile201 3.1 ± 0.7 
Ile202 1.2 ± 0.2 
Glu206 1.7 ± 0.5 
Median 3.4 ± 1.6 
 
Table 4.3 Interaction of the AmyE-peptide with the NC domain of PrsA. Dissociation 
constants for the interaction of PrsA with AmyE-peptide for selected PrsA residues of the 
NC-domain, as determined by NMR spectroscopy titrations. 
Residue 1H [ppm] 15N [ppm] PrsA KD [mM] 
A 8.52 123.4 4.5 ± 1.2 
B 7.52 118.5 2.9 ± 0.7 
C 7.50 118.0 1.5 ± 0.4 
D 8.00 117.8 2.0 ± 0.7 
E 7.44 112.3 2.9 ± 0.5 
Median ––– ––– 2.8 ± 1.1 
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4.5! Discussion 
In Gram-positive bacteria, most secreted proteins are translocated in an unfolded 
state into the space between the cell membrane and the cell wall333,334. This 
compartment is characterized by high concentrations of cations bound to 
teichoic acid, a high negative charge density, and a low pH335, which together 
form a challenging environment for protein folding. PrsA-like proteins are key 
folding factors to support post-membrane protein maturation and secretion in 
Gram-positive bacteria336. The crystal structure of PrsA demonstrates that PrsA 
folds into two subdomains, the chaperone-like helical NC domain and the PPIase 
domain, which is inserted into the NC domain. PrsA shares this domain 
architecture with folding factors from Gram-negative organism such as trigger 
factor or SurA322, despite a lack of sequence homology in the respective N- and 
C-terminal regions. In PrsA, PPIase activity is independent of the presence of the 
NC domain, as demonstrated by the fact that the isolated, monomeric parvulin 
domain resembles the catalytic properties of the full-length protein169,322. It should 
also be noted that other chaperones such as prefoldin, Skp, or the mitochondrial 
small Tim proteins also use helical protrusions ("tentacles") to interact with 
folding proteins330,337,338. 
Despite the structural homology of the NC domain to the chaperone domains of 
other folding factors, non-membrane tethered PrsA is not active in common 
chaperone assays (Figure 4.7). So is the NC domain a true chaperone relevant for 
PrsA function? In vivo experiments have clearly demonstrated that the isolated 
NC domain alone is sufficient for promoting the secretion of various substrates 
and even rescues a PrsA deletion knockout169,174; still all domains of a PrsA 
homologue in L. monocytogenes (PrsA2) are required for full virulence174. 
Together, these results indicate, that the PPIase activity of PrsA is relevant for a 
subset of substrates, but that the most essential functions of PrsA are mediated 
by the NC domain. The most likely reason for the absence of chaperone activity 
of PrsA in solution assays is a requirement on dimerization, although other 
reasons, such as mismatch between test substrates and PrsA specificity cannot 
be completely ruled out at this point. We demonstrate that PrsA lacking its 
membrane anchor is monomeric, but has an inherent tendency for dimer 
formation at high protein concentration.  




Figure 4.9 Surface properties and dimensions of PrsA.  
A. Surface representation of PrsA color coded ranging from hydrophobic (green) to 
hydrophilic (gray) according to the normalized consensus hydrophobicity scale of the 
exposed residues339. B. Surface representation of PrsA color-coded ranging from 
negative charged (red) to positive charged (blue). C. The crevice of the PrsA dimer can 
accommodate domain-sized polypeptides. Monomer structure of PrsA; The parvulin 
domain and the NC domain are colored blue and yellow, respectively. The PPIase active 
site is indicated as ellipse. The arm1-arm2 distance (20 $) as well as the distance from 
the parvulin domain to the opposite site of the NC domain (35 $) within one PrsA 
molecule are given. D. Representation of PrsA dimer with approximate dimensions of the 
cavity indicated; PrsA molecule A, is colored as in (C). For PrsA molecule B, the parvulin 
domain and the NC domain are colored red and gray, respectively. The intermolecular 
distance of arm1, arm2 and parvulin regions are 28 $, 40 $ and 29 $, respectively. 
 
It crystallizes in a dimeric arrangement, which is fully compatible with membrane 
tethering and employs exclusively the NC domain for dimerization. In vivo, lipid 
anchoring dramatically favors dimer formation, and in fact, PrsA2 of L. 
monocytogenes and PrsA of B. subtilis have been reported to form dimers at the 
cell membrane173,174. 
4 Dimeric Structure of the Bacterial Extracellular Foldase PrsA 
 131 
In the dimeric assembly, PrsA forms a bowl-like crevice (Figure 4.4E) between the 
NC domains of two monomers. The inside surface of the crevice is enriched in 
hydrophobic residues (Figure 4.9A), whereas the outside contains many charged 
amino acids (Figure 4.9B). Analogous hydrophobicity profiles are observed for 
the NC domains of related bona fide chaperones, e.g. trigger factor329, 
suggesting that the inside of the crevice could provide a chaperone function in 
vivo. Enlarging the interaction surface for unfolded peptides in the dimer might be 
critical to permit productive substrate interaction by avidity of multiple, low 
affinity interactions. With dimension of about 20 x 30 x 35 $ (Figure 4.9C, D), the 
bowl-shaped crevice in the PrsA dimer could completely accommodate 
polypeptides of up to 20 kDa, but the observed flexibility of the NC domains 
(Figure 4.4D) and the attached parvulin domain may even permit adaptation to 
larger substrates. The only other chaperone with PPIase/NC domain architecture, 
for which dimerization and the formation of an enlarged crevice has been 
observed is Peb4 from Campylobacter jejuni167. However, its NC region is more 
distantly related to SurA/trigger factor and dimerization under unusual domain-
swapping is required for completion of the NC-domain fold. Many Gram-positive 
bacteria contain only a single PrsA-like protein. Others, such as B. cereus, 
contain several PrsA homologs336. For L. monocytogenes and B. anthracis it was 
shown that PrsA homologs have non-overlapping functions and cannot 
substitute each other176,177. Interestingly, the parvulin domains, but not the NC 
chaperone domains of PrsA homologues are highly conserved (Figure 4.10). The 
high conservation in the PPIase domain is necessary to preserve the enzymatic 
function; the variations in the NC-domain may reflect differing substrate 
specificities.  
PrsA substrates exert functions in cell wall metabolism (penicillin binding 
proteins), swimming motility (flagellin), oligopeptide transport (OppA), and 
membrane bioenergetics (quinol oxidase), act as virulence factors or as enzymes 
such as "-amylase or subtilisin336,340. The molecular weight of substrates ranges 
from 20 to 80 kDa, and thus includes proteins, which are clearly too large to be 
accommodated in the PrsA crevice. The lateral openings of the crevice might 
serve to provide the possibility for interactions of multiple PrsA molecules with 
one substrate polypeptide, as found for trigger factor, where e.g. three molecules 
bind to a 45 kDa protein329.  




Figure 4.10 Sequence conservation in the PrsA family.  
A. Consurf representation341 of sequence conservation within the PrsA family; residues 
that are highly conserved are shown in red, sequences with lower identity are shown in 
yellow, green and blue. B. Multiple sequence alignment to analyze the sequence and 
secondary structure conservation of PrsA. Highly conserved residues are red (>70% 
conservation) or white in red boxes (100% conservation). The secondary structure of B. 
subtilis PrsA is shown on top of the protein sequence. Sequences of representative PrsA 
proteins were retrieved from the UniProt database342 and aligned using MULTALIN343. The 
final figure was generated using the ESPript server344. Species abbreviations and UniProt 
accession numbers are BsPrsA, Bacillus subtilis (P24327); BaPrsA1, Bacillus anthracis 
(Q81U45); LmPrsA1 Listeria monocytogenes (Q71ZM6); LmPrsA2, Listeria 
monocytogenes (Q71XE6); SpPrsA, Streptococcus pneumoniae (B2IPD4); SgPrsA, 
Streptococcus gordonii (A8AYJ0); LlPrsA, Lactococcus lactis (P0C2B5); SaPrsA, 
Staphylococcus aureus (A6QI23).  
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We show that PrsA directly interacts with substrate propeptides and analyze the 
binding of PrsA to a prototypic eleven residues peptide. The NMR experiments 
indicate that PrsA uses both the NC chaperone and the parvulin domain for 
transient and dynamic substrate interactions.  
To our knowledge, PrsA is the first authentic member of the SurA/trigger factor 
class of foldases, which has been structurally characterized as a symmetric 
dimer and may require dimer formation for exerting chaperone activity. Our 
current structural and functional characterization of PrsA provides a basis for 
future in-depth studies on the role of self-association e.g. by targeted trapping of 
dimeric states for solution studies. The structural information will help to identify 
PrsA regions involved in polypeptide recognition, and to understand its role in the 
maturation of larger proteins. This paves the way for new strategies to optimize 
protein export in biotechnological applications and may yield opportunities for 
developing small molecule inhibitors of extracellular protein folding as 
antibacterial agents against Gram-positive pathogens. 
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4.6! Supplemental Data 





C 2 2 21 
Unit cell 69.29 87.68 234.1 90 90 90 
Resolution ($) 117-2.63 (2.79-2.63) * 
Total reflections 144433 
Unique reflections 21428 
Multiplicity 6.7 (5.4) 
Completeness (%) 98.8 (90.2) 
Mean I/sigma(I) 19.7 (1.6) 
Wilson B-factor 90.7 
R-merge 0.054 (1.097) 
CC1/2 0.998 (0.65) 
R-work 0.2160 (0.4199) 
R-free 0.2470 (0.4284) 
Number of atoms 8281 
macromolecules 4079 
water 37 
Protein residues 513 
RMS(bonds) 0.009 
RMS(angles) 0.95 
Ramachandran favored (%) 97 
Ramachandran outliers (%) 0.2 
Clashscore 1.7 
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5! Discussion & Outlook 
5.1! Summary of results  
The bacterial extracellular foldase PrsA in its membrane-bound form is a dimeric 
protein responsible for folding of secreted proteins in Gram-positive bacteria. The 
PPIase subdomain is highly conserved, while the NC exhibits higher variability. 
The NC domain shares a common fold with chaperone domains of cytosolic and 
periplasmic folding helpers, such as trigger factor and SurA. The dimeric, 
membrane-anchored PrsA creates a bowl-like crevice that is enriched with 
hydrophobic residues on the inside, where both the PPIase and the NC domain 
interact with the substrate.   
PrsA is the first reported foldase of the SurA/trigger factor family that dimerizes in 
its active form, and the presented results may guide future optimization of protein 
export in biotechnological applications. Research groups will continue to work on 
this and related systems in order to reveal functional principles of chaperone 
action, e.g. with respect to surface properties or shape parameters. A further 
area of interest is the role of protein-protein interaction in the biogenesis 
pathways of secreted and outer-membrane proteins.  
The core focus area of this thesis was the structural and functional 
characterization of biotin-dependent carboxylase multienzymes. We provide a 
structural analysis of yeast ACC, which reveals a detailed mechanism for 
phosphorylation-based short-term regulation. In detail, we obtained a crystal 
structure of the unique ACC central domain of S. cerevisae at 3.0 $ resolution, 
along with several intermediate- and low-resolution structures of larger fragments 
up to near-full length constructs. In combination with EM and SAXS analyses, 
these results reveal an overall elongated architecture with the CD acting as a 
flexible hinge between the rigid CT dimer and the BC. ACC inhibition is mediated 
by a regulatory loop, which is phosphorylated at a strictly conserved serine 
residue. In its phosphorylated state, this loop wedges into a crevice between two 
domains of the CD and restricts conformation freedom of interdomain 
orientation. A model is proposed where the removal of the phosphate group 
would reduce the affinity of the loop for interdomain binding, resulting in 
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increased flexibility of CD that is required to adopt a competent state for 
catalysis.  
The hybrid structure of YCC from D. radiodurans provides novel insights into 
active site architecture, overall assembly and dynamic architecture of acyl-CoA 
carboxylase multienzymes. EM and SAXS experiments elucidate the flexible 
tethering and mobility of the BC domains relative to the rigid CT core, which are 
key characteristic and unique functional features of singe-chain bacterial 
carboxylase multienzymes.  
The following sections will focus on discussing the structure, function and 
regulation of multienzyme carboxylases in the context of general multienzyme 
architecture. Prospects of structural studies on multienzymes for combinatorial 
biosynthesis and synthetic biology will be outlined.  
5.2! A compact structure of active full-length yeast ACC 
Most recently, Wei & Tong reported a structure of full-length yeast ACC (flACC) in 
biotinylated and unbiotinylated form along with several structures of CD 
fragments345. In flACC, the ACC dimer obeys two-fold symmetry and assembles 
in a triangular architecture, with dimeric BC domains and a large channel through 
the center of the compact assembly (Figure 5.1). The CT dimer and the C-
terminal half of CD form one edge of the triangle, while the N-terminal half of CD 
constitutes for the other edges, with the BC dimer and the CDC1 serving as the 
corners. The mobile BCCP domain was resolved bound to the active site of the 
CT. Despite the modest resolution and the fully independent structure 
determination, the novel CD structures reported by Wei & Tong agree very well 
with the CD structure presented in chapter 2 at the level of individual 
subdomains. 
However, the overall architecture of the CD and the entire ACC depicted in our 
work and by Wei & Tong differs dramatically. The transition from an elongated 
shape that is presented in this thesis towards a compact triangular shape is 
based on an intricate interplay of several hinge-bending motions in the CD, which 
are discussed in detail below.  
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Figure 5.1 Compact crystal structure of active yeast flACC.  
The crystal structure of yeast flACC expressed in E. coli exhibits a triangular architecture 
with dimeric BC domains. The domains of both protomers are colored according to the 
sequence scheme. Dimensions are indicated and domains of one protomer are labeled. 
 
The largest conformational change is located at the CDC2-CT hinge  
(Figure 5.2A,B). The angle between CT and CDC2, tethered via a connecting helix 
to the N-terminus of the CT domain, differs between the two models by about 
120°. Propagating this transition all the way to the N-terminal BC domain would 
already results in a displacement of BC by >200 $. The conserved RxxGxN on 
the surface of the CT N-lobe, which interacts with the CDC2 domain in the 
elongated ACC model, is solvent exposed without further interactions in the 
compact form of flACC.  
A second hinge is identified between the CDC1 and CDC2 domains (Figure 5.2C). 
In this thesis, this hinge was described as blocked, allowing only limited tilting 
and rotation, due to the wedging of the phosphorylated regulatory loop into the 
CDC1/CDC2 interface. Since the protein was expressed in E. coli for flACC 
structure determination, this loop is not phosphorylated in flACC. Consistent with 
the regulatory mechanism proposed in this work, the non-phosphorylated 
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regulatory loop remains disordered in flACC. Concomitantly, the elongated and 
compact models of ACC differ by a considerable rotation of about 30° around the 
CDC1/CDC2 hinge. This rotation leads to a displacement of the CDN anchor point 
by 21 $. 
 
 
Figure 5.2 Conformational freedom governed by three main flexible hinges.  
A. CT based overlay of Cth%BCCP (colored according to sequence scheme) and flACC 
(gray, same view as in Figure 5.1), displaying strikingly different orientation of the CD. 
Squares mark the regions that are shown in detail, viewing angles may diverge from A. B. 
CT based overlay (Cth%BCCP in color, flACC in gray) demonstrating the extensive hinge-
motion (120°) occurring at the connecting helix. Position of the conserved RxxGxN is 
marked by a dashed ellipse. Corresponding structural elements in CDC1 and CDC2 are 
marked with red symbols (star, triangle, square, circle) for better orientation. CT of flACC 
was omitted for clarity and all visible domains are labeled. C. Superposition based on 
CDC2 (SceCD in color, flACC in gray) demonstrating the 30° angular movement in this 
hinge between phosphorylated and non-phosphorylated ACC. The anchor point to CDN is 
displaced by 21 A. D. Superposition based on CDC1 (Cth%BCCP in gray, flACC in color). 
The displayed Cth%BCCP is the instance that was observed to be closest to flACC. Still, 
an additional translation by 13 $ of CDN at the end distal to the interaction between BT, 
CDN and CT (marked with a circle) is observed. All visible domains are labeled according 
to the sequence scheme and the hinge is denoted with a black triangle. 
 
When comparing all individual protomer and fragment structures in their study, 
Wei & Tong also identify the CDN/CD1 connection as a highly flexible hinge, in 
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good agreement with our observations (Figure 5.2D). In the flACC structure, 
however, the hinge is fixated by interactions of CDN with BT and CT in a 
particular conformation that was not observed in our work and results in a 13 $ 
translational offset of the distal part of CDN between the elongated and compact 
ACC models.  
The only bona-fide regulatory phosphorylation site of fungal ACC in the 
regulatory loop is directly participating in CDC1/CDC2 domain interactions and thus 
influences the hinge conformation at the CDC1/CDC2 hinge. Modeling the 
CDC1/CDC2 hinge conformation observed here in the phosphorylated SceCD onto 
the compact flACC structure demonstrates that phosphorylation and subsequent 
wedging of the regulatory loop prevents the formation of a compact flACC 
structure with catalytically competent dimeric BC: When keeping all other hinges 
fixed as in flACC, the CD as well as the BC would severely clash with other parts 
of the protein, and the two BC domains would be separated by >150 $. The 
catalytically competent conformation could also not be restored by applying any 
combination of hinge-bending motions observed by Wei & Tong or in this work.  
 
 
Figure 5.3 SceCD hinge conformation distorts flACC architecture.  
On the left, the same view as in Figure 5.1, all domains of one protomer are labeled and 
the scale is indicated. On the right, the architecture after applying the CDC1-CDC2 hinge 
conformation from SceCD. A large distortion of the architecture can be observed leading 
to severe clashes (circles) and to the BC domains being separated by >150 $. The arrows 
point to helix described in Figure 5.2C and a black star marks the CDC1-CDC2 hinge. The 
same domains as on the left side are labeled. 
 
Further comparative mutational and structural studies will be required to analyze 
whether the binding of the phosphorylated regulatory loop to CDC1/CDC2 has 
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long-range conformational effects, plausibly mediated via allostery by contacts of 
CDC1/CDC2 to other domains. Amongst all ACC fragment structures, the 
orientation of CDN in our isolated yeast CD structure is unique, and differs from 
other fragments and flACC by a 180° rotation relative to CDL/CDC1. Modeling the 
rotated orientation of CDN onto the flACC structure yields a plausible structure 
without steric clashes. It thus currently remains open, whether the rotated 
orientation of CDN also occurs in the context of intact yeast, eventually with lower 
occupancy. It should be noted that Wei & Tong observed in isolated structures of 
phosphorylated CD domain fragments (comprising BT, BCCP and CD) the same 
conformation of the CDC1/CDC2 hinge that we observe in our phosphorylated 
yeast CD structure, but with a disordered regulatory loop. This clearly indicates 
that regulation occurs by conformational selection, where binding of the 
phosphorylated loop considerably increases the population of a pre-existing 
extended ACC conformational state.  
Altogether, the comparative structural analysis clearly establishes a unique 
mechanism of fungal ACC based phosphorylation-mediated conformational 
trapping of the characteristic CD domain.   
5.3! Implications for the regulation of eukaryotic ACC 
Yeast ACC in its active form adopts a compact, triangular structure. Mutational 
analysis of the BC dimer interface demonstrates that BC dimerization in the 
compact flACC is relevant for activity345. A functional role of BC dimerization is 
also indicated by a lack of activity of monomeric eukaryotic ACC BC in solution. 
As described in detail above, the CDC1/CDC2 hinge conformation observed in the 
structure of phosphorylated CD is not compatible with BC dimerization in the 
holo-enzyme, explaining why the phosphorylated form is in an elongated shape 
with flexible BC-CD arms, relative to the dimeric CT, as confirmed by EM. This 
establishes a direct link between phosphorylation of the conserved Ser1157, the 
overall conformation and the enzymatic activity and thus reveals a 
conformational trapping mechanism of phosphorylation control of yeast 
ACC80,131,132.  
Preliminary activity assays (unpublished), based on incorporation of radioactive 
carbon into stable malonyl-CoA193, support the role of the Ser1157 
phosphorylation site. An increase in activity is observed after treatment of 
5 Discussion & Outlook 
 141 
phosphorylated ACC with & protein phosphatase, which decreases levels of 
Ser1157 by at least 60-fold based on MS analysis. In addition, a similar increase 
in activity is observed for a non-phosphorylatable S1157A mutant. Mutational 
analysis of the arginine residues involved in phosphor-Ser1157 binding confirms 
their involvement in yeast ACC regulation: Arginine to alanine mutations of the 
coordinating Arg1173 and Arg1260 restore activity of phosphorylated yeast ACC. 
These preliminary experiments are currently being extended to obtain a valid 
functional mapping of the control mechanisms in yeast ACC. 
 
 
Figure 5.4!Dephosphorylation of Ser1157 activates S. cerevisae ACC.  
Activity assay based on incorporation of radioactive 13C into acid-stable products. 
Activity of wild-type (wt) ACC increases drastically upon dephosphorylation. A non-
phosphorylatable mutant (S1157A) and arginine to alanine mutants (R1173A, R1260A, 
R1173A/R1260A), incapable of phospho-serine coordination, display similar levels of 
activity as observed for dephosphorylated wild-type ACC. All values normalized to the 
activity of dephosphorylated wild-type ACC. Error bars are based on triplicate 
measurements. – ATP and – enzyme mark controls, where either ATP or ACC was 
omitted from the reaction. 
 
Human ACC is also regulated by phosphorylation and our crystal structure of 
human CD clearly resembles instances of yeast CD observed in various yeast 
ACC fragments or flACC. However, based on biochemical analysis, the 
mechanism of regulation diverges from those of the homologous yeast ACC. 
Reversible phosphorylation of human ACC mediated by AMPK and PKA occurs 
at Ser80 and Ser1201127. Ser1201 is located in the equivalent of the yeast ACC 
regulatory loop and it would be tempting to speculate that inhibition via Ser1201-
phosphorylation works similarly as Ser1157 phosphorylation in yeast ACC, 
particularly because the phosphate-coordinating arginines R1173 and R1260 of 
yeast ACC are conserved in human ACC. Ser1201. However, Ser1201 does not 
align to Ser1157 in yeast and is only moderately conserved in higher eukaryotes. 
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It is also not phosphorylated to high-levels and consequently disordered in our 
human CD domain. Earlier biochemical analysis revealed that phosphorylation of 
Ser1201 alone has no significant role in control of human ACC.  
Instead, regulatory inhibition is mainly driven by phosphorylation of Ser80126, 
which is not conserved in yeast ACC. Ser80, conserved amongst all higher 
eukaryotes, resides in a flexible N-terminal extension preceding the BC domain. 
Upon phosphorylation, Ser80 binds into the dimer interface of BC, preventing 
dimerization. Interestingly, the antifungal and antibiotic compound Soraphen A 
binds into the same pocket in yeast and human BC, and mimicks the inhibitory 
effect of phosphorylated Ser80 binding.  
Thus, while human and yeast ACC are controlled via regulating the dimerization 
of the BC domain, they employ to completely distinct strategies: Direct 
interference with interface formation vs. allosteric control. Principal components 
of both regulatory systems, the Soraphen A–binding site and the regulatory loop, 
appear to be present in both, human and yeast ACC. This may indicate that both 
systems have evolved from a common precursor, which used both control 
pathways and opens the possibility that some current ACC variants may still do 
so. 
Human ACC in its most active form assembles into large symmetric linear 
polymers (Figure 5.5A)93,187. A direct link between phosphorylation and 
polymerization is not established yet, but could eventually explain why another 
mechanism of regulation is employed by human ACC compared to yeast ACC. 
The mechanism of locking the CD conformation, as seen in phosphorylated yeast 
ACC, may be incompatible with polymerization and might thus have lost its role 
in controlling BC dimerization.  
There are no data available on how human ACC polymers are assembled at a 
structural level. Conceptually distinct modes of interaction could be envisioned 
based on ACC structure (Figure 5.5B): (i) Filaments could form via CD-CD 
contacts under structural rearrangement of the CD and eventually the entire 
assembly. (ii) Filament formation may result from dimerization of BC domains 
from different dimeric ACC molecules. This would lead to a sandwiched 
assembly of CT dimers at the bottom and on top, with four BCs between them, 
where one BC belonging to the bottom dimer is contacting a BC of the upper 
dimer. This may result, as in the first model, in modulations of CD geometry and 
altered active site distances, ultimately leading to increased activity. To form a 
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filament in this model, however, CT dimers have to interact and form stable 
dimers of dimers with the next CT dimer, which has not been reported so far. (iii) 
Filaments could form by interactions of BC alone, similar to the second assembly 
mode, outlined above, but without further contributions from the CT. (iv) They 
could also form by combined interactions from BC and CD or (v) CD and CT, 
respectively. While some of these qualitative models cannot explain the 
increased activity, others seem to be incompatible with the EM micrographs. The 
assembly mode of these filaments remains one of the big mysteries in the field 
and will be addressed in future research. 
 
 
Figure 5.5 Conceptual models of filamentous human ACC.  
A. Negative-stain electron micrograph of a human ACC1 polymer (unpublished data). B. 
Schematic of various possible filament architectures, sorted by their base of interaction 
(see main text). Coloring according to the sequence scheme. For simplicity, BT, BCCP 
and CDL are omitted. 
 
The mechanisms of other regulatory interactions of human ACC, including the 
binding of the regulatory protein MIG1284, as well as allosteric inhibition by 
palmitate or allosteric activation by citrate, remain elusive187. MIG12 is involved in 
filament formation; possibly MIG12 binding induces a conformational change or 
shifts a conformational equilibrium and thus primes the ACC for polymerization. 
5 Discussion & Outlook  
 
 144
So far, no allosteric citrate binding sites have been observed in structures of 
isolated BC or CT domains of eukaryotic ACCs. Citrate may indeed interact with 
the CD, and it is tempting to speculate that the CDC1/CDC2 interface, which binds 
the regulatory loop in yeast ACC and is enriched in arginine residues in all 
eukaryotic ACCs, may also provide a binding site for citrate. Citrate binding to 
arginines would occupy the binding sites without inducing a stabilized 
interdomain interface and thus could plausibly lead to an activation of ACC. 
5.4! D. radiodurans YCC is a dynamic multienzyme 
carboxylase 
Besides the hybrid structure of D. radiodurans YCC presented above, only one 
additional structure, Map LCC, which has been published during the course of 
this work, is available for a bacterial multienzyme acyl-CoA carboxylase86. The 
two structures reflect a common, highly dynamic architecture, with distinct 
specializations. The crystal structure of Map LCC revealed a rigid CT core 
flanked laterally with dimeric BC domains, which are partially flexible based on 
EM analysis. The same type of conformational freedom, but with even larger 
amplitudes due to longer BC-BCCP linkers, is observed and partially quantified in 
our work on Dra YCC by SAXS and EM experiments.  
Even though YCC shares the domain composition of BC, BCCP and CT with 
other bacterial acyl-CoA carboxylases, such as MCC and PCC, it exhibits a 
completely distinct architecture. Two main differences can be identified on a 
sequence level. First, YCC is lacking a BT domain, that mediates contacts 
between BC and CT in MCC and PCC, and second, BCCP is double-tethered at 
both termini due to the multienzyme nature of YCC. In other biotin-dependent 
carboxylases, except eukaryotic ACC, BCCP is exclusively located at the end of 
a polypeptide chain and therefore only single-tethered. 
Although the active site cleft is partially occluded in Map LCC, this enzyme 
prefers long-chain acyl-CoA substrates although it is active towards acyl-CoA 
chains ranging from C2 to C16. Based on the active site architecture of the CT 
with its elongated substrate tunnel, the genomic synteny with an enzyme 
categorized as very-long-chain fatty acyl-CoA ligase, Dra YCC could act on long-
chain or very-long chain acyl-CoAs. In preliminary activity assays, however, no 
activity could be detected for Dra YCC towards fully-saturated linear C16/C18 
substrates. Possibly, Dra YCC is active on distinct specialized long-chain acyl 
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substrates, which were not included in the initial assays. It might be less 
promiscuous than Map LCC with higher specificity for a unique substrate specific 
to D. radiodurans or related species. Additional activity assays including D. 
radiodurans whole cell extract, will be performed in the future to further 
characterize this multienzyme. Whether the increased flexibility is linked to overall 
activity or specificity is currently not known. 
5.5! Dynamics of biotin-dependent carboxylase 
multienzymes 
As discussed in the previous three sections, yeast ACC and Dra YCC are 
characterized by distinct architectures, but share an outstanding extent of 
conformational dynamics. The only two acyl-CoA carboxylases with available 
structures, besides yeast ACC, Dra YCC and Map LCC, are the multi-subunit 
enzymes PCC and MCC58,59. A comparable degree of conformational variability 
cannot be detected in neither of the two, as both are rigid enzyme complexes 
with limited large-scale flexibility, with the exception of the mobile BCCP. This 
observation is based not only on the analysis of static crystal structures, but also 
using negative stain EM, which reveals a high-level of conformational 
homogeneity for PCC and MCC. Thus, based on the available data for acyl-CoA 
carboxylases, the dynamic architecture is a unique feature of multienzymes.  
More extensive structural data is available for biotin-dependent carboxylases 
acting on non-acyl-CoA substrates. In PC, a comparable conformational freedom 
has not been reported, although divergent overall architectures have been 
depicted. Staphylococcus aureus PC (SaPC) and human PC are symmetrical 
tetramers61, formed by dimerization of dimers, while PC from Rhizobium etli 
(RePC) exhibits an asymmetric architecture60, even though it is also built by a 
dimer of dimers (Figure 5.6). Initially, it was proposed that the distinct 
architectures might represent different states of the enzyme along the reaction 
coordinate, since RePC was crystallized in the presence of an activator, acetyl-
CoA. This hypothesis was falsified later by x-ray crystallographic and EM 
analyses revealing that SaPC retains its symmetric organization also when acetyl-
CoA is bound346, and that the overall shape of RePC is asymmetric also without 
bound activator347. Thus the architectural difference between these SaPC and 
RePC is not representing different states of one enzyme, but is rather a further 
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example for varying architectures encountered frequently in biotin-dependent 
carboxylases, even within families of closely related enzymes. 
 
 
Figure 5.6 Different overall architectures for prokaryotic PC.  
Surface representations of PC from Staphylococcus aureus (SaPC, pdb: 2QF7) and 
Rhizobium etli PC (RePC, pdb: 3G8C). SaPC is a symmetric tetramer, except for the 
mobile BCCP, with the same architecture of BC, BT and CT in the top and the bottom 
layer (one BCCP in ‘bottom’ layer not resolved in the electron density). RePC shows 
asymmetry between the top and the bottom layer, exemplified in the positioning of the PT 
domain. BCCP domains of RePC are only defined in the top layer. All coloring according 
to the sequence scheme. 
 
The UC component of urea amidolyase from K. lactis is, in contrast to all other 
biotin-dependent carboxylases, catalytically active as a monomer, and there is 
no evidence for large-scale movement of the domains relative to each other, 
except for the BCCP translocation57.  
In summary, divergent architectures are common in the family of prokaryotic 
multienzyme carboxylases, and further examples of this may still await. However, 
the dynamic architecture observed in yeast ACC and Dra YCC is unique amongst 
biotin-dependent carboxylases. It may well be linked to their unique multienzyme 
organization where all enzymatic subunits are integrated into a single type of 
polypeptide chain together with a double-tethered BCCP. In particular the carrier 
protein tethering may require additional conformational freedom to compensate 
for a more restricted range of BCCP mobility.  
5.6! Implications for carrier protein-dependent enzymes 
Extensive conformational flexibility is not a common feature of large or oligomeric 
enzyme systems. However, it has previously been observed in carrier protein-
dependent enzyme systems, such as the FAS and PKS multienzymes as well as 
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the giant multi-subunit PDC, and is now also confirmed for BCCP-dependent 
multienzyme acyl-CoA carboxylases. Previously, substrate transfer in carrier 
protein based enzyme systems has commonly been discussed only in terms of 
the mobility of the carrier protein. However, the cumulative data on the 
organization of carrier protein-dependent multienzymes now suggest an 
important role of large-scale conformational dynamics beyond the mobile carrier 
protein in substrate transfer and catalysis. 
 
 
Figure 5.7!Dynamics of carrier protein-dependent multienzymes.  
This figure is adapted and expanded from Figure 3.6. Transparent domains show the 
approximate range of motion of the domains. Arrows represent the possible domain 
movements. A. Schematic representation mammalian FAS with acyl-carrier protein, 
thioesterase domain and the linker tethering them the enzyme19 B. Schematic 
representation of the E. coli pyruvate dehydrogenase complex. Only three E3 subunits 
are shown for clarity. Distances according to Murphy et al20. C. Schematic representation 
of Dra YCC containing only one set of BC and BCCP. D. Schematic representation of the 
dimeric S. cerevisiae ACC demonstrating the large-scale movements between the 
elongated, inactive architecture and the triangular, active conformation. BT and CDL are 
not shown. The location where the regulatory loop can wedge between CDC1 and CDC2 is 
depicted with black dots in two instances of the CD. 
 
Mammalian FAS and the related PKS undergo large rotational and hinge-like 
conformational changes during catalysis in order for ACP to reach all active sites, 
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and coupling between conformational and catalytic states has been 
proposed26,348. Interestingly, fungal FAS adopts a completely different and rather 
rigid architecture, which relies on a rigid scaffolding matrix. This altered 
architecture goes hand-in-hand with a highly specialized and unique variant of 
the ACP carrier protein as well as a rigidified ACP linker structure19,349,350. 
Presumably, these specializations establish a highly optimized rotational path for 
ACP-based substrate delivery even in the rigid fungal FAS barrel structure349. The 
fact that two fundamentally different architectures, where one is highly flexible 
and the other one is rigid, emerged for the same multi-step reaction and using 
the same set of domains, is reminiscent of variations of architectures between 
multi-subunit and multienzyme carboxylases, which also differ in ACP tethering.  
The gigantic multi-subunit PDC employs a highly flexible and mobile architecture, 
with a rigid E2 core and flexibly tethered peripheral domains (E1, E3), with an 
allowed range of motion of approximately 150 $. During catalysis, the lipoyl 
domain shuttles between these tethered domains351.  
Conceptually, the organization of Dra YCC resembles those of PDC, with one or 
more carrier protein domains shuttling between a rigid, symmetric core and 
highly mobile peripheral domains, which may reside at a distance to the core of 
up to 130 $. In both, PDC and YCC, the large domain motions complement the 
mobility of the carrier protein. In PDC, however, the lipoyl domain carrier protein 
is only tethered on one side, N-terminally to the core-forming protein, and the 
flexible connection between the core and the peripheral units is provided by non-
covalent interactions of the linker with binding domains. 
The architecture of yeast ACC revealed in our and concomitant work however is 
truly unique: Yeast ACC employs a highly structured and functional 80 kDa CD 
linker region for connecting the BC-BCCP didomain to the dimeric CT core. 
Amongst the families of carrier protein-dependent multienzymes, the CD is by far 
the most complex linking region and comprises at least three distinct domains. 
Resolving multiple conformations of yeast ACC (fragments) at high-resolution 
additionally uncovers variable interactions within the CD and between the CD 
and catalytic domains in detail. These data indicate, that the CD is not used for a 
simple scaffolding-type positioning of catalytic domains, but has an active role in 
providing a series of flexible hinges governing large-scale movements that are 
linked to catalytic activity.  
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A comparison of high-resolution crystal structures of non-phosphorylated and 
authentically phosphorylated CD, demonstrates a unique regulatory mechanism 
of yeast ACC based on the restriction of hinge-bending motions in the CD. To 
our best knowledge, such a “mechanical” phosphorylation-based control 
mechanism has not been described for any other (carrier protein-based) 
multienzyme. However, the detailed role of confirmed phosphorylation sites in 
linker regions e.g. observed in animal FAS has not been uncovered so far. The 
current results on yeast ACC may thus well guide and inspire the search for novel 
linker-based regulatory mechanisms in animal FAS and other multienzymes.   
5.7! Prospects for synthetic biology 
Multienzymes are an attractive target for synthetic biology and combinatorial 
biosynthesis due to their numerous advantages over single enzymes, such as the 
prevention of side reactions, the stoichiometric presence and the common 
regulation of expression and activity. Researchers strive to engineer 
multienzymes in order to produce biologically active and relevant compounds. By 
swapping domains on a sequence level the outcome of the reaction catalyzed by 
the respective multienzyme can be altered. This was already successful, for 
example in the case of the PKS deoxyerythronolide B synthase, that was 
engineered to produce over 50 new unnatural compounds40. However, it is a 
difficult task since domain boundaries, domain interfaces and the dynamics of a 
system cannot be predicted with absolute certainty.  
Interdomain connectivity is yet another feature that can often not directly be 
derived from the sequence, as seen for MCC, PCC and Map LCC, where 
extensive domain swaps happen in the core CT region, possibly depending on 
the nature of the substrate58,59,86. In addition, in many biotin-dependent 
carboxylases, the carrier protein from one protomer serves the active sites of 
another protomer, explaining why these enzymes are only active as oligomers. 
For such an intricate and flexible network to work properly, it is crucial that all 
linkers are of the appropriate length and that domains are positioned in exactly 
the right way relative to each other. In some cases, the ‘simple’ swapping of 
whole domains may thus not be sufficient without considering domain 
interactions, inter-domain connectivity and orientation. 
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In light of the increasing number of atomic structures of full-length multienzymes 
it becomes evident that dynamic architecture and large-range conformational 
changes are an integral functional aspect of many of these enzyme complexes. In 
order to modify biosynthetic pathways, there is a requirement to not only 
engineer the domain arrangement, but to also engineer the correct dynamics, in 
order to ensure full functionality of a multienzyme complex. Such requirement for 
overall conformational changes in multienzymes with a large number of distinct 
functional domains, such as animal FAS and PKS, is obvious and has been 
documented. The current work now reveals that even in systems combining only 
two distinct catalytic activities, large-scale conformational dynamics are an 
inherent part of the catalytic process. Thus, even for the design of simple two-
step enzymatic systems based on carrier protein mediated substrate transfer, 
proper engineering of linking regions may be critical. Further detailed studies will 
be required to provide a more comprehensive description of the dynamics of 
linking regions, their interactions and conformational equilibria also in other 
multienzyme system.  
The architecture of yeast ACC CD provides an exciting paradigm for engineering 
linker-regions with dual functionality. Conformational switching based on post-
translational or chemical modification may be employed to control engineered 
enzymatic systems. Such linker-based mechanical control mechanisms enable a 
series of combinatorial control modes already in simple enzymatic systems, 
including (i) turning a two-enzyme system on or off (ii) uncoupling a two-enzyme 
system (iii) converting a three enzyme in a two-enzyme system (iv) switching 
between two synthetic routes in three-enzyme systems. Such control options 
open new prospects for combinatorial biosynthesis, which so far mostly relied on 
direct modification or swapping of catalytic domains, and may yield more 
versatile assemblies. Such novel engineered systems may ultimately contribute 
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